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In response to actual or anticipated stressors, the central nervous system elicits neural, 
neuroendocrine, and behavioral stress responses that facilitate survival and restoration of 
homeostatic balance. Caloric deficit attenuates many of these responses, including neural drive to 
the hypothalamic-pituitary-adrenal (HPA) axis, anxiety-like behavior, and stress-induced 
hypophagia. These alterations may represent an adaptive shift in stress responses during periods 
of negative energy balance, however, the neural mechanisms by which they occur remain 
unclear. Hindbrain glucagon-like peptide-1 (GLP-1) neurons and prolactin-releasing peptide-
positive noradrenergic A2 (PrRP+ A2) neurons are stress-sensitive and receive robust 
ingestive/metabolic information. Moreover, signaling from these populations contributes to each 
of the stress responses altered during fasting. Considering this, we hypothesized that the ability 
of caloric deficit to decrease anxiety-like behavior, stress hypophagia, and central drive to the 
HPA axis depends on reduced signaling from hindbrain GLP-1 and PrRP+ A2 neurons.  
In Chapter 2, we demonstrate that overnight fasting markedly reduces visceral stress-
induced cFos activation of GLP-1 neurons, A2 neurons, and forebrain neurons implicated in 
HPA axis drive. Furthermore, the results of Chapter 3 reveal that overnight fasting nearly 
eliminates cognitive stress-induced activation of GLP-1 and PrRP+ A2 neurons. Fasting also 
decreased anxiety-like behavior, in conjunction with attenuated cognitive stress-induced cFos 
expression within a limbic forebrain nucleus implicated in anxiogenesis and HPA axis activation. 
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Finally, using central administration of a GLP-1 receptor antagonist, we demonstrated that 
central GLP-1 signaling is critical for cognitive stress-induced hypophagia. Together, these 
findings document the metabolic tuning of stress-induced GLP-1 and PrRP+ A2 neural activation 
and implicate fasting-mediated reductions in activation of these neurons in the attenuation of 
behavioral stress responses. Considering this, we investigated the mechanisms by which fasting 
alters activation of GLP-1 and PrRP+ A2 neurons. Our results revealed that systemic ghrelin 
receptor antagonist administration partially rescued stress-induced activation of GLP-1 and 
PrRP+ A2 neurons in fasted rats. In sum, the results of this dissertation work support the 
hypothesis that metabolic tuning of hindbrain GLP-1 and PrRP+ A2 neurons is a mechanism 
through which caloric deficit decreases central drive to the HPA axis, promotes anxiolysis, and 
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1.0  INTRODUCTION 
1.1 HOMEOSTASIS, STRESS, AND CENTRAL NERVOUS SYSTEM-MEDIATED 
STRESS RESPONSES 
Despite marked variation in environmental conditions, the internal milieu of mammals is 
maintained in a state of dynamic equilibrium known as homeostasis. The maintenance of 
homeostasis is necessary for survival and well-being, as homeostatic regulation influences a 
number of critical physiological outcomes, such as body temperature, blood pressure, and blood 
glucose levels. Homeostasis is frequently challenged by internal and external forces, referred to 
as stressors, which can be as salient as an attack by a predator or as subtle as a drop in blood 
pressure when moving from a seated to standing position (Sapolsky, 2004). In response to 
stressors, the central nervous system (CNS) elicits a constellation of neural, neuroendocrine, and 
behavioral responses that facilitate immediate survival and eventual restoration of homeostatic 
balance. These stress responses provide an important means by which to adapt the physiological 
and neural state to the frequent homeostatic threats that pervade daily life. Hyperactivity of 
centrally-mediated stress responses (i.e., responses of increased duration and/or magnitude), 
however, has been linked to numerous neuropsychiatric, neurological, and physiological diseases 
and disorders, emphasizing the need to better understand how the brain coordinates responses to 
acute and chronic stress exposure (Chrousos, 2009). 
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Importantly, central stress responses are malleable, and can be modified and reorganized 
based on current physical state and/or prior experience (Bhatnagar and Dallman, 1998; Ma and 
Morilak, 2005; Zhang et al., 2010). Caloric deficit (i.e., periods of food restriction or 
deprivation) substantially attenuates many centrally-mediated responses to stress, including 
neural drive to the hypothalamic-pituitary-adrenal (HPA) axis (Hanson et al., 1994; Kiss et al., 
1994), anxiety-like behavior (Genn et al., 2003; Inoue et al., 2004), and stress-induced 
suppression of food intake (a.k.a., stress-induced hypophagia) (Lennie et al., 1995; Youngblood 
et al., 1997). It has been posited that this reorganization decreases the ability of stressors to 
reduce exploration, foraging behavior, and food intake during periods of negative energy 
balance, thus increasing the likelihood of finding food and repleting energy stores (Dallman et 
al., 1999; Genn et al., 2003). The mechanisms by which caloric deficit alters central stress 
responses, however, remain unclear. The overarching aim of the research presented within this 
dissertation is to establish foundational evidence that a brief period of complete food deprivation 
alters central stress responses by attenuating activation of stress-sensitive neurons residing in the 
hindbrain, providing insights into the mechanisms by which metabolic state elicits widespread 
reconfiguration of centrally-mediated stress responses. 
1.2 THE HYPOTHALAMIC-PITUITARY-ADRENAL (HPA) AXIS 
The HPA axis is the major neuroendocrine component of the stress response. The apex of the 
HPA axis lies within corticotropin-releasing hormone (CRH) neurons of the medial parvocellular 
paraventricular nucleus of the hypothalamus (mpPVN). Activation of these neurons causes CRH 
release into the hypophyseal portal system, which circulates CRH into the anterior pituitary 
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gland. Here, CRH acts at corticotropes to cause systemic release of adrenocorticotropic hormone 
(ACTH), which results in corticosterone (CORT) synthesis in the adrenal cortex (Chrousos, 
1998). CORT, a steroid hormone, then acts at glucocorticoid receptors (GRs) throughout the 
body. CORT has many adaptive effects that facilitate survival in the face of actual or anticipated 
environmental insults, of which energy mobilization is arguably the most important (Sapolsky et 
al., 2000). In conjunction with activation of the sympathetic nervous system (SNS), CORT 
facilitates muscular and hepatic glycogenolysis to mobilize energy substrates, while stimulating 
gluconeogenesis to maintain/elevate circulating glucose. Synthesis and mobilization of glucose is 
critical to fuel numerous energy-demanding stress responses, notably the skeletal muscle 
contractions integral for the “fight or flight” response. Concurrently, CORT functions to suppress 
energy expensive, long-term processes, such as immune system function and growth, shifting the 
allocation of resources to processes adaptive for immediate survival (Sapolsky, 2004). Activation 
of the HPA axis is regulated by a complex network of central circuits, all of which converge on 
hypophysiotropic neurons of the mpPVN (Ulrich-Lai and Herman, 2009), and major changes in 
the neuroendocrine response can be elicited by influencing individual or multiple components of 
these circuits. 
1.3 BEHAVIORAL STRESS RESPONSES 
In addition to the neural and physiological responses critical for survival following stress 
exposure, threatening and stressful stimuli elicit a number of adaptive behavioral responses. In 
rodents, behavioral responses to stress can be characterized generally by inhibition. Exploration 
and food intake represent a substantial contribution to the rodent behavioral repertoire, and each 
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is adaptive when considered in the context of maintaining internal energy and nutrient 
availability. Following stress exposure, however, these responses can each be considered 
maladaptive: exploration of novel environments may increase the likelihood of predation, while 
food intake initiates the energetically-expensive process of digestion, diverting energy resources 
away from functions with more immediate value. Thus, it is not surprising that a wide range of 
stressors cause increased behavioral anxiety and decreased food intake (i.e., hypophagia). 
1.3.1 Anxiety-like behavior 
In rodents, anxiety is characterized by behavioral avoidance, hyper-vigilance, and increased 
attention, which depend on the output of widely distributed neural circuits (Walker et al., 2003). 
An accumulated literature has implicated the bed nucleus of the stria terminalis (BST) and the 
central nucleus of the amygdala (CeA), collectively referred to as the “central extended 
amygdala,” in the coordination of these responses. The CeA and BST receive neural input from 
the cortex, hippocampus, brainstem, and other amygdalar subnuclei (e.g., the basolateral 
amygdala) that process stimuli associated with stress and fear (Bienkowski and Rinaman, 2013). 
In turn, the BST and CeA convey this information to widespread target areas that mediate 
individual components of the anxiety state (Dong et al., 2001; Walker et al., 2003). This 
connectivity optimally positions the BST and CeA to integrate diverse information regarding 
stressful/anxiogenic stimuli and produce behavioral responses to both internal and external 
threats.  
Behavioral and pharmacological studies substantiate the role of the central extended 
amygdala in anxiety-like behavior, as lesions or pharmacological inactivation of the CeA or BST 
produce anxiolytic effects, as measured by behavioral avoidance or freezing/startle responses 
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(Sullivan et al., 2004; Waddell et al., 2006; Sajdyk et al., 2008; Ventura-Silva et al., 2013). Work 
by Davis and colleagues suggests that the CeA is critical for eliciting short-lasting, stimulus-
specific responses to conditioned threat cues (i.e., fear responses), while neurons of the BST are 
critical for eliciting sustained behavioral responses to innate, unconditioned threatening stimuli, 
such as those to open spaces, bright light, and predator odor (i.e., anxiety responses) (Lee and 
Davis, 1997; Walker and Davis, 1997; Fendt et al., 2003; Walker et al., 2003). Thus, by 
modulating neural activity in the BST, it is possible to modify the behavioral responses 
associated with a sustained state of anxiety. 
1.3.2 Suppression of food intake 
Suppression of food intake is a well-documented response to a wide array of acute stressors 
(Uehara et al., 1989; Rybkin et al., 1997; Liu et al., 2007; Calvez et al., 2011; Maniam and 
Morris, 2012); however, the neural mechanisms by which this phenomenon occurs are not 
entirely clear. While stress-induced suppression of food intake (i.e., stress hypophagia) can be 
broadly considered as a decrease in food intake over time, factors that change intake may do so 
by altering meal size, meal frequency, or both (Smith, 1998; Smith, 2000), and an understanding 
of the way in which stress decreases food intake can provide important information regarding the 
neural mechanisms likely to be involved. Diverse stressors, such as restraint, forced swimming, 
and (LiCl) chloride administration, elicit hypophagia via decreases in meal size (Dess and 
Vanderweele, 1994; Calvez et al., 2011). As satiation – the process that determines meal size – is 
a brainstem-mediated phenomenon (Grill and Norgren, 1978; Seeley et al., 1994; Grill and 
Kaplan, 2002; Grill, 2010), it is likely that stress-induced hypophagia results from influence on 
brainstem circuits responsible for satiation.  
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Following food intake, the hormonal and mechanical indices of nutrient and caloric 
presence in the gut are transmitted to the caudal (“visceral”) nucleus of the solitary tract (cNTS) 
predominantly via direct inputs from vagal afferent sensory neurons (Rinaman, 2007). In the 
cNTS, glutamatergic vagal afferent signaling produces tightly synced, large-amplitude excitatory 
postsynaptic currents, providing high-fidelity transmission of sensory nerve activity (Appleyard 
et al., 2007). Activation of cNTS neurons then restricts meal size via regulation of pre-oral motor 
neurons within the brainstem parvocellular and intermediate reticular formation (Nasse et al., 
2008). These reticular neurons maintain efferent synaptic connections with motor neurons 
innervating muscles of the tongue (Travers and Rinaman, 2002; Travers et al., 2005) and other 
orofacial targets to directly control the motor patterns leading to ingestion or rejection of oral 
contents (Chen et al., 2001), thus determining meal size. In essence, these brainstem neurons 
produce a complex reflex arc by which ingestion of a meal provides feedback to the motor 
neurons responsible for the process of food intake.  
Although neural processing within the brainstem is sufficient for satiation (Grill and 
Smith, 1988), direct descending projections from the cortex, limbic forebrain, and hypothalamus 
to the cNTS provide a route through which emotional and cognitive events can modulate 
initiation or avoidance of feeding and other responses to diverse threats, including conditioned 
responses that are based on past experience (Li et al., 1996; Li and Sawchenko, 1998; Woods 
and Ramsay, 2000; Dayas and Day, 2001; Taché et al., 2001; Buller et al., 2003; Dayas et al., 
2004; Blevins and Baskin, 2010; Grill and Hayes, 2012). Considered together, it appears likely 




1.4 VISCERAL AND COGNITIVE STRESSORS 
HPA axis activation, anxiety-like behavior, and hypophagia are consistent responses to a wide 
array of stressors. The neural circuits by which these responses are elicited, however, vary 
considerably based on the stimulus attributes of the stressor (Herman and Cullinan, 1997), which 
has led to the categorization of stressors into visceral and cognitive categories. 
1.4.1 Visceral stressors 
Visceral (a.k.a. interoceptive or systemic) stressors represent a class of stimuli that have already 
disrupted homeostasis (e.g., infection, hemorrhage, hypoxia) and present an immediate threat to 
survival. Visceral stressors originate within the body and signals from stressful visceral stimuli 
are conveyed to the cNTS via direct or indirect sensory input. Predominant sources of cNTS 
sensory input arise from spinal afferents, area postrema (AP) sensory neurons, and the vagus and 
glossopharyngeal cranial nerves, which ramify throughout a majority of peripheral structures 
(Rinaman, 2007). These inputs are responsive to signals of visceral stress and their axons 
converge onto cNTS neurons that are positioned to 1) suppress food intake, via influence over 
brainstem reticular neurons (Grill et al., 2004), 2) to activate the HPA axis, via direct innervation 
of the mpPVN (Rinaman, 2010), and 3) to elicit behavioral anxiety, via dense projections to the 
BST (Banihashemi and Rinaman, 2006). Thus, adaptive neuroendocrine and behavioral anxiety 
responses to visceral stressors are contingent upon signaling between afferent sensory inputs, the 
cNTS, and the forebrain, while visceral stress-induced hypophagia can be mediated by cNTS 











Figure 1. Schematic representation of selected stress-sensitive neural circuits and their putative relationships 
with behavioral and neuroendocrine stress responses.  
cNTS, caudal nucleus of the solitary tract; GLP-1, glucagon-like peptide-1; PrRP+ A2, prolactin-releasing peptide-
positive noradrenergic A2; mpPVN, medial parvocellular paraventricular nucleus of the hypothalamus. Note: 
“limbic forebrain” includes the bed nucleus of the stria terminalis and the central nucleus of the amygdala. 
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1.4.2 Cognitive stressors 
Cognitive (a.k.a. psychogenic or processive) stressors represent a class of stimuli that have not 
yet produced an actual physical challenge, but rather indicate imminent disruption of 
homeostasis based on instinctual or learned processes (e.g., the odor of a predator, isolation in a 
threatening environment, a tone that has been previously paired with an electrical shock). 
Complex and anticipatory in nature, responses to cognitive stressors require neural processing by 
regions responsible for integration of multiple sensory modalities (e.g., the cortex and thalamus), 
executive function (e.g. the medial prefrontal cortex), and memory (e.g. the hippocampus) before 
eliciting changes in neuroendocrine, autonomic, or behavioral output (Jankord and Herman, 
2008; Ulrich-Lai and Herman, 2009), largely via relays in the medial and baslolateral amygdalar 
subnuclei (Figure 1) (Dunn and Whitener, 1986; Cullinan et al., 1995; Dayas et al., 1999; 
LeDoux, 2000; Dayas et al., 2001b). Cognitive stressors also activate neurons within the cNTS, 
in part through descending projections from the PVN (Dayas and Day, 2001; Dayas et al., 2004), 
and we propose that these descending projections underlie the ability of cognitive stressors to 
suppress food intake. Interestingly, neuroendocrine responses to cognitive stressors require 
recruitment of mpPVN-projecting cNTS neurons (Kinzig et al., 2003), placing this nucleus in a 
position to influence both visceral and cognitive stress responses (Figure 1). 
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1.5 CALORIC DEFICIT ALTERS STRESS RESPONSES 
In rodents, periods of food restriction or fasting (i.e., caloric deficit) substantially attenuate 
neurally-mediated stress responses. Chronic food restriction for a period of days to weeks, in 
which daily caloric intake is limited to reduce body weight to a defined degree, consistently 
decreases behavioral measures of anxiety in rodents (Heiderstadt et al., 2000; Genn et al., 2003; 
Levay et al., 2007). Interestingly, the anxiolytic effect of caloric deficit can be observed 
following a single day of restricted access to food (Inoue et al., 2004), suggesting that the 
neurophysiological changes mediating this shift in behavior occur rapidly. Similar effects of 
caloric restriction on stress-induced suppression of food intake have been observed. Chronic 
caloric restriction prevents restraint stress, a robustly hypophagic cognitive stressor in ad libitum 
(ad lib)-fed rats (Krahn et al., 1986), from decreasing food intake (Youngblood et al., 1997). 
Caloric deficit is also sufficient to decrease hypophagic responses to an acute inflammatory 
event (Lennie et al., 1995) or cholecystokinin treatment (McMinn et al., 2000), indicating that 
caloric deficit reduces the ability of both cognitive and visceral stressors to suppress food intake. 
 Consistent with these findings, chronic caloric restriction, prolonged periods of complete 
fasting (2-4 days), or a single overnight fast attenuate central drive to the HPA axis, as evidenced 
by decreased mpPVN CRH mRNA expression (Brady et al., 1990; Kiss et al., 1994), decreased 
baseline mpPVN cFos activation (Dallman et al., 1999), and decreased plasma ACTH 
concentrations at baseline and in response to restraint stress (Akana et al., 1994; Hanson et al., 
1994; Chacon et al., 2005). Paradoxically, caloric deficit increases basal and restraint stress-
induced plasma CORT levels in these same animals (Akana et al., 1994; Chacon et al., 2005), 
evidence that fasting “uncouples” neurally-mediated behavioral stress responses (i.e., anxiety 
and hypophagia) and ACTH release from adrenocortical CORT responses.  
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It is posited that the benefits of this uncoupling are three-fold. First, since central CRH 
signaling has potent anorexigenic effects (Rothwell, 1990) and contributes to hypophagic 
responses to stress exposure (Krahn et al., 1986), downregulating central CRH signaling may 
attenuate stress hypophagia, limiting the ability of stress to suppress food intake during periods 
of negative energy balance. Second, as CORT signaling stimulates glycogenolysis, energy 
substrate mobilization, and gluconeogenesis, increased circulating CORT concentrations during 
fasting may facilitate energy mobilization to support glucose-dependent processes, despite 
negative energy balance (Dallman et al., 1999). Third, attenuated anxiety may promote foraging 
in threatening environments, increasing the likelihood of encountering food. Together, these 
alterations represent an adaptive reorganization of stress responses during caloric deficit, catering 
the response to the animal’s current metabolic state; however the neural mechanisms by which 
this shift occurs remain unclear.  
We hypothesize that the ability of caloric deficit to decrease stress hypophagia, anxiety-
like behavior, and central drive to the HPA axis depends on reduced signaling from prolactin-
releasing peptide (PrRP)-positive noradrenergic (NA) A2 neurons (PrRP+ A2 neurons) and 
glucagon-like peptide-1 (GLP-1)-positive neurons in the cNTS and medullary reticular 
formation. These neural populations are stress-sensitive, responsive to changes in the 
interoceptive environment, and have been implicated anatomically and functionally in HPA axis 
activation, anxiety-like behavior, and stress hypophagia. 
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1.6 STRESS RESPONSIVE HINDBRAIN NEURONS 
1.6.1 PrRP+ A2 neurons & hindbrain GLP-1 neurons: Anatomy & stress-sensitivity 
The A2 cell group is composed of NA neurons that are located entirely within the NTS, and 
predominantly within the medial and commissural NTS subnuclei. The A2 cell group extends 
from the upper cervical spinal cord to just rostral to the AP at the level of the caudal fourth 
ventricle (Rinaman, 2011). These neurons can be identified by immunolabeling for tyrosine 
hydroxylase (TH), the rate-limiting enzyme for dopamine synthesis, as well as dopamine-β-
hydroxylase (DβH), the enzyme responsible for conversion of dopamine to norepinephrine (NE). 
A majority of A2 neurons co-localize PrRP (Roland et al., 1999; Maruyama et al., 2001), a 
neuropeptide originally named for its stimulatory effect on prolactin release from the anterior 
pituitary in vitro (Hinuma et al., 1998). More recent studies indicate that PrRP+ A2 neurons do 
not have access to prolactin cells of the anterior pituitary (Morales et al., 2000) and PrRP 
signaling does not alter prolactin release in vivo (Taylor and Samson, 2001). 
GLP-1 neurons reside within both the cNTS and subjacent reticular formation (Larsen et 
al., 1997b; Rinaman, 1999b, 2003a), extending from the upper cervical spinal cord to the caudal 
level of the AP (Vrang and Larsen, 2010). Despite the largely overlapping hindbrain distribution 
of A2 neurons and GLP-1 neurons, the latter are a completely distinct population of non-
adrenergic neurons that expresses mRNA for preproglucagon (PPG), the protein precursor of 
GLP-1 (Figure 20). Within the brain, PPG mRNA expression is limited to the olfactory bulb, the 
cNTS, and the caudal medullary reticular formation (Larsen et al., 1997b; Merchenthaler et al., 
1999). Since PPG-expressing neurons within the olfactory bulb are interneurons with very short 
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axons, GLP-1 fibers and terminals throughout the rest of the CNS can be assumed to originate 
from PPG-expressing hindbrain neurons. 
The cNTS is considered the “visceral” NTS, distinct from the more rostral “gustatory” 
NST (Lundy-Jr. and Norgren, 2004), and is a key component of the dorsal vagal complex 
(DVC), which also includes the AP and dorsal motor nucleus of the vagus. The DVC is a critical 
central node for relaying interoceptive visceral, hormonal, and somatic feedback from body to 
brain, and regulating glucose homeostasis and other aspects of energy balance (Zagon et al., 
1999; Berthoud et al., 2006; Rinaman, 2007; Grill and Hayes, 2009; Rinaman, 2010; Zhang et 
al., 2010; Rinaman, 2011; Grill and Hayes, 2012). The AP and a significant portion of the 
subjacent cNTS contain fenestrated capillaries, and AP neurons innervate the cNTS (Shapiro and 
Miselis, 1985a; Kachidian and Pickel, 1993; Cunningham-Jr. et al., 1994), allowing bloodborne 
factors to affect neurons in this region (Yamamoto et al., 2003). Sensitivity to circulating factors, 
in addition to robust spinal and cranial nerve afferent innervation (Sections 1.3.2 & 1.4.1), 
positions the cNTS to integrate multimodal input regarding metabolic state and to monitor 
changes in the internal environment.  
Numerous studies show that cNTS PrRP+ A2 and GLP-1 neurons are activated by a broad 
array of visceral stressors, including: hemorrhage (Morales and Sawchenko, 2003; Uchida et al., 
2010), high doses of cholecystokinin-8 (CCK) (Rinaman, 1999b; Lawrence et al., 2002), 
lipopolysaccharide (LPS) (Mera et al., 2006), lithium chloride (Rinaman, 1999b), and 
interleukin-1 (Li et al., 1996; Sawchenko et al., 2000). Notably, PrRP+ A2 neurons are also 
activated by cognitive stressors, including: restraint (Dayas et al., 2001b; Maruyama et al., 2001; 
Banihashemi et al., 2011), footshock (Li et al., 1996; Morales and Sawchenko, 2003), predator 
odor (Day et al., 2004), and conditioned fear cues (Zhu and Onaka, 2003). Activation of cNTS 
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neurons by cognitive stressors is likely a result of descending projections from limbic and 
hypothalamic forebrain regions (Section 1.4.2; Figure 1). However, despite pharmacological 
evidence that GLP-1 receptor signaling is critical for neuroendocrine and behavioral responses to 
cognitive stressors (Kinzig et al., 2003), no study has histologically demonstrated activation of 
GLP-1 neurons by cognitive stress. 
In these cited studies and many others, including those in Chapters 2-4, stimulus-induced 
“activation” of NA, PrRP, and/or GLP-1 neurons is generally characterized by double 
immunolabeling to localize nuclear cFos, the protein product of the immediate-early response 
gene, cfos, together with cytoplasmic proteins identifying the chemical phenotype of activated 
neurons. As a binary index of neural activation, the visible presence or absence of cFos 
immunolabeling in a given neuron poorly reflects the degree to which the neuron has been 
activated, and provides no information about that neuron’s spike frequency. However, 
quantitative and regional analyses of neural cFos expression permit assessment of stimulus-
induced activation across multiple populations of phenotypically identified neurons under control 
and experimental conditions, making it an ideal approach for testing hypotheses regarding neural 
sensitivity and/or function. As demonstrated above, the collective results of studies utilizing cFos 
indicate that GLP-1 and PrRP+ A2 neurons are consistently activated by stimuli that present 
actual or anticipated threats to bodily homeostasis. 
As reviewed above, hindbrain GLP-1 neurons and PrRP+ A2 neurons receive broad 
sensory information regarding interoceptive state, and these populations are recruited by both 
visceral and cognitive stressors. Considering this, these neurons are optimally positioned to 
integrate information regarding metabolic state into neurally-mediated stress responses. 
Importantly, anatomical and functional evidence clearly demonstrate the capability of these 
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neurons to activate the HPA axis, elicit anxiety-like behavior, and produce stress-induced 
hypophagia. 
1.6.2 PrRP+ A2 & GLP-1 neurons activate the HPA axis 
A2 NA and PrRP+ neurons influence the HPA axis directly (Plotsky, 1987), as indicated by 
dense terminal arborizations within the mpPVN (Cunningham-Jr. and Sawchenko, 1988; 
Morales et al., 2000; Rinaman, 2010), asymmetric synapses between catecholaminergic 
terminals and CRH-positive neurons (Liposits et al., 1986b), and the presence of postsynaptic 
NA and PrRP receptors (Day et al., 1999; Roland et al., 1999). Functional evidence bolsters 
these anatomical findings, as NE increases excitatory postsynaptic potential frequency in the 
mpPVN, in part by enhancing glutamate signaling (Daftary et al., 2000), and the presence of NE 
or PrRP drives mpPVN cellular activity, stimulates CRH synthesis and release, and elevates 
plasma ACTH and CORT levels (Plotsky, 1987; Itoi et al., 1999; Helmreich et al., 2001; Cole 
and Sawchenko, 2002; Seal et al., 2002; Itoi et al., 2004; Mera et al., 2006). Furthermore, HPA 
axis activation is enhanced by co-administration of NE and PrRP (Maruyama et al., 2001), 
suggesting that these transmitters act in concert to increase hypothalamic outflow. Indeed, 
stimulation of A2 neurons (Day et al., 1985) or their ascending fiber tract (Plotsky, 1987) is 
sufficient to drive mpPVN activity and CRH secretion, while selective lesions of A2 NA 
projections to the mpPVN result in a substantial loss of neuroendocrine response to visceral 
stressors (Schiltz and Sawchenko, 2007; Bienkowski and Rinaman, 2008).  
Hindbrain GLP-1 neurons are also poised to directly influence HPA axis activity, as these 
neurons densely innervate the mpPVN (Larsen et al., 1997b; Rinaman, 1999b, 2007; Tauchi et 
al., 2008) – which expresses GLP-1 receptors (Merchenthaler et al., 1999) – and synapse directly 
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onto CRH neurons (Sarkar et al., 2003a). GLP-1 signaling has strong excitatory effects on neural 
drive of the HPA axis, as in vitro recordings show that GLP-1 signaling increases the spike 
frequency of neurons in the PVN via facilitation of presynaptic glutamate release (Acuna-
Goycolea and Pol, 2004). Furthermore, central administration of GLP-1 elicits cFos activation in 
mpPVN CRH neurons, subsequently elevating plasma ACTH and CORT (Larsen et al., 1997a; 
Kinzig et al., 2003). Recent findings from our lab indicate that GLP-1 soma (within the cNTS) 
and terminal arbors within the mpPVN co-localize vesicular glutamate transporter 2 (vGlut2) 
(Zheng & Rinaman, submitted), evidence that GLP-1 neurons are glutamatergic, and suggesting 
that activation of cNTS GLP-1 neurons can directly drive postsynaptic spiking via glutamate 
release. Together, this evidence strongly supports a role for PrRP+ A2 neurons and hindbrain 
GLP-1 neurons in generating neuroendocrine stress responses. 
1.6.3 NA/PrRP & GLP-1 signaling elicit anxiety-like behavior 
Signaling from hindbrain GLP-1 neurons and PrRP+ A2 neurons can elicit anxiety-like behavior 
via receptor activation within numerous midbrain and forebrain regions, including the 
ventrolateral (vl)BST and CeA, two highly interconnected nuclei responsible for the coordination 
of behavioral anxiety responses (Section 1.3.1). The vlBST gets particularly dense input from 
medullary NA and PrRP neurons (Forray et al., 2000; Banihashemi and Rinaman, 2006) (Figure 
9), resulting in the highest concentrations of NE in the entire brain (Kilts and Anderson, 1986). 
Moreover, immobilization stress results in substantial increases in NE release within the vlBST, 
while pharmacological antagonism of NA receptors within this region decrease stress-induced 
anxiety-like behavior (Cecchi et al., 2002). Furthermore, selective lesion of NA innervation of 
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the vlBST (likely including PrRP+ A2 neurons) prevents systemic yohimbine, an α2 adrenergic 
receptor antagonist, from increasing anxiety-like behavior (Zheng and Rinaman, 2013).  
Both the CeA and vlBST receive axonal input from hindbrain GLP-1 neurons (Goke et 
al., 1995; Rinaman, 2010), providing a route through which GLP-1 neuronal activation can 
influence anxiety-like behavior. Indeed, anxiogenic behavioral outcomes can be attributed to 
forebrain GLP-1 signaling, since antagonism of central GLP-1 receptors decreases anxiety-like 
behavior, and GLP-1 injections directly into the CeA are sufficient to increase behavioral anxiety 
(Kinzig et al., 2003). Despite the presence of GLP-1 terminals within the vlBST (Rinaman, 
2010), the contribution of vlBST GLP-1 signaling to anxiety-like behavior has not been 
determined. Together, these studies indicate that ascending projections from PrRP+ A2 and GLP-
1 neurons to the central extended amygdala contribute to anxiety-like behavior.  
1.6.4 Signaling from hindbrain PrRP+ A2 & GLP-1 neurons contribute to stress-induced 
hypophagia  
A2 NA/PrRP+ neurons are activated by stimuli that produce hypophagia, such as 
cognitive/visceral stressors (Section 1.6.1) and intake of a meal (Rinaman et al., 1998; 
Takayanagi et al., 2008). The strongest evidence that, once activated, these neurons play a causal 
role in stress-induced hypophagia comes from studies using a DβH-conjugated saporin toxin, 
which selectively lesions NA neurons. Selective lesions of A2 neurons (presumably including 
the PrRP+ subset) result in reduction of visceral stress-induced hypophagia, and the degree to 
which food intake is suppressed is directly related to the degree of A2 neuron loss (Rinaman, 
2003a; Rinaman and Dzmura, 2007). These studies, however, cannot differentiate the effects of 
functional loss of NE signaling from loss of PrRP signaling. Interestingly, DβH knockout mice – 
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which lack NE – continue to display hypophagic responses to visceral stress (Cannon and 
Palmiter, 2003). In these rodents, NA neurons are not lesioned and maintain the ability to 
synthesize and release PrRP, suggesting that PrRP signaling may be sufficient for stress-induced 
hypophagia. In support of this, central administration of PrRP reduces food intake (Lawrence et 
al., 2000; Lawrence et al., 2002), while knockout of PrRP (Takayanagi et al., 2008) or its 
receptor (Gu et al., 2004) results in hyperphagia. Lastly, varicose axons of NA and PrRP neurons 
can be found in the brainstem reticular formation (Yano et al., 2001), providing an anatomical 
route by which to influence meal size (Section 1.3.2) 
GLP-1 neurons are also activated by stimuli that inhibit feeding (Rinaman, 1999b; 
Kreisler et al., 2014), and due to the development of selective and efficacious GLP-1 analogues 
and receptor antagonists, an abundance of pharmacological evidence supports the role of GLP-1 
signaling in stress-induced hypophagia. First, lateral ventricular administration of GLP-1 
suppresses food intake (Tang-Christensen et al., 1996; Turton et al., 1996; Rinaman, 1999a), an 
effect that is recapitulated with 4th ventricular GLP-1 administration in both intact and chronic 
supracollicular decerebrate rats (Kinzig et al., 2002; Hayes et al., 2008), indicating that GLP-1 
signaling within the brainstem is sufficient to suppress food intake. While beneficial, 
pharmacological manipulations utilizing administration of agonist have limited physiological 
relevance, and much stronger evidence comes from studies blocking endogenous function using 
selective antagonists. When GLP-1 receptor antagonists are administered into the 4th ventricle or 
directly into the cNTS, rats indeed increase food intake (Hayes et al., 2009). Additionally, results 
from a study utilizing viral-mediated RNAi knockdown of GLP-1 in the NTS indicate that GLP-
1 signaling is critical for regulation of food intake over a period of weeks (Barrera et al., 2011). 
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Together, these results show that GLP-1 signaling in the caudal brainstem is sufficient to 
suppress food intake.  
The necessity of GLP-1 signaling for visceral stress-hypophagia has been demonstrated, 
as i.c.v. administration of GLP-1 receptor antagonist dose-dependently attenuates LiCl-induced 
hypophagia (Rinaman, 1999a; Seeley et al., 2000), and 4th i.c.v. antagonist administration 
diminishes suppression of food intake following peripheral LPS (Grill et al., 2004). As varicose 
axons of GLP-1 neurons are found in the reticular formation and other brainstem sites known to 
control oromotor outflow (e.g., the pontine parabrachial nucleus) (Rinaman, 2010; Llewellyn-
Smith et al., 2011), it is likely that GLP-1 signaling suppresses food intake via modulation of 
pre-motor brainstem circuits. No studies, however, have assessed whether GLP-1 signaling is 
critical for hypophagic responses to cognitive stressors. Together, these findings indicate that 
PrRP+ A2 neurons and GLP-1 neurons play a critical role in visceral stress-induced hypophagia 
and are well positioned to mediate hypophagic responses to cognitive stressors as well.  
1.7 HOW DOES FASTING ALTER CENTRALLY MEDIATED STRESS 
RESPONSES? 
In response to actual or anticipated homeostatic stressors, the CNS elicits a constellation of 
neural, neuroendocrine, and behavioral stress responses that facilitate immediate survival and 
eventual restoration of homeostatic balance. A growing body of literature indicates that periods 
of caloric deficit attenuate many of these responses, including neural drive to the HPA axis, 
anxiety-like behavior, and stress-induced hypophagia. It is believed that these alterations 
represent an adaptive shift in stress responses during periods of negative energy balance, catering 
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stress responses to the animal’s current metabolic state; however, the neural mechanisms by 
which this occurs remain unclear. Hindbrain GLP-1 and PrRP+ A2 neurons are stress-sensitive 
and receive robust ingestive/metabolic information. Moreover, signaling from these populations 
of neurons contributes to each of the stress responses altered in the fasted state. Considering this, 
we proposed that the ability of caloric deficit to decrease stress hypophagia, central drive to the 
HPA axis, and anxiety-like behavior depends on reduced signaling from hindbrain GLP-1 and 
PrRP+ A2 neurons. My dissertation project, comprised of the studies that follow, was designed to 
address various components of this overarching hypothesis.  
In Chapter 2 we hypothesized that overnight food deprivation would attenuate the ability 
of supraphysiological doses of cholecystokinin-8 (CCK), a visceral stressor, to activate cFos 
within NA A2 neurons and hindbrain GLP-1 neurons. We further hypothesized that this would 
occur in conjunction with attenuation of neural activation in the mpPVN, indicative of reduced 
neural drive to the HPA axis. Our results indicate that, indeed, fasting substantially attenuated 
activation of brainstem A2/GLP-1 neurons and mildly reduced mpPVN activation.  
Therefore, in Chapter 3 we hypothesized that cognitive stressors (i.e., restraint and 
elevated platform exposure) would activate GLP-1 and PrRP+ A2 neurons in ad libitum-fed rats, 
and that fasting would attenuate this response. Furthermore, we proposed that fasting would 
reduce neural activation in the mpPVN and vlBST – forebrain regions implicated in HPA axis 
activation and behavioral anxiety, with a concomitant decrease in anxiety-like behavior. Finally, 
we utilized central pharmacological antagonism of GLP-1 receptors to empirically test the role of 
GLP-1 signaling in cognitive stress-induced hypophagia. We found that cognitive stressors 
robustly activated cFos within both GLP-1 and PrRP+ A2 neurons, and this activation was nearly 
eliminated following an overnight fast. A similar reduction in stress-induced activation of the 
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vlBST was observed following fasting in conjunction with reduced anxiety-like behavior. Lastly, 
central antagonism of GLP-1 receptor signaling abolished cognitive stress-induced hypophagia. 
Considering the marked ability of fasting to reduce both visceral and cognitive stress-
induced activation of hindbrain neurons, we investigated the mechanisms by which metabolic 
state might attenuate activation of GLP-1 and PrRP+ A2 neurons. Thus, in Chapter 4, we 
hypothesized that exogenous leptin administration and/or antagonism of ghrelin receptors in 
fasted rats would rescue the ability of systemic CCK to activate hindbrain GLP-1 and PrRP+ A2 
neurons. Our results indicate that ghrelin receptor antagonism – but not leptin administration – 
partially rescued activation of both GLP-1 and PrRP+ A2 neurons in response to CCK. 
Taken together, the results of my dissertation work demonstrate significant metabolic 
tuning of neural, behavioral, and neuroendocrine responses to visceral and cognitive stressors. It 
is not yet clear, however, whether fasting-mediated reductions in activation of brainstem neurons 
cause the attenuations observed in forebrain neural activation and anxiety-like behavior, leaving 
the door open for future investigation. 
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2.0  OVERNIGHT FOOD DEPRIVATION MARKEDLY ATTENUATES 
HINDBRAIN NORADRENERGIC, GLUCAGON-LIKE PEPTIDE-1, AND 
HYPOTHALAMIC NEURAL RESPONSES TO EXOGENOUS CHOLECYSTOKININ 
IN MALE RATS1 
2.1 INTRODUCTION 
It is well established that moderate to high systemic doses (i.e., > 3 μg/kg BW) of 
cholecystokinin-8 (CCK) suppress food intake (Gibbs et al., 1973; Gibbs and Smith, 1977) and 
activate hypothalamic endocrine neurons (Parrott et al., 1991; Verbalis et al., 1991; Katsuura et 
al., 1992; Chen et al., 1993).  These behavioral and endocrine responses are critically dependent 
on CCK-A receptor-mediated activation of vagal sensory neurons that provide glutamatergic 
axonal input to the caudal nucleus of the solitary tract (NTS) (Smith et al., 1981; Raybould et al., 
1985; Smith et al., 1985; Raybould et al., 1988; Moran et al., 1990; Kamilaris et al., 1992; Corp 
et al., 1993; Schwartz et al., 1994; Monnikes et al., 1997; Zittel et al., 1999; Sutton et al., 2004; 
Appleyard et al., 2007; Ritter, 2011). While neural circuits contained within the brainstem are 
                                                 
1 The entirety of the work presented in Chapter 2 is from “Overnight food deprivation markedly 
attenuates hindbrain noradrenergic, glucagon-like peptide-1, and hypothalamic neural responses 
to exogenous cholecystokinin in male rats,” by J.W. Maniscalco and L. Rinaman, 2013, 




sufficient for the hypophagic effects of CCK (Grill and Smith, 1988), the ability of CCK to 
recruit hypothalamic endocrine neurons requires ascending projections from the NTS to the 
hypothalamus (Rinaman, 2003a). 
A large variety of neurotransmitter molecules are expressed by neurons within the caudal 
NTS (Rinaman, 2011). Subsets of these NTS neurons directly modulate the neuroendocrine 
hypothalamic-pituitary-adrenal (HPA) axis via axonal projections to the medial parvocellular 
paraventricular nucleus of the hypothalamus (mpPVN) (Rinaman, 2007, 2011). Most of these 
projections arise from two phenotypically distinct populations of NTS neurons: noradrenergic 
(NA) neurons of the A2 cell group, and glucagon-like peptide-1 (GLP-1) neurons (Plotsky, 1987; 
Plotsky et al., 1989; Larsen et al., 1997b; Larsen et al., 1997a; Kinzig et al., 2003; Bienkowski 
and Rinaman, 2008). A2 and GLP-1 neurons densely innervate the mpPVN (Cunningham-Jr. and 
Sawchenko, 1988; Larsen et al., 1997b; Rinaman, 1999b; Tauchi et al., 2008), synapsing directly 
onto corticotropin-releasing hormone (CRH)-positive neurons at the apex of the HPA axis 
(Liposits et al., 1986b; Sarkar et al., 2003a). Furthermore, intraventricular and local parenchymal 
injections of either GLP-1 or norepinephrine (NE) induce cFos expression within the mpPVN 
and increase plasma levels of corticosterone (CORT) (Larsen et al., 1997a; Cole and Sawchenko, 
2002; Kinzig et al., 2003). Accumulated evidence suggests that CCK-induced activation of A2 
and GLP-1 neurons underlies the ability of CCK to activate the HPA axis and generate other 
neuroendocrine responses (Kendrick et al., 1991; Verbalis et al., 1991; Rinaman et al., 1995; 
Verbalis et al., 1995; Rinaman, 1999b; Babic et al., 2009).  Several published studies have 
reported dose-response relationships for the ability of systemic CCK to inhibit food intake 
(Gibbs et al., 1973; Moran et al., 1997), increase NTS cFos expression (Monnikes et al., 1997; 
Zittel et al., 1999; Babic et al., 2009), and activate the HPA axis (Verbalis et al., 1991; Kamilaris 
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et al., 1992). However, none of these reports included phenotypic identification of the NTS 
neurons activated by CCK, and none has assessed the degree to which NTS cFos expression is 
associated with cFos activation within the mpPVN.  
Interestingly, food deprivation attenuates the ability of systemic CCK to suppress food 
intake (Stein et al., 1986; McMinn et al., 2000), perhaps due to reduced circulating levels of 
leptin in food-deprived rats (Dallman et al., 1999; Mastronardi et al., 2000; Pico et al., 2002). 
Leptin potentiates the excitatory effects of exogenous CCK on vagal sensory afferents (Peters et 
al., 2006c; Peters et al., 2006a) and NTS neurons (Wang et al., 1998; Emond et al., 1999; Wang 
et al., 2000), including A2 neurons (Williams et al., 2008), and the ability of food deprivation to 
attenuate CCK-induced hypophagia is abolished by systemic leptin administration (McMinn et 
al., 2000). While it is clear that food deprivation reduces the hypophagic potency of CCK, the 
ability of CCK to activate phenotypically-identified A2 and GLP-1 neurons in rats after food 
deprivation has not been assessed, and there are no published reports regarding the effect of food 
deprivation on CCK-induced activation of the HPA axis. Considering this, the present study was 
designed to test three hypotheses: first, that increasing doses of CCK activate increasing numbers 
of A2, GLP-1, and mpPVN neurons to express cFos; second, that A2, GLP-1, and mpPVN 
neuronal activation occurs in a correlated manner; and third, that food deprivation significantly 
attenuates the ability of CCK to increase cFos expression within these populations of hindbrain 





Adult male Sprague-Dawley rats (Harlan, IN; 225-275g BW; n = 51) were housed singly in 
hanging stainless steel wire mesh cages in a temperature-controlled room (20-22°C) with a 12/12 
hr light/dark cycle (lights on at 0700 hr). Rats had ad libitum access to pelleted chow (Purina 
5001) and water, except as noted. All experiments were conducted in accordance with the NIH 
Guide for the Care and Use of Laboratory Animals and were approved by the University of 
Pittsburgh Institutional Animal Care and Use Committee. 
 
Injections and perfusion 
Rats were weighed one day before CCK administration to determine proper dosage. Rats were 
returned to their home cage with ad libitum chow access (ad lib; n = 28), or were deprived of 
food (but not water) for 16-18 hours overnight in their home cage (DEP; n = 23) before CCK or 
vehicle treatment. On the day of the experiment rats from each group were removed from their 
home cage between 0830 and 1030 hr and injected intraperitoneally (i.p.) with 1.0 ml of sterile 
0.15M NaCl containing sulfated CCK-8 (Bachem; H-2080) as follows: 0 μg/kg BW (n = 9 ad 
lib; n = 9 DEP); 3 μg/kg BW (n = 7 ad lib; n = 4 DEP); 10 μg/kg BW (n = 7 ad lib; n = 4 DEP). 
These CCK doses significantly inhibit food intake in rats (McCann et al., 1989; McMinn et al., 
2000; Rinaman, 2003a), stimulate pituitary hormone secretion (McCann et al., 1989; Kamilaris 
et al., 1992), and activate cFos expression by CRH-positive and other PVN neurons (Verbalis et 
al., 1991; Day et al., 1994; Noetzel et al., 2009). CCK was dissolved in vehicle just before 
injection, and rats were returned to their home cage immediately after injection.  Additional 
nonhandled (NH) control rats (n = 5 ad lib; n = 6 DEP) received no i.p. injection and remained 
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undisturbed in their home cages until perfusion within the same time period. Ninety minutes 
after i.p. injection, rats were deeply anesthetized with pentobarbital sodium (39 mg/1.0 ml i.p., 
Fatal Plus Solution; Butler Schein) and perfused transcardially with a brief saline rinse followed 
by fixative (100 ml of 2% paraformaldehyde and 1.5% acrolein in 0.1M phosphate buffer, 
followed by 100 ml of 2% paraformaldehyde alone) (McLean and Nakane, 1974). Brains were 
post-fixed in situ overnight at 4°C, then removed from the skull and cryoprotected for 24-48 hr 
in 20% sucrose. Brains were blocked and sectioned coronally (35μm) on a freezing stage 
microtome. Sections were collected in six serial sets, and stored at -20°C in cryopreservant 
solution (Watson et al., 1986) until immunocytochemical processing. 
 
Immunohistochemistry 
Primary and secondary antisera were diluted in 0.1M phosphate buffer containing 0.3% Triton 
X-100 and 1% normal donkey serum. One set of tissue sections from each rat was incubated in a 
rabbit polyclonal antiserum against cFos (1:50,000; kindly provided by Dr. Philip Larsen, 
Denmark), followed by biotinylated donkey anti-rabbit IgG (1:500; Jackson ImmunoResearch). 
Sections were treated with Elite Vectastain ABC reagents (Vector) and reacted with 
diaminobenzidine (DAB) intensified with nickel sulfate to produce a blue-black nuclear cFos 
reaction product. To identify NA neurons of the A2 cell group, cFos-labeled sections were 
subsequently processed to localize dopamine-β-hydroxylase (DβH) using mouse anti-DβH 
(1:50,000; Millipore, MAB308) followed by biotinylated donkey anti-mouse IgG (1:500; 
Jackson ImmunoResearch). Sections were reacted using Elite Vectastain ABC reagents and plain 
DAB to produce a brown cytoplasmic reaction product.  
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A second set of sections from each rat was incubated in a rabbit polyclonal antiserum 
against GLP-1 (1:10,000; Bachem, T-4363), followed by biotinylated donkey anti-rabbit IgG 
(1:500; Jackson ImmunoResearch), Elite Vectastain ABC reagents, and plain DAB to produce a 
brown cytoplasmic reaction product. These sections then were processed for immunofluorescent 
localization of cFos using a higher primary antibody concentration (1:5,000) followed by 
incubation in Cy3-conjugated donkey anti-rabbit IgG (1:300, Jackson ImmunoResearch) to 
produce a red fluorescent nuclear signal. 
 
Quantification of cFos expression by NTS A2 neurons 
Hindbrain tissue sections were analyzed using a light microscope and a 40X objective to 
determine the number of double-labeled, DβH/cFos-positive neurons within the NTS. Double-
labeled neurons were counted bilaterally through the rostrocaudal extent of the A2 cell group 
(i.e., from the cervical spinal cord through the NTS just rostral to the area postrema; ~15.46 mm 
to 13.15 mm caudal to bregma), and then averaged as counts per section. Criteria for counting a 
neuron as double-labeled included brown DβH cytoplasmic labeling and a nucleus that contained 
visible blue-black cFos immunolabeling, regardless of intensity. 
 
Quantification of cFos expression by GLP-1 neurons 
As there is no current evidence that GLP-1 neurons residing in the lateral reticular formation are 
anatomically or functionally distinct from their counterparts residing in the NTS, all visible GLP-
1 neurons were imaged in the NTS and adjacent reticular formation using a 20X objective on an 
Olympus microscope equipped for brightfield and epifluorescence, and photographed using a 
digital camera (Hamamatsu Photonics, Hamamatsu, Japan). Neurons were counted in 
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photographic images using Adobe Photoshop CS4 image software. Criteria for counting a neuron 
as GLP-1-positive included brown cytoplasmic labeling and a visible nucleus. Neurons were 
considered cFos positive if their nucleus contained red fluorescent cFos immunolabeling, 
regardless of intensity. Counts of GLP-1 neurons were performed throughout the rostrocaudal 
extent of the GLP-1 cell group (i.e., from the cervical spinal cord through the NTS just rostral to 
the area postrema; ~15.46 mm to 13.15 mm caudal to bregma), and then averaged as counts per 
section.  
 
Quantification of cFos expression in the mpPVN 
cFos/GLP-1-labeled sections were viewed on the Olympus photomicroscope described above.  
Using a 10X objective, photographic images were captured from a single selected rostrocaudal 
level of the mpPVN (approximately 1.78 mm caudal to bregma).  This selected level was 
characterized by dense GLP-1 terminal labeling that clearly defined the boundaries of the 
mpPVN (see Figure 4).  cFos-positive neurons within this defined region of the mpPVN were 
counted bilaterally on images using Adobe Photoshop CS4 image software. The criterion for 
counting a neuron as cFos-positive was the presence of visible red fluorescent nuclear 
immunolabeling, regardless of intensity. 
 
Statistics 
Two-way multivariate ANOVA was used to reveal main effects of, or interactions between, 
CCK injection group (NH, 0, 3, & 10 μg/kg BW) and feeding status (ad lib vs. DEP) on cFos 
counts within the hindbrain and hypothalamus. When F-values indicated significant interactions 
or main effects, the ANOVA was followed by post hoc tests with Bonferroni correction for 
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multiple comparisons. Differences were considered significant when p < 0.05. Pearson’s R 
correlation coefficient was used to determine whether significant correlations existed between 
treatment-induced activation of A2 neurons, GLP-1 neurons, and mpPVN neurons. Outlier tests 
identified 4 animals with data that lay more than 2 standard deviations from the group mean for a 
given dependent variable. Data from these animals were excluded from all analyses and do not 
contribute to the results. 
2.3 RESULTS 
Two-way ANOVA revealed significant main effects of CCK injection group and feeding status 
on cFos expression in DβH- and GLP-1-positive hindbrain neurons, and on cFos expression 
within the mpPVN. There also were significant interactions between injection group and feeding 





Table 1. Multivariate ANOVA Statistics 
Multivariate ANOVA main effects, interactions, and p-values for cFos counts in ad lib-fed or DEP rats following 





A2 neuronal activation 
CCK increased cFos expression within the caudal NTS (Figure 2A), consistent with 
previous reports (Monnikes et al., 1997; Zittel et al., 1999; Babic et al., 2009). Our new findings 
indicate that this includes a dose-dependent recruitment of DβH-positive A2 neurons (Figure 
2B). Very few A2 neurons expressed cFos in NH control rats, regardless of feeding status. A2 
activation was significantly increased in ad-lib fed rats, but not in DEP rats, after i.p. injection of 
saline vehicle (0 μg/kg CCK). CCK delivered at doses of 3 or 10 μg/kg further increased cFos 
expression by A2 neurons in both feeding status groups, but these effects were significantly 





Figure 2. Overnight fasting attenuates CCK-induced cFos activation of A2 neurons 
Representative color images and summary data for neuronal cFos expression (black nuclear label) within the A2 
region of the caudal NTS. A, NTS cFos activation at the rostrocaudal level of the area postrema, approximately 
14.16 mm caudal to bregma. In the larger image, robust cFos expression is present in a rat after CCK (10 μg/kg 
BW), including activation of DβH-positive (brown) neurons comprising the A2 cell group. Inset, little or no cFos 
activation is present in an ad lib-fed rat after i.p. vehicle (0 μg/kg BW CCK). B, bar graph illustrating the number of 
double labeled (i.e., both cFos- and DβH-positive) NTS neurons in ad lib-fed rats (solid bars) or food-deprived rats 
(DEP; open bars) after no i.p. injection (nonhandled) or after injection of CCK at doses of 0 (vehicle), 3, or 10 μg/kg 
BW. See Table 1 for two-way ANOVA results. In both feeding status groups, CCK dose-dependently increased 
cFos expression in DβH-positive A2 neurons, but cFos activation was significantly attenuated in food-deprived rats 
after vehicle or CCK injections. Asterisks over DEP bars indicate significant differences (p < .05) in the number of 
double-labeled NTS neurons compared to ad lib-fed rats in the same i.p. treatment group. Within the same feeding 





GLP-1 neuronal activation 
In contrast to the cFos activation profile for DβH-positive A2 neurons, GLP-1 neurons 
did not respond to CCK in a dose-dependent manner (Figure 3). In ad lib-fed rats, GLP-1 cFos 
activation was robustly increased by every i.p. treatment, with no additional effect of CCK 
(Figure 3C).  In DEP rats, cFos expression by GLP-1 neurons was virtually abolished in NH 
controls and after i.p. injection of vehicle or 3 μg/kg.  DEP rats displayed a trend towards 





Figure 3. Overnight fasting nearly eliminates CCK-induced cFos activation of hindbrain GLP-1 neurons 
Representative color images and summary data for neuronal cFos expression (red fluorescence) within GLP-1-
positive neurons (green fluorescence) of the caudal NTS. A, in an ad lib-fed rat, many GLP-1 neurons express cFos 
after i.p. injection of CCK (3 μg/kg BW). Inset, higher magnification view of several double-labeled neurons. B, in a 
food-deprived rat, GLP-1 neurons are not activated to express cFos after CCK (3 μg/kg BW), despite activation of 
other caudal NTS neurons. C, bar graph illustrating the number of double labeled (i.e., both cFos- and GLP-1-
positive) neurons within the NTS and adjacent reticular formation in ad lib-fed rats (solid bars) or food-deprived rats 
(DEP; open bars) after no i.p. injection (nonhandled) or after injection of CCK at doses of 0 (vehicle), 3, or 10 μg/kg 
BW. See Table 1 for two-way ANOVA results.  In ad lib-fed rats, a moderate number of GLP-1 neurons express 
cFos in the nonhandled control condition, and this number more than doubled after i.p. injection of vehicle or CCK, 
regardless of dose. Food deprivation markedly suppressed cFos expression by GLP-1 neurons, with a non-
significant trend towards increased activation seen after the highest CCK dose (10 μg/kg BW). Asterisks indicate 
significantly reduced (p < .05) GLP-1 cFos expression in DEP rats compared to GLP-1 cFos expression in ad lib-fed 
rats in the same i.p. treatment group. Within the same feeding status group (i.e., ad lib or DEP), bar values with 




mpPVN neuronal activation 
The mpPVN displayed relatively low levels of cFos labeling in both ad lib-fed and DEP 
rats in the NH and vehicle-injected control groups (Figure 4A,C), and cFos was markedly 
increased in rats from both feeding status groups after 3 or 10 μg/kg of CCK (Figure 4B,C). DEP 
rats, however, displayed less mpPVN cFos labeling overall compared to labeling in ad lib-fed 





Figure 4. Overnight fasting modestly attenuates mpPVN cFos activation 
Representative color images and summary data for neuronal cFos expression (red fluorescence) within the GLP-1 
(green fluorescence) terminal-rich region of the mpPVN. A, little cFos is present in the mpPVN of an ad lib-fed, 
nonhandled control rat. B, robust mpPVN cFos activation is present in an ad lib-fed rat injected with CCK (10 μg/kg 
BW). mpPVN images were captured and cFos quantified in sections approximately 1.78 mm caudal to bregma, as 
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schematized in the inset in panel A (Swanson, 2004). C, bar graph illustrating the number of cFos-positive mpPVN 
neurons in ad lib-fed rats (solid bars) or food-deprived rats (DEP; open bars) after no i.p. injection (nonhandled) or 
after injection of CCK at doses of 0 (vehicle), 3, or 10 μg/kg BW. See Table 1 for two-way ANOVA results. In both 
feeding status groups, low levels of mpPVN cFos activation were present in nonhandled or vehicle-injected rats, and 
CCK delivered at doses of 3 and 10 μg/kg produced marked activation of mpPVN cFos. Food-deprived rats 
displayed less mpPVN cFos labeling overall compared to labeling in ad lib-fed rats. Within the same feeding status 
group (i.e., ad lib or DEP), bars with different letters indicate significant i.p. treatment-induced differences (p < .05) 
in mpPVN cFos activation. mp = medial parvocellular subdivision of the PVN; ml = lateral magnocellular 
subdivision of the PVN; 3V = third ventricle. Scale bars in A and B = 100 μm. 
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Correlational analyses 
Activation of NTS DβH-positive A2 neurons correlated strongly with activation of 
mpPVN neurons (Figure 5A). This positive correlation existed in both ad lib-fed and DEP rats 
when data from these groups were analyzed independently (see Table 2 for a breakdown of 
Pearson correlation values and significance by injection and feeding status group). The number 
of cFos-positive GLP-1 neurons also significantly correlated with cFos expression in the mpPVN 
(Figure 5B), although the GLP-1/mpPVN cFos correlation was less robust than the DβH/mpPVN 
cFos correlation (Figure 5A). The GLP-1/mpPVN correlation also was significant in both ad lib-
fed and DEP animals when these groups were analyzed independently (Table 2). In addition, the 
number of cFos-positive GLP-1 neurons correlated positively with cFos expression in DβH 
neurons (Figure 5C), and this GLP-1/DβH cFos correlation also remained significant when the 





Figure 5. A2 & GLP-1 cFos activation correlate strongly with mpPVN cFos activation 
Scatter plots depicting significant positive correlations between treatment-induced activation of (A) mpPVN and 
NTS DβH neurons, (B) mpPVN and GLP-1 neurons, and (C) GLP-1 and DβH neurons. In each plot, individual 
symbols represent data from a single animal. Different symbol styles represent different i.p. treatment groups, as 
indicated in the key. See Table 2 for a breakdown of correlation R values and significance by i.p. treatment and 
feeding status groups.  
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Results from previous studies indicate that CCK elicits neuroendocrine responses via vagally-
mediated recruitment of NTS neurons, including NA neurons of the A2 cell group, that project to 
the hypothalamus (Rinaman et al., 1995; Monnikes et al., 1997; Rinaman, 2003a). Hindbrain 
GLP-1 neurons are also known to be activated in rats receiving a very high (i.e., 100 μg/kg BW) 
dose of CCK (Rinaman, 1999b), and GLP-1 axonal projections target the mpPVN (Larsen et al., 
1997b; Tauchi et al., 2008; Rinaman, 2010), suggesting an additional role for GLP-1 signaling in 
CCK-induced stimulation of the HPA axis. Although we did not measure stress hormone release 
in the present study, CCK at doses lower, higher, and similar to those used here stimulates 
pituitary hormone secretion (McCann et al., 1989; Kamilaris et al., 1992) and activates cFos 
expression by CRH-positive and other PVN neurons in rats (Verbalis et al., 1991; Day et al., 
1994; Noetzel et al., 2009). However, the degree to which lower doses of CCK recruit 
phenotypically identified A2 and GLP-1 neurons, and the specific relationship between 
activation of these brainstem neurons and those in the mpPVN, has not been examined. Results 
from the present study reveal a CCK dose-dependent increase in A2 neuronal activation that 
strongly correlates with activation of mpPVN neurons. Conversely, i.p. injection by itself 
robustly increased the number of GLP-1 neurons expressing cFos, with no additional effect of 
CCK.  Overnight food deprivation nearly abolished cFos expression in GLP-1 neurons, 
significantly attenuated CCK-induced cFos expression in A2 neurons, and had an overall effect 
to reduce cFos expression within the mpPVN.  
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Our results point to heterogeneity between A2 and GLP-1 neurons in their sensitivity to 
i.p. injection stress and CCK, although both hindbrain neuronal populations are clearly sensitive 
to changes in feeding status, as are neurons within the mpPVN.  We propose that the apparent 
metabolic sensitivity of A2 and GLP-1 neurons contributes to the overall suppressive effect of 
food deprivation on mpPVN cFos expression. Since i.p. injection and exogenous CCK are 
capable of recruiting stress-sensitive hindbrain and hypothalamic neurons, the robust effect of an 
overnight fast to dampen treatment-induced cFos expression suggests that central neuronal 
responses to other stressful stimuli may also be modulated by feeding status.  Indeed, fasting has 
been reported to interfere with the ability of animals to mount an HPA axis response to 
psychological stress (De Boer et al., 1989; Rohleder and Kirschbaum, 2007). 
 
A2 neurons 
A2 neurons rarely expressed cFos in non-manipulated, ad lib-fed rats, but i.p. vehicle and CCK 
dose-dependently activated this neuronal population. These new findings extend previous reports 
that CCK dose-dependently increases global NTS cFos expression (Monnikes et al., 1997; Zittel 
et al., 1999). Interestingly, while food deprivation attenuated A2 cFos expression across all i.p. 
injection groups, deprivation did not abolish CCK dose-dependent increases in A2 cFos 
activation. Thus, while A2 neurons are sensitive to feeding status, this neuronal population 
retains CCK sensitivity in food-deprived rats. Since rats in the present study were not acclimated 
to handling or i.p. injection before experimental treatment, it is possible that fasting attenuated 
A2 neural sensitivity to the stress of the injection procedure without altering sensitivity to CCK, 
or vice versa. Additionally, injection stress may interact non-additively with CCK to elicit A2 
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cFos activation, obfuscating the precise contribution of each stimulus to A2 cFos recruitment in 
non-acclimated rats. It will be important to empirically assess these possibilities in future studies.   
The strong correlation between CCK-induced activation of A2 and mpPVN neurons 
suggests, but does not demonstrate, a causal relationship between these variables. Additional 
evidence supporting this suggestion comes from studies in which loss or interruption of NA 
projections from the NTS to the PVN markedly reduces the ability of visceral stimuli – including 
CCK – to recruit the HPA stress axis (Rinaman, 2003a; Ritter et al., 2003; Rinaman and Dzmura, 
2007; Bienkowski and Rinaman, 2008).  A2 neurons are also necessary for exogenous CCK to 
reduce food intake in rats (Rinaman, 2003a).  Thus, our finding that fasting attenuates treatment-
induced A2 neuronal activation may reveal a mechanism through which feeding status modulates 
both behavioral (e.g., hypophagic) and neuroendocrine responses to CCK and other visceral 
stimuli.  Importantly, however, NTS inputs to the hypothalamus – and thus HPA axis activation 
– are unnecessary for CCK-induced hypophagia, as chronic decerebrate and neonatal rats (both 
of which lack functional connectivity between the NTS and PVN) display hypophagia after CCK 
treatment (Grill and Smith, 1988; Robinson et al., 1988; Rinaman et al., 1994). Moreover, it is 
likely that the A2 neurons responsible for brainstem-mediated hypophagic responses are distinct 
from those that mediate HPA axis responses to exogenous CCK, as toxin-induced loss of PVN-
projecting A2 neurons does not alter CCK-induced hypophagia (Ritter et al., 2001). We interpret 
these collective results as evidence that exogenous CCK recruits A2 neurons that inhibit food 
intake via local brainstem projections, while also recruiting A2 neurons that project to the 





Hindbrain GLP-1 neurons displayed moderate baseline levels of cFos expression (i.e., ~2-3 
activated neurons/section, corresponding to ~20% of all GLP-1 neurons) in non-manipulated, ad 
lib-fed rats. In contrast to the A2 population, GLP-1 neurons were markedly and similarly 
activated to express cFos in ad lib-fed rats subjected to any i.p. injection, regardless of CCK 
content.  Approximately 10 GLP-1 neurons per section (i.e., ~60% of all GLP-1 neurons) were 
activated in each i.p. treatment group.  Thus, GLP-1 neurons appear to be uniquely sensitive to 
the mild stress of handling and/or i.p. injection, which might have masked any additional 
activation by CCK.   
Surprisingly, GLP-1 neural cFos expression was nearly abolished in rats after overnight 
food deprivation, evidence that the baseline cFos expression and robust response to i.p. injection 
displayed by GLP-1 neurons is strongly modulated by feeding status. Despite an apparent trend 
towards increased GLP-1 cFos activation in food-deprived rats after the 10 μg/kg dose of CCK, 
this increase did not reach significance.  A higher CCK dose (e.g., 50-100 μg/kg) might be 
sufficient to overcome the dampening effect of food deprivation on GLP-1 cFos activation, but 
this remains to be determined. Although GLP-1 and mpPVN cFos expression was positively 
correlated, the correlation was much stronger for A2 and mpPVN cFos expression, suggesting 
that GLP-1 neurons have less direct effects on mpPVN responses to CCK.  Consistent with this, 
previous results from our laboratory indicate that in the absence of normal A2 neuronal 
signaling, the ability of exogenous CCK to activate hindbrain GLP-1 neurons is preserved, but is 
insufficient to support either CCK-induced hypophagia or PVN cFos expression (Rinaman, 
2003a).  Nevertheless, central GLP-1 receptor signaling has been implicated in HPA stress axis 
and anxiogenic responses to visceral stress (Kinzig et al., 2003), perhaps through gating the post-
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synaptic effects of another transmitter molecule (Acuna-Goycolea and Pol, 2004). Thus, the 
observed attenuation of GLP-1 cFos activation following deprivation suggests that reduced GLP-
1 signaling might contribute to the blunted neuroendocrine stress responses that have been 




Considering the well-documented excitatory effects of NA and GLP-1 signaling on mpPVN 
neural activity (Day et al., 1985; Daftary et al., 2000; Cole and Sawchenko, 2002; Rinaman, 
2007) and the markedly blunted A2 and GLP-1 cFos activation in food-deprived rats, it is 
surprising that food deprivation generated only a mild overall attenuation of mpPVN cFos 
expression under all treatment conditions.  In both ad lib-fed and food-deprived rats, mpPVN 
cFos activation occurred in a step-wise manner, with comparable levels of cFos observed in NH 
and i.p. vehicle-injected control groups, and substantially increased cFos after CCK administered 
at either the 3 or 10 μg/kg dose.  It is possible that the comparable magnitude of mpPVN cFos 
activation after both CCK doses is due to a ceiling effect, as a previous study reported that doses 
of 5 and 10 g/kg CCK elicit large but similar increases in plasma adrenocorticotropic hormone 
(ACTH) (Kamilaris et al., 1992).  The similar number of cFos-positive mpPVN neurons after 
both CCK doses may also reflect an inherent limitation in interpreting cFos data, as the visible 
presence or absence of cFos protein in a given neuron is binary, poorly reflecting the degree to 
which the neuron has been activated, and providing no information about that neuron’s spike 
frequency or amplitude. Furthermore, we do not know the extent to which hypophysiotropic 
CRH-positive mpPVN neurons were activated after each CCK dose. Nevertheless, the overall 
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blunted mpPVN cFos expression observed in food-deprived rats in the present report is 
consistent with prior evidence that fasting blunts ACTH responses to stress (De Boer et al., 1989; 
Rohleder and Kirschbaum, 2007), which may result from reduced excitatory drive to the mpPVN 
from hindbrain A2 and GLP-1 neurons.    
 
Potential signals of feeding status 
Attenuation of A2, GLP-1, and mpPVN neural cFos expression in food-deprived rats could result 
from loss of an excitatory signal that is present in ad lib-fed rats, generation of an inhibitory 
signal associated with food deprivation, or both.  Fasting produces a multitude of metabolic and 
physical changes (Dallman et al., 1999), with reductions in circulating leptin, increases in 
circulating ghrelin, and reduced gastric distention standing out as potential candidate effectors of 
deprivation-induced changes in central neural activity. Leptin levels fall in rats after overnight 
food deprivation (Dallman et al., 1999; Pico et al., 2002), and leptin enhances CCK signaling at 
the level of the vagus nerve (Peters et al., 2004; Peters et al., 2006b), the NTS (Wang et al., 
1998; Emond et al., 1999) (particularly A2 neurons (Williams et al., 2008)), and the PVN (Wang 
et al., 1998; Emond et al., 1999). Reduced gastric distention signals in food deprived rats might 
also attenuate central neural cFos responses to CCK, since CCK and gastric distention act 
synergistically to activate vagal afferent inputs (Schwartz et al., 1991b; Schwartz et al., 1993) 
that modulate NTS neuronal activity (Raybould et al., 1988).  It is less likely that increased 
ghrelin signaling after fasting (Toshinai et al., 2001) is responsible for attenuated central neural 
responses to CCK, since i.p. ghrelin does not suppress the ability of CCK to activate cFos 




Our results show that CCK- and i.p. injection-induced cFos activation of A2, GLP-1, and 
mpPVN neurons is strongly modulated by short-term fasting. As these neural populations are 
activated following a diverse array of stressors (Li et al., 1996; Rinaman, 1999b), including 
“cognitive-type” restraint stress (Dayas et al., 2001b; Maniscalco et al., 2012), we expect that 
food deprivation would also alter hindbrain and hypothalamic neural responses to restraint and 
other stressors. Considering that A2, GLP-1, and mpPVN neurons play important roles in 
generating behavioral and physiological responses to stress, feeding status may impact an 
animal’s ability to mount these responses by altering the sensitivity of hindbrain and 
hypothalamic neurons to their afferent inputs. It will be critical for future studies to identify the 
mechanisms by which food deprivation alters neural activation in these brainstem and 
hypothalamic populations, and to assess the functional consequences of altered neuronal 
signaling. 
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3.0  OVERNIGHT FASTING REVEALS A LINK BETWEEN HINDBRAIN 
GLUCAGON-LIKE PEPTIDE-1 AND PROLACTIN-RELEASING 
PEPTIDE/NORADRENERGIC NEURONS AND BEHAVIORAL AND 
PHYSIOLOGICAL RESPONSES TO COGNITIVE STRESS  
3.1 INTRODUCTION 
Health and well-being depend on appropriate physiological and behavioral responses to 
perceived and actual homeostatic threats (i.e., stressors) (Chrousos, 1998). These responses 
include activation of the hypothalamic-pituitary-adrenal (HPA) axis, which occurs following 
recruitment of corticotropin-releasing hormone (CRH) neurons in the medial parvocellular 
paraventricular hypothalamus (mpPVN) (Ulrich-Lai and Herman, 2009). CRH neural activation 
promotes systemic release of adrenocorticotropic hormone (ACTH) to drive glucocorticoid (GC) 
synthesis in the adrenal cortex, GCs then elicit a multitude of adaptive physiological, neural, and 
behavioral changes (Sapolsky et al., 2000; Charmandari et al., 2005). Stress-induced activation 
of the HPA axis often occurs in concert with affective anxiety and suppression of food intake 
(i.e., hypophagia), producing a state characterized by behavioral inhibition, hyper-vigilance, and 
avoidance responses (Davis, 2002; Davis et al., 2010; Calvez et al., 2011; Maniam and Morris, 
2012).  
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Acute or chronic periods of caloric deficit attenuate anxiety-like behavior (Genn et al., 
2003; Inoue et al., 2004) and central drive to the HPA axis, as evidenced by decreased mpPVN 
CRH mRNA expression (Brady et al., 1990; Kiss et al., 1994), decreased baseline mpPVN cFos 
activation (Dallman et al., 1999), and decreased plasma ACTH concentrations at baseline and in 
response to restraint stress (Hanson et al., 1994; Chacon et al., 2005). Paradoxically, caloric 
deficit increases basal and restraint stress-induced plasma corticosterone (CORT) levels in the 
same animals (Akana et al., 1994; Chacon et al., 2005), evidence that fasting “uncouples” 
anxiety-like behavior and ACTH release from CORT responses. It is posited that the benefits of 
this are three-fold: first, downregulated central CRH signaling attenuates its anorexigenic effects 
(Krahn et al., 1986; Krahn et al., 1988; Rothwell, 1990), limiting the ability of stress to suppress 
food intake during periods of negative energy balance. Second, increased CORT facilitates 
energy mobilization to support glucose-dependent processes, despite negative energy balance 
(Dallman et al., 1999). Third, attenuated anxiety may promote foraging in threatening 
environments, increasing the likelihood of encountering food. Although metabolic tuning of 
stress responses has clear adaptive value, the underlying neural mechanisms by which this shift 
occurs remain unclear. 
We propose that the ability of caloric deficit to decrease stress hypophagia, central drive 
to the HPA axis, and anxiety-like behavior depends on reduced signaling from prolactin-
releasing peptide (PrRP)-positive noradrenergic (NA) A2 neurons and glucagon-like peptide-1 
(GLP-1)-positive neurons in the caudal nucleus of the solitary tract (cNTS). NA/PrRP and GLP-
1 neurons receive substantial visceral sensory input (Rinaman, 2007), allowing them to readily 
monitor the interoceptive environment. In turn, these neurons project to brain regions integral for 
HPA axis activation, anxiety-like behavior, and suppression of food intake (Rinaman, 2010, 
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2011). Loss of signaling from GLP-1 or NA/PrRP neurons substantially attenuates stress-induced 
HPA axis activation, hypophagia, and anxiety-like behavior (Cecchi et al., 2002; Kinzig et al., 
2003; Rinaman, 2003a; Ritter et al., 2003; Rinaman and Dzmura, 2007; Schiltz and Sawchenko, 
2007; Bienkowski and Rinaman, 2008; Zheng and Rinaman, 2013), and we recently reported that 
overnight fasting prevents visceral stress-induced activation of hindbrain GLP-1 and A2 NA 
neurons (Maniscalco and Rinaman, 2013). 
Considering this, we hypothesize that cognitive stressors activate hindbrain GLP-1 and 
NA/PrRP neurons in rats fed ad libitum. We propose that overnight fasting attenuates cognitive 
stress-induced activation of GLP-1 and NA/PrRP neurons in conjunction with reduced anxiety-
like behavior and reduced neural activation within the mpPVN and bed nucleus of the stria 
terminalis (BST), forebrain regions critical for HPA axis activation and anxiogenesis. Third, we 
predict that basal and cognitive stress-induced plasma CORT concentrations will be elevated in 
fasted rats, despite reduced mpPVN activation. Finally, we propose that pharmacological 
blockade of central GLP-1 receptor signaling will attenuate the hypophagic effects of cognitive 
stress in rats fed ad libitum.  
3.2 MATERIALS & METHODS 
Animals 
Adult male Sprague-Dawley rats (Harlan Laboratories, Indianapolis, IN) were housed singly in 
hanging stainless steel wire mesh cages in a temperature-controlled room (20-22°C) on a 12/12 
hr light/dark cycle (lights off at 1900 hr). Rats had ad libitum (ad lib) access to pelleted chow 
(Purina 5001) and water, except as noted. All experiments were conducted in accordance with 
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the NIH Guide for the Care and Use of Laboratory Animals and were approved by the 
University of Pittsburgh Institutional Animal Care and Use Committee. 
 
Experiment 1: Fasting-induced changes in neural cFos responses to cognitive stressors 
Rats (225-275g BW) were given ad lib chow access, or were deprived of food (but not water) for 
16-18 hr overnight in their home cage (DEP) prior to stressor treatment. On the day of the 
experiment rats were removed from their home cage between 0830 and 1030 hr and were either 
restrained for 30 min in a perforated plexiglass tube (RES; n = 4 ad lib; n = 8 DEP), or were 
placed on a brightly lit (~550 lux) elevated platform (45 X 10 cm with 1-cm-high edging, 90 cm 
above floor) for 5 min (EP; n = 6 ad lib; n = 6 DEP). Additional nonhandled (NH) control rats (n 
= 6 ad lib; n = 7 DEP) remained undisturbed in their home cages during the same time period. 
Ninety minutes after stressor onset, rats were deeply anesthetized with pentobarbital 
sodium (39 mg/1.0 ml i.p., Fatal Plus Solution; Butler Schein) and perfused transcardially with a 
brief saline rinse followed by fixative (100 ml of 2% paraformaldehyde and 1.5% acrolein in 
0.1M phosphate buffer, followed by 100 ml of 2% paraformaldehyde alone). Brains were post-
fixed in situ overnight at 4°C, then removed from the skull and cryoprotected for 24-48 hr in 
20% sucrose. Brains were blocked and sectioned coronally (35μm) using a Leica freezing-stage 
sliding microtome. Tissue sections were collected in six serial sets, and stored at -20°C in 
cryopreservant solution (Watson et al., 1986) until immunohistochemical processing. 
 
Immunohistochemistry 
Primary and secondary antisera were diluted in 0.1M phosphate buffer containing 0.3% Triton 
X-100 and 1% normal donkey serum. Two sets of tissue sections from each rat were incubated in 
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a rabbit polyclonal antiserum against cFos (1:20,000; EMD Chemicals, PC38), followed by 
biotinylated donkey anti-rabbit IgG (1:500; Jackson ImmunoResearch). Sections were then 
treated with Elite Vectastain ABC reagents (Vector Laboratories) and reacted with 
diaminobenzidine (DAB) intensified with nickel sulfate to produce a blue-black nuclear cFos 
reaction product. To visualize cFos within hindbrain GLP-1 neurons, one set of cFos-labeled 
tissue sections was subsequently incubated in a rabbit polyclonal antiserum against GLP-1 
(1:10,000; Bachem, T-4363), followed by biotinylated donkey anti-rabbit IgG (1:500; Jackson 
ImmunoResearch), Elite Vectastain ABC reagents (Vector), and reacted with plain DAB to 
produce a brown cytoplasmic reaction product.  
The second set of cFos immunoperoxidase-labeled tissue sections was used to 
simultaneously visualize cFos expression by dopamine beta hydroxylase (DβH-) and PrRP-
positive A2 neurons in the cNTS, and within the PrRP terminal-rich region of the anterior 
ventrolateral (vl)BST. For this purpose, sections were incubated in a cocktail of mouse anti-DβH 
(1:5,000; Millipore, MAB308) and rabbit anti-PrRP (1:1,000; Phoenix Pharmaceuticals, H-008-
52), followed by a cocktail of AlexaFluor 488-conjugated donkey anti-mouse IgG (1:300, 
Jackson ImmunoResearch) and Cy3-conjugated donkey anti-rabbit IgG (1:300, Jackson 
ImmunoResearch) to produce green and red fluorescent cytoplasmic signals, respectively.  
A third set of tissue sections from each rat was used to visualize cFos within the GLP-1 
terminal-dense mpPVN. Tissue sets were first processed for GLP-1 immunoperoxidase labeling, 
as described above. Reacted sections were then incubated in one of two rabbit antisera raised 
against cFos protein: one was provided by Dr. Philip Larsen, Denmark (1:5,000) and the second 
was purchased from EMD Chemicals (1:2,000; PC38). Statistical comparisons confirmed that 
these cFos antisera produced similar results. Tissue sections were then incubated in Cy3-
 53 
conjugated donkey anti-rabbit IgG (1:300, Jackson ImmunoResearch) to produce a red 
fluorescent nuclear signal localizing cFos protein. 
 
Imaging & Quantification of cFos expression by GLP-1 neurons 
GLP-1 neurons were visualized using a light microscope and 20X/40X objectives to determine 
the number of GLP-1-positive neurons and the proportion that were double-labeled for cFos. 
GLP-1 neurons were counted bilaterally within the cNTS and adjacent reticular formation 
through the entire rostrocaudal extent of both GLP-1 cell groups (i.e., from the cervical spinal 
cord through the cNTS just rostral to the area postrema (AP); ~15.46 mm to 13.15 mm caudal to 
bregma). Criteria for counting a neuron included brown GLP-1 cytoplasmic labeling and a 
visible nucleus; double-labeled GLP1 neurons were those that displayed visible blue-black 
nuclear cFos immunolabeling, regardless of intensity. cFos-positive GLP-1 neurons were 
represented as a proportion of total GLP-1 neurons counted within the cNTS and/or reticular 
formation. 
 
Imaging & Quantification of cFos expression by PrRP+ and PrRP- A2 neurons 
PrRP+ and PrRP- A2 neurons (all of which were DβH-positive) were imaged using a 20X 
objective on an Olympus microscope equipped for brightfield and epifluorescence illumination, 
and photographed using a digital camera (Hamamatsu Photonics, Hamamatsu, Japan). Neurons 
were counted in photographic images using Adobe Photoshop CS4 image software. Criteria for 
counting a neuron included clear cytoplasmic DβH labeling and a visible nucleus. PrRP+ A2 
neurons were also immunopositive for cytoplasmic PrRP, whereas PrRP- A2 neurons were not. 
Neurons were considered cFos positive if their nucleus contained blue/black cFos 
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immunoperoxidase labeling, regardless of intensity. Single-, double-, and triple-labeled neurons 
were counted bilaterally through the rostrocaudal extent of the A2 cell group (i.e., from the 
cervical spinal cord through the cNTS just rostral to the AP; ~15.46 mm to 13.15 mm caudal to 
bregma). In each analyzed case, cFos-positive A2 neurons that were PrRP+ or PrRP- were 
represented as a percent of total PrRP+ and PrRP- A2 neurons counted, respectively. 
 
Imaging & Quantification of cFos expression in the mpPVN 
Forebrain tissue sections labeled for GLP-1 immunoperoxidase and cFos immunofluorescence 
were viewed on the Olympus photomicroscope described above. Using a 10X objective, 
photographic images were captured from a single selected rostrocaudal level through the mpPVN 
(~ 1.78 mm caudal to bregma). This selected level was characterized by dense GLP-1 terminal 
labeling that clearly defined the boundaries of the mpPVN (e.g., see Figure 4). cFos-positive 
neurons within this defined region were counted bilaterally on captured images using Adobe 
Photoshop CS4 image software. The criterion for counting a neuron as cFos-positive was the 
presence of visible red fluorescent nuclear immunolabeling, regardless of intensity. 
 
Imaging & Quantification of cFos expression in the PrRP terminal-dense region of the anterior 
vlBST 
Forebrain tissue sections labeled for cFos immunoperoxidase and PrRP/DβH 
immunofluorescence were viewed on the Olympus photomicroscope described above. Using a 
10X objective, photographic images were captured from a single selected rostrocaudal level of 
the anterior vlBST (~ 0.3 mm caudal to bregma) that is characterized by particularly dense PrRP 
and DβH terminal labeling (see Figure 9). Using Adobe Photoshop CS4 image software, a region 
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of interest (ROI) was mapped around the densest PrRP terminal labeling bilaterally by an 
investigator blinded to experimental group. cFos-positive neurons were then counted bilaterally 
within the defined ROI, which largely corresponded to the fusiform subnucleus of the anterior 
vlBST. The criterion for counting cFos-positive neurons within each ROI was the presence of 
blue-black nuclear immunoperoxidase labeling, regardless of intensity. Within the ROI, number 
of cFos-positive neurons per 100 μm2 was quantified and averaged bilaterally in each rat. 
 
Statistics 
Paired samples t-tests were used to compare the proportion of GLP-1 neurons located within the 
reticular formation versus the cNTS, and to compare cFos activation percentages between 
reticular and cNTS GLP-1 neurons following each experimental treatment. Two-way 
multivariate ANOVA was used to reveal main effects of and interactions between stress 
treatment (NH vs. RES vs. EP) and feeding status (ad lib vs. DEP) on cFos activation of GLP-1 
neurons, PrRP+ A2 neurons, PrRP- A2 neurons, mpPVN neurons, and vlBST neurons. When F-
values indicated significant main or interaction effects, ANOVAs were followed by Fisher’s 
LSD post hoc analyses. Differences were considered significant when p < .05. Pearson’s R 
correlation coefficient was used to determine whether significant correlations existed between 
the proportion of GLP-1 neurons activated within the reticular formation and the cNTS. 
 
Experiment 2: Fasting-induced changes in anxiety-like behavior 
Rats (225-275g BW) were deprived of food (but not water) for 16-18 hr overnight (n = 4) or 
were fed ad lib (n = 4) prior to behavioral assessment. On the day of the experiment rats were 
removed from their home cage between 0830 and 1030 hr and tested for anxiety-like behavior on 
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the elevated plus maze (EPMZ). The EPMZ is a validated test of behavioral anxiety in rats that 
measures approach-avoidance conflict generated by the motivation and fear associated with 
exploring novel environments (Montgomery, 1955; Pellow et al., 1985). The EMPZ consisted of 
two open arms (45 X 10 cm, ~ 550 lux) with transparent 1 cm-high edging, and two closed arms 
(45 X 10 X 48 cm, ~ 12 lux) extending from a common central platform (10 X 10 cm) elevated 
90 cm above the floor. The EPMZ was located in a quiet, evenly lit behavioral testing room 
immediately adjacent to the animal housing room. Behavior on the EPMZ was videotaped for 5 
min, and then rats were returned to their home cage. The EPMZ was cleaned with a mild odor-
neutralizing cleanser and allowed to dry between rats. Tapes were later manually scored by an 
investigator blinded to experimental group to determine open arm time, closed arm time, center 
time, open arm entries, closed arm entries, and total entries, according to previously described 
procedures (Walf and Frye, 2007). A rat was considered to have entered an open or closed maze 
arm when all four paws initially occupied it. A significant decrease in open arm time and/or open 
arm entries or an increase in closed arm time and/or closed arm entries is interpreted as increased 
anxiety-like behavior (Pellow et al., 1985). Additionally, an automated software system (ANY-
maze, Stoelting Co.) was used to determine total distance traveled by each rat during the 5 min 
EPMZ test.   
 
Statistics 
Independent-samples t-tests were used to reveal differences between ad lib and DEP rats on open 
arm time, closed arm time, center time, open arm entries, closed arm entries, total entries, and 
total distance traveled. Differences were considered significant when p < .05. 
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Experiment 3: Fasting-induced changes in CORT response to cognitive stress 
CORT responses to restraint (RES) 
Rats (225-275g BW) were deprived of food (but not water) for 16-18 hr overnight (n = 5) or 
were fed ad lib (n = 6) prior to RES. On the day of the experiment rats were removed from their 
home cage between 0830 and 1030 hr and were immediately placed into perforated Plexiglass 
RES tubes. Using a within-subjects design, blood was sampled from the tail vein within 90 
seconds of placement in the restrainer (baseline sample) and again after 30 minutes of RES (peak 
sample), after which rats were removed from the restrainers and returned to their home cage. 
Thirty minutes following return to the home cage (i.e., 60 minutes following onset of RES 
stress), rats were decapitated and trunk blood was collected (recovery sample).  
 
CORT responses to elevated platform (EP) exposure 
Rats were deprived of food (but not water) for 16-18 hr overnight (n = 14) or were fed ad lib (n = 
16) prior to EP exposure. On the day of the experiment rats were removed from their home cage 
between 0830 and 1030 hr and were immediately placed on a brightly lit elevated platform for 5 
minutes, as described above. Using a between-subjects design, rats were decapitated and trunk 
blood was collected either 15 min (peak sample, n = 6 ad lib; n = 5 DEP) or 35 minutes 
(recovery sample, n = 4 ad lib; n = 4 DEP) after the onset of the 5 min EP exposure. Peak sample 
timing was selected based on a prior report that platform exposure maximally increases plasma 
CORT concentrations within 15 min (Kinzig et al., 2003), and the recovery sample timepoint 




Corticosterone Enzyme Immunoassay 
All blood samples were collected into EDTA-coated tubes and placed immediately on ice. Blood 
samples were then centrifuged (5500 rpm, 10 min, 4°C), and plasma was removed and stored at -
80°C until processing. Plasma CORT concentrations were determined using a competitive 
enzyme immunoassay (Immunodiagnostic Systems Ltd., Fountain Hills, AZ), according to the 
manufacturer’s instructions. Assay sensitivity for CORT was 0.55ng/ml, with synthetic CORT 
recovery of 98.6 ± 2.8% and linearity of 99.7 ± 1.78%. 
 
Statistics 
Two-way ANOVA with repeated measures was used to reveal main effects of and interactions 
between sample time (baseline vs. peak vs. recovery) and feeding status (ad lib vs. DEP) on 
plasma CORT concentration during and after RES stress (within-subjects design). When F-
values indicated a significant effect, the ANOVA was followed by post hoc tests with Bonferroni 
correction for multiple comparisons. Differences were considered significant when p ≤ .05.  
Two-way ANOVA was used to reveal main effects of and interactions between sample 
time (baseline vs. peak vs. recovery) and feeding status (ad lib vs. DEP) on plasma CORT 
concentration following EP exposure. Baseline samples used for the between-subjects EP 
comparisons were those collected from the cohort of rats sampled at the outset of RES. When F-
values indicated significant main or interaction effects, ANOVAs were followed by Fisher’s 





Experiment 4: Role of central GLP-1 signaling in stress-induced hypophagia 
Cannulation Procedures 
Rats (290-310 g BW) were anesthetized by inhalation of isoflurane (Halocarbon Laboratories, 
River Edge, NJ, USA; 1-3% in oxygen) and placed into a stereotaxic frame in the flat-skull 
position. Rats were fitted with chronic indwelling 26-gauge stainless steel guide cannulas 
(Plastics One) aimed at the lateral ventricle. Guide cannulae were positioned 1.4 mm lateral and 
0.9 mm caudal to bregma, with the cannula tip protruding 2.7 mm below the surface of the skull. 
Cannulae were fixed to the skull with anchor screws and dental acrylic and fitted with removable 
obturators that extended to the tip of the cannula. Rats were allowed to recover for 4-5 days 
following surgery, at which point all rats exceeded their pre-surgery BW.  
 
Hypophagia Experiments 
Beginning 4-5 days after surgery, rats (n = 16) were acclimated for 3 days to mock cannula 
injections at 1800 hr. This included gentle restraint and obturator manipulation, intended to 
mimic the injection procedure except for infusions. On each food intake measurement day, rats 
were deprived of food (but not water) for 2 hr prior to dark onset. The following treatments were 
administered in a counterbalanced design: 1) i.c.v. saline (3 μl over 1.5 min), 2) i.c.v. saline + 
RES, 3) i.c.v exendin-(9-39) (Ex9; a specific GLP-1 receptor antagonist; Tocris Bioscience, 
2081; 100 μg in 3 μl saline over 1.5 min), and 4) i.c.v. Ex9 + RES.  I.c.v. saline or Ex9 was 
administered 15 min prior to the 30 min RES, which was completed just before lights out. At 
dark onset (1900 hr), pre-weighed pelleted chow was placed on the home cage floor, and intake 
was measured to the nearest 0.1 g at 30 and 60 min (corrected for spillage beneath the cage). 
Baseline intake was measured in the same manner the day before each experimental treatment 
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day. The amount of food consumed was represented as percent of BW to correct for small 
between-animal BW differences. Each rat received 2 of the 4 possible treatment combinations, 
but no rat received the same i.c.v. injection or RES stress more than once. Thus, for statistical 
purposes, data obtained for each treatment group condition were considered independent and 
were analyzed according to a between-subjects rather than within-subjects design. 
 
Evaluation of Cannula Placement 
Correct cannula placement was verified within 1 week after feeding data collection. For this 
purpose, water-replete rats were injected i.c.v. with 2 μl of sterile saline containing 5 ng of 
angiotensin II (AngII; Bachem, H-1705). Only data from rats that drank at least 5ml of water 
within 30 min after AngII injection were included in the study.  
 
Statistics 
Two-way ANOVA with repeated measures (time) was used to reveal main effects of and 
interactions between experimental treatment group (i.e., baseline, i.c.v. saline, i.c.v. saline + 
RES, i.c.v. Ex9, and i.c.v. Ex9 + RES) and time (0-30 min, 30-60 min, and 0-60 min) on chow 
intake. When F-values indicated significant main effects or interactions, the ANOVA was 
followed by post hoc tests with Bonferroni correction for multiple comparisons. Differences 




Experiment 1: Fasting-induced changes in neural cFos responses to cognitive stressors 
Feeding status and/or stress treatment did not affect the total number of immunoreactive 
hindbrain GLP-1, PrRP+, or PrRP- A2 neurons. Two-way ANOVA did, however, reveal 
significant main effects of and interactions between stressor treatment and feeding status on cFos 
expression by hindbrain GLP-1 neurons, PrRP+ A2 neurons, PrRP- A2 neurons, and within the 
vlBST (Table 3). There also was a significant main effect of stress treatment on cFos expression 
within the mpPVN, but no main effect of feeding status and no interaction effect.  
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Table 3. Multivariate ANOVA Statistics 
Multivariate ANOVA main effects, interactions, and p-values for cFos counts in ad lib fed or DEP rats following 




GLP-1 neuronal distribution and activation 
Similar to our recent report examining the effect of fasting on visceral stress-induced neural 
activation (Chapter 2), a moderate proportion (~ 32%) of GLP-1 neurons were cFos+ in ad lib-
fed, NH control rats. Conversely, GLP-1 neurons did not express cFos in NH rats following DEP 
(Figure 6E). Compared to baseline activation, RES and EP stress each significantly increased the 
proportion of GLP-1 neurons expressing cFos in ad lib-fed rats, with a greater degree of 
activation induced by EP compared to RES (Figure 6E). However, GLP-1 neurons were not 





Figure 6. Overnight fasting eliminates cognitive stress-induced cFos activation of GLP-1 neurons 
Representative color images depicting neuronal cFos expression (black nuclear label) within GLP-1+ neurons 
(brown cytoplasmic label) in the cNTS (A, C) and reticular formation (B, D) in rats exposed to elevated platform 
stress. A, robust cFos activation within the cNTS (~14.36 mm caudal to bregma) in an ad lib-fed rat. Inset, higher 
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magnification view of several cFos+ GLP-1 neurons. B, cFos+/GLP-1+ neurons within the reticular formation in an 
ad lib-fed rat. C, cNTS GLP-1+ neurons do not express cFos in a fasted rat after elevated platform exposure. Inset, 
higher magnification view of several GLP-1+ neurons, none of which express cFos. D, reticular GLP-1 neurons do 
not express cFos in a fasted rat after elevated platform exposure. E, summary data illustrating the proportion of 
double-labeled neurons (i.e., both cFos+ and GLP-1+) within the cNTS and adjacent reticular formation in ad lib-fed 
rats (solid bars) or fasted rats (DEP; open bars) after no manipulation (nonhandled), restraint stress, or elevated 
platform stress. See Table 3 for two-way ANOVA results. Fasting completely eliminated cFos expression by GLP-1 
neurons. Asterisks indicate significantly reduced (p < 0.05) GLP-1 cFos expression in DEP vs. ad lib-fed rats in the 
same treatment group. Within the same feeding status group (i.e., ad lib or DEP), bars with different letters are 
significantly different (p < 0.05). cc, central canal. Scale bar in A = 200 μm, applies also to C. Scale bar in B = 50 
μm, applies also to D. 
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A t-test for paired samples demonstrated that the proportion of all GLP-1 neurons located 
within the cNTS (56.55 ± 1.37%) was significantly greater than the proportion of located within 
the reticular formation (43.45 ± 1.37%), [t (36) = 4.775, p < .001]. However, there were almost 
no significant differences between the proportion of cNTS and reticular GLP-1 neurons that 
expressed cFos after each combination of experimental treatments (Table 4). The one exception 
was a small but statistically significant difference in the distribution of activated neurons after 
RES in DEP rats, in which activation was very low overall but was significantly higher among 
the reticular population. Activation of cNTS GLP-1 neurons correlated strongly with activation 
of reticular GLP-1 neurons across all stress treatment conditions and both feeding groups (R = 
0.972, p < .001), and also selectively within ad lib-fed rats (R = 0.917, p < .001).  Activation of 
GLP-1 neurons among DEP rats was so low that the absence of a correlation within this feeding 
group was not surprising. 
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Table 4. Paired-samples t-test statistics. 
Paired-samples t-tests comparing mean differences between percent cFos activation of NTS GLP-1 neurons and 




A2 neuronal activation 
Similar to GLP-1 neurons, ad lib-fed rats displayed moderate cFos activation of PrRP+ A2 
neurons under NH control conditions (~28%), and significantly increased activation after either 
RES or EP (Figure 7C). Markedly smaller proportions of PrRP- A2 neurons expressed cFos 
under NH control or stress conditions (Figure 7D). In contrast to the increased effectiveness of 
EP vs. RES in activating GLP-1 neurons in ad lib-fed rats (Figure 7E), RES activated 
significantly larger proportions of PrRP+ and PrRP- A2 neurons than were activated by EP in ad 
lib-fed rats (Figure 7C, D). Similar to the effect of DEP to virtually abolish GLP-1 neural 
activation under all treatment conditions (Figure 7E), DEP eliminated cFos expression by PrRP+ 
and PrRP- A2 neurons under NH control conditions and after EP stress (Figure 7C, D). 
Compared to activation in ad lib-fed rats, DEP significantly attenuated (but did not eliminate) the 
ability of RES to activate both PrRP+ and PrRP- A2 neurons compared to activation under NH 





Figure 7. Overnight fasting reduces cFos activation within PrRP+ and PrRP- A2 neurons 
Representative color images depicting neuronal cFos expression (blue nuclear label) within PrRP+ (red) and DβH+ 
(green) neurons in the cNTS in rats exposed to restraint stress. A, robust cFos activation within the cNTS (~14.36 
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mm caudal to bregma) in an ad lib-fed rat, including activation of most PrRP+/DβH+ neurons and a smaller 
proportion of PrRP-/DβH+ neurons. Inset, higher magnification view of several cFos+/PrRP+/DβH+ neurons. B, few 
PrRP+/DβH+ or PrRP-/DβH+ neurons express cFos in a fasted rat after restraint stress. Inset, higher magnification 
view of several PrRP+/DβH+ and PrRP-/DβH+ neurons, a few of which express cFos. C & D, summary data 
illustrating the proportion of triple-labeled (i.e., cFos+, PrRP+, DβH+) or double-labeled (i.e., cFos+, PrRP-, DβH+) 
cNTS neurons in ad lib-fed rats (solid bars) or fasted rats (DEP; open bars) after no manipulation (nonhandled), 
restraint stress, or elevated platform stress. C, Fasting eliminated cFos expression by PrRP+/DβH+ neurons in rats 
exposed to nonhandled control conditions or elevated platform stress, and significantly reduced cFos expression by 
PrRP+/DβH+ neurons in rats exposed to restraint. D, few PrRP-/DβH+ neurons expressed cFos in the nonhandled 
control condition, regardless of feeding status. Fasting attenuated stress-induced cFos expression in PrRP-/DβH+ 
neurons. See Table 3 for two-way ANOVA results. In C & D, asterisks indicate significantly reduced (p < 0.05) 
neural cFos expression in DEP rats vs. ad lib-fed rats in the same treatment group. Within the same feeding status 
group (i.e., ad lib or DEP), bars with different letters are significantly different (p < 0.05). cc, central canal. Scale 
bar in A = 200 μm, applies also to B. 
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mpPVN neuronal activation 
Irrespective of feeding status, cFos activation within the mpPVN was increased to a similar 
degree following RES and EP stress as compared to NH controls (Table 3, Figure 8). A main 
effect of feeding status on cFos counts approached, but did not reach, statistical significance (p = 
.07; Table 3), and there was no significant interaction between feeding status and stress treatment 
on mpPVN cFos counts.  Although this precluded post hoc comparisons between ad lib-fed and 
DEP rats in each stress treatment group, the data shown in Figure 8 are consistent with the 
hypothesis that DEP reduced cFos activation in the mpPVN under NH control conditions and 





Figure 8. Overnight fasting does not attenuate cognitive stress-induced mpPVN cFos activation 
Summary data illustrating the number of cFos+ mpPVN neurons in ad lib-fed rats (solid bars) or fasted rats (DEP; 
open bars) after no manipulation (nonhandled), restraint stress, or elevated platform stress. See Table 3 for two-way 
ANOVA results. Compared to nonhandled control rats, either restraint or elevated platform exposure increased cFos 
expression within the mpPVN, regardless of feeding status. Despite the apparent trend towards less mpPVN cFos 
activation in fasted rats under nonhandled control conditions or after elevated platform exposure, there was no 




Anterior vlBST neuronal activation 
Low baseline levels of cFos expression were observed within the vlBST in NH control rats, 
regardless of feeding status (Figure 9C). RES and EP stress each significantly increased cFos 
activation in the vlBST, with RES stress evoking a larger increase than EP stress (Table 3, Figure 
9C). The ability of RES or EP to activate cFos in the vlBST was modestly but significantly 
attenuated in DEP rats, in which RES-induced cFos activation remained significantly higher than 





Figure 9. Overnight fasting reduces cFos activation within the anterior vlBST after cognitive stress 
Fasting reduces cFos activation within the anterior vlBST after cognitive stress. Representative color images 
depicting neuronal cFos expression (blue nuclear label) within the PrRP (red) and DβH (green) terminal-rich region 
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of the vlBST (~0.26 mm caudal to bregma). A, in an ad lib-fed rat, many vlBST neurons express cFos after restraint. 
B, fewer vlBST neurons express cFos in a fasted rat after restraint. C, summary data illustrating the number of cFos+ 
neurons per 100 μm2 area of the PrRP/DβH terminal-rich vlBST in ad lib-fed rats (solid bars) or fasted rats (DEP; 
open bars) after no manipulation (nonhandled), restraint stress, or elevated platform stress. See Table 3 for two-way 
ANOVA results. Fasting did not affect baseline cFos but significantly attenuated stress-induced cFos expression in 
the vlBST. Asterisks indicate significantly reduced (p < 0.05) vlBST neural cFos expression in DEP rats vs. ad lib-
fed rats in the same treatment group. Within the same feeding status group (i.e., ad lib or DEP), bars with different 
letters are significantly different (p < 0.05). AC, anterior commissure; vlBST, ventrolateral bed nucleus of the stria 
terminalis. Scale bar in A = 200 μm, applies also to B. 
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Experiment 2: Fasting-induced changes in anxiety-like behavior 
Overnight DEP significantly attenuated anxiety-like behavior on the EPMZ (Figure 10). 
Independent-samples t-tests indicated that, as compared to ad lib-fed rats, DEP rats spent 
significantly more time in the EPMZ open arms [t(6) = 5.599, p = .001] and significantly less 
time in the EPMZ closed arms [t(6) = 5.507, p = .002]. There was no effect of feeding status on 
the amount of time spent in the EPMZ center zone [t(6) = 1.223, p > .05] (Figure 10A). DEP rats 
also made significantly more open arm entries [t(6) = 9.000, p < .001] and significantly fewer 
closed arm entries [t(6) = 2.615, p < .05] than ad lib-fed rats, with no between-group difference 
in the total number of arm entries [t(6) = 0.747, p > .05] (Figure 10B). There also was no effect 
of feeding status on total distance traveled during the 5-min EPMZ test (DEP rats = 16.98 ± 3.09 





Figure 10. Overnight fasting attenuates anxiety-like behavior 
Fasting attenuates anxiety-like behavior. A, summary data illustrating time spent in the open arms, closed arms, and 
center of the elevated plus maze by ad lib-fed rats (solid bars) or fasted rats (DEP; open bars). B, summary data 
illustrating the number of entries into the open arms, closed arms, or total arm entries on the elevated plus maze by 
ad lib-fed or fasted rats. Asterisks indicate significant differences between ad lib-fed vs. fasted groups (p < 0.05). 
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Experiment 3: Fasting-induced changes in CORT response to cognitive stress 
Restraint (RES) stress  
Two-way ANOVA with repeated measures revealed a significant main effect of feeding status 
on plasma CORT, [F(1,9) = 11.478, p < 0.01], such that overnight DEP significantly increased 
plasma CORT concentrations at baseline and in response to RES (Figure 11A). There also was a 
significant main effect of time on CORT concentrations [F(2,18) = 59.5, p < 0.001]. Post hoc 
analyses indicated that plasma CORT levels were lowest at baseline, were increased significantly 
at 30 min after RES onset (peak), and were significantly decreased 30 min after return to the 
home cage (recovery) (Figure 11A). The interaction between feeding status and time also was 
significant [F(2,18) = 7.54, p < 0.01]. In ad lib-fed rats, plasma CORT was significantly elevated 
at peak and then fell significantly during the recovery period. Conversely, in DEP rats, increased 
plasma CORT levels in the peak and recovery samples were statistically similar (Figure 11A). 
Pairwise comparisons indicated that plasma CORT levels in DEP rats were significantly higher 
than in ad lib-fed rats at baseline (ad lib rats = 5.89 ± 1.24 ng/ml; DEP rats = 39.9 ± 12.13 





Figure 11. Overnight fasting increases plasma corticosterone levels in response to cognitive stress 
Fasting increases plasma corticosterone levels at baseline and in response to cognitive stress. A, corticosterone 
levels in ad lib-fed (solid line) or fasted rats (DEP; dashed line) prior to restraint stress (0 min), at the end of restraint 
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stress (30 min), and 30 minutes after return to the home cage (60 min). Ad lib-fed rats displayed a significant 
increase in plasma CORT after 30 min of restraint stress, which decreased significantly by the 60 min recovery time 
point. Compared to ad lib-fed rats, fasted rats displayed significantly higher baseline (0 min) corticosterone levels, 
and a significantly larger increase after 30 min of restraint stress.  Corticosterone levels remained significantly more 
elevated at the 60 min recovery time point in fasted vs. ad lib-fed rats. Asterisks at each time point indicate 
significant differences (p < 0.05) between fed and fasted rats. B, plasma corticosterone levels in ad lib-fed rats (solid 
bars) or fasted rats (DEP; open bars) at baseline (nonhandled), 15 min after the start of a 5-min elevated platform 
exposure (15 min), and 30 min after return to the home cage following elevated platform exposure (35 min). Ad lib-
fed rats sacrificed at the 15 min time point displayed significantly higher plasma corticosterone levels compared to 
baseline, whereas ad lib fed rats sacrificed at the 35 min time point were similar to baseline levels. Plasma 
corticosterone levels were significantly elevated in fasted rats sacrificed at the 15 min time point, and remained 
significantly elevated in fasted rats sacrificed at the 35 min time point. Plasma corticosterone levels were 
significantly higher in fasted vs. fed rats at baseline (nonhandled), 15 min, and 35 min (astericks, p < 0.05).  Within 
the same feeding status group (i.e., ad lib or DEP), bars with different letters are significantly different (p < 0.05). 
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Elevated platform (EP) stress 
Two-way ANOVA indicated a significant main effect of feeding status on plasma CORT 
[F(1,24) = 21.409, p < 0.001], such that DEP rats had significantly higher overall plasma CORT 
levels than ad lib-fed rats (Figure 11B). ANOVA also revealed a main effect of sampling time on 
CORT levels [F(2,24) = 25.216, p < 0.001]. Post hoc analyses indicated that plasma CORT 
concentrations were significantly elevated 15 min after the onset of EP (peak) compared to 
CORT levels sampled at baseline or 30 min after return to the home cage (recovery). A feeding 
status X sampling time interaction was also significant [F(2,24) = 4.203, p < 0.05].  Overnight 
DEP significantly increased plasma CORT levels at baseline and in response to EP as compared 
to CORT responses in ad lib-fed rats (Figure 11B). In ad lib-fed rats, plasma CORT levels were 
significantly elevated in the peak sample group as compared to both the baseline and recovery 
sample groups, while CORT levels in the baseline and recovery sample groups did not differ. 
Conversely, in DEP rats, CORT levels in the recovery sample group remained significantly 
elevated compared to levels in the DEP baseline sample group.  
 
Experiment 4: Role of central GLP-1 signaling in stress-induced hypophagia 
Two-way ANOVA indicated significant main effects of treatment [F(4,40) = 6.593, p < 0.001] 
and time [F(2,80) = 216.254, p < 0.001] on food intake, along with a significant interaction effect 
[F(8,80) = 11.329, p < .001]. RES stress significantly reduced food intake during the first 30 min 
when rats were pre-treated with i.c.v. saline (Figure 12).  Intake during the next 30 min period 
(i.e., 30-60 min) was not significantly reduced by restraint stress, although rats did not 
compensate for the initial period of hypophagia. Thus, total intake from 0-60 min remained 
suppressed after restraint stress in i.c.v. saline-treated rats compared to intake after all other 
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treatments. In the absence of restraint stress, i.c.v. administration of Ex9, the specific GLP-1 
receptor antagonist, slightly but significantly increased intake during the first 30 min compared 
to baseline intake, but not compared to intake after i.c.v. saline alone (Figure 12). Subsequently, 
i.c.v. Ex9-treated rats slightly decreased intake during the second 30 min, as compared to 
baseline, such that 0-60 min intake in i.c.v. Ex9-treated rats was no different than baseline or 
i.c.v. saline. Ex9 pre-treatment significantly attenuated restraint-induced hypophagia during the 
first 30 min, and also from 0-60 min. Food intake was statistically similar in rats under baseline, 





Figure 12. Central (lateral i.c.v.) GLP-1 receptor antagonism ameliorates restraint stress-induced hypophagia 
Dark-onset chow intake (expressed as percentage of body weight) is illustrated during the first 0-30 min, the 
subsequent 30-60 min, and the cumulative 0-60 min period of analysis. Saline vehicle infusion alone did not affect 
chow intake. After i.c.v. saline, restraint stress significantly reduced food intake during the first 30 min. This 
hypophagic effect did not recover during the second 30 min, such that cumulative 60 min intake remained 
suppressed after restraint. On its own, i.c.v. Ex9 slightly but significantly increased food intake compared to baseline 
intake during the first 30 min, but not as compared to intake after i.c.v. saline alone. Intake after Ex9 treatment alone 
was subsequently reduced during the second 30 min, such that no significant effect remained at the cumulative 60 
min time point. Pretreatment with i.c.v. Ex9 significantly attenuated restraint stress-induced hypophagia during the 
first 30 min and at the cumulative 60 min time point. At all time points, food intake was statistically similar in rats 
under baseline, i.c.v. saline, and i.c.v. Ex9 + Restraint conditions. *, significantly different (p < 0.05) compared to 
all other treatment groups at the same time point. #, significantly different (p < 0.05) compared to baseline and Ex9 




Periods of caloric deficit attenuate central drive to the HPA axis, anxiety-like behavior, and 
stress-induced hypophagia in rats, while concurrently increasing circulating levels of CORT at 
baseline and in response to stress (Akana et al., 1994; Hanson et al., 1994; Lennie et al., 1995; 
Youngblood et al., 1997; Heiderstadt et al., 2000; Levay et al., 2007). This metabolic tuning of 
behavior and physiology may promote foraging and food intake during periods of negative 
energy balance, while concurrently facilitating the maintenance of glucose-dependent processes 
(Dallman et al., 1999). Results from the present study reveal a potential central neural 
mechanism for this shift in stress responsiveness: food deprivation eliminates or markedly 
reduces the ability of cognitive stress to activate GLP-1 and PrRP/NA neurons within the cNTS. 
These hindbrain neural populations are known to contribute to anxiety-like behavior, HPA axis 
activation, and stress-induced hypophagia via axonal projections to brainstem, hypothalamic, and 
limbic forebrain targets (Rinaman, 1999a; Lawrence et al., 2000; Cecchi et al., 2002; 
Ciccocioppo et al., 2003; Kinzig et al., 2003; Mera et al., 2006; Choi et al., 2007). Consistent 
with this, we report that overnight fasting reduces anxiety-like behavior and that central GLP-1 
receptor signaling is necessary for cognitive stress-induced hypophagia, reminiscent of previous 
findings that central GLP-1 signaling contributes to anxiety-like behavior and endocrine 
responses to stress (Kinzig et al., 2003). Thus, fasting-induced "silencing" of GLP-1 and 
PrRP/NA neurons offers a potential mechanism through which negative energy balance 
decreases centrally mediated behavioral responses to stress.  
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Fasting Decreases GLP-1 cFos Activation 
We report that GLP-1 neurons within the cNTS and medullary reticular formation are activated 
by cognitive stress (i.e., restraint and elevated platform exposure) in rats fed ad libitum. 
Considering that GLP-1 neurons in rats are glutamatergic (Zheng & Rinaman, submitted) and 
that their axon terminals synapse directly onto CRH neurons within the mpPVN (Sarkar et al., 
2003a), stress-induced activation of hindbrain GLP-1 neurons likely drives activation of mpPVN 
neurons at the apex of the HPA axis. Indeed, GLP-1 receptor signaling facilitates glutamate 
release and increases spike frequency in PVN neurons (Acuna-Goycolea and Pol, 2004), 
contributing to increased plasma CORT concentrations (Kinzig et al., 2003). 
In marked contrast to the results summarized above in rats fed ad libitum, an overnight 
fast abolished GLP-1 cFos activation under all conditions assessed in the present study, evidence 
that caloric deficit inhibits GLP-1 neurons, blocks their responses to excitatory synaptic input, 
and/or silences that input. These results extend a previous report indicating that fasting 
eliminates GLP-1 cFos activation in response to visceral stress (Maniscalco and Rinaman, 2013). 
The consequences of abolished GLP-1 neural recruitment could include anxiolysis and blunted 
activation of mpPVN neurons at the apex of the HPA axis (Kinzig et al., 2003), attenuation of 
stress-induced hypophagia (present study), and modification of other stress-related responses in 
which GLP-1 signaling has been implicated, including sympathetic activation, reduced gastric 
emptying, hyperthemia, and increased colonic motility (O'Shea et al., 1996; Gulpinar et al., 
2000; Yamamoto et al., 2002).  
While numerous studies have noted the presence of GLP-1 neurons within the medullary 
reticular formation (Larsen et al., 1997b; Rinaman, 1999b), ours is the first to quantify and report 
their substantial contribution (i.e., ~44%) to the total GLP-1 population. Our results revealed no 
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difference between cNTS and reticular GLP-1 neurons in their activation after cognitive stress 
(Table 4), suggesting that both populations receive similar direct and relayed central inputs from 
hypothalamic and limbic forebrain regions that convey cognitive stress signals to the caudal 
medulla (Dayas and Day, 2001; Dayas et al., 2004). 
 
Fasting Decreases Activation of PrRP+ and PrRP- NA neurons of the A2 cell group 
In addition to activating GLP-1 neurons, restraint and elevated platform stress also significantly 
increased cFos activation of the PrRP+ subpopulation of NA A2 neurons in ad lib-fed rats, with a 
greater degree of activation induced by restraint (~90%) compared to elevated platform exposure 
(~ 52%). These results are consistent with previous reports that PrRP+ A2 neurons are activated 
in rats after cognitive stress, including water-immersion restraint (Maruyama et al., 2001), 
footshock (Morales and Sawchenko, 2003), and conditioned fear cues (Zhu and Onaka, 2003), 
and provide the first evidence that they also are activated after 5-min exposure to an elevated 
platform. Further, we discovered that overnight fasting eliminates cFos activation of PrRP+ A2 
neurons under baseline control conditions and after elevated platform exposure, and substantially 
attenuates their otherwise robust responses to restraint stress.  These results indicate that PrRP+ 
A2 neurons within the cNTS are inhibited or otherwise "silenced" by overnight food deprivation, 
similar to GLP-1 neurons.  
Activation of NA/PrRP A2 neurons likely contributes to stress-induced activation of the 
HPA axis and to behavioral anxiety, since these neurons project densely to the mpPVN and 
anterior vlBST (Maruyama et al., 1999; Morales et al., 2000; Banihashemi and Rinaman, 2006; 
Rinaman, 2010). Central ventricular or intra-PVN administration of norepinephrine (NE) or 
PrRP drives HPA axis activation (Plotsky, 1987; Itoi et al., 1999; Cole and Sawchenko, 2002; 
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Seal et al., 2002; Mera et al., 2006), and pharmacological antagonism of NA signaling or 
immunotoxic lesion of A2 neurons (presumably including the PrRP+ subset) that innervate the 
mpPVN and anterior vlBST attenuates behavioral anxiety and neuroendocrine responses to stress 
(Cecchi et al., 2002; Bienkowski and Rinaman, 2008; Zheng and Rinaman, 2013). Considering 
this, our findings support the view that fasting-induced attenuation of A2 NA/PrRP neuronal 
signaling plays a key role in attenuating behavioral and physiological responses to acute stress. 
Less is known regarding the specific functions of the PrRP- population of NA neurons 
within the cNTS. PrRP- NA neurons displayed negligible cFos activation at baseline, regardless 
of feeding status. In ad lib-fed rats, cFos activation of PrRP- NA neurons was increased after 
both cognitive stressors, with a larger increase after restraint stress compared to elevated 
platform exposure, similar to the PrRP+ neural population. Notably, however, PrRP- NA neurons 
were significantly less stress responsive than PrRP+ or GLP-1 neurons, with a maximal response 
of only ~25% activation after restraint. This difference in relative stress sensitivity may result 
from the anatomical location of PrRP- NA neurons. The more stress-responsive PrRP+ 
population of A2 neurons and GLP-1 neurons are located caudal to the AP, whereas most PrRP- 
NA neurons are located at and rostral to the AP. Comparisons of stress-induced cFos activation 
of A2 neurons indicates that cognitive stressors recruit A2 neurons at more caudal levels than 
those recruited by visceral stressors (Dayas et al., 2001b), consistent with a report that visceral 
stressors do not activate PrRP+ NA neurons as robustly as do cognitive stressors (Morales and 
Sawchenko, 2003). Despite the lower sensitivity of PrRP- A2 neurons to cognitive stress, their 




Mechanisms Underlying Fasting-Mediated Suppression of GLP-1 and A2 Neural Activation 
We can only speculate as to how an overnight fast reduces cFos activation within hindbrain 
GLP-1 and NA A2 neurons. Since rats consume most of their calories during the dark cycle, a 
single overnight fast generates acute negative energy balance and elicits marked changes in 
physiology, including activation of the HPA axis during the dark cycle in a pattern that 
corresponds to the missed meals (Akana et al., 1994; Dallman et al., 1999). Conceivably, this 
could generate feedback signals that inhibit GLP-1 and A2 neurons, desensitize them to 
excitatory inputs, and/or silence those inputs during the subsequent morning (i.e., when 
experiments were conducted in the present study). Neurons within the cNTS receive direct 
glutamatergic innervation from vagal afferent neurons as well as inputs from neurons in a variety 
of brainstem, hypothalamic, and limbic forebrain regions, and are also sensitive to circulating 
factors that convey information regarding digestive and metabolic status (Altschuler et al., 1989; 
Miselis et al., 1991; Schwartz et al., 1991a; Stornetta et al., 2002; Appleyard et al., 2007; 
Hisadome et al., 2010; Potes and Lutz, 2010; Maniscalco et al., 2013). Fasting may reduce 
excitatory inputs or increase inhibitory inputs to GLP-1 and A2 neurons, thereby preventing their 
activation after cognitive stress. For example, circulating levels of leptin are decreased while 
levels of the gut hormone ghrelin are increase during fasting (Dallman et al., 1999; Tschop et al., 
2000; Pico et al., 2002), and vagal sensory signaling to the cNTS is increased by leptin signaling 
and decreased by ghrelin signaling (Date et al., 2002; Peters et al., 2004; Date et al., 2005; Peters 
et al., 2006a; Cui et al., 2011), providing two routes through which fasting-mediated peripheral 




Fasting Decreases Neural Activation in the Anterior vlBST 
Neurons within the anterior vlBST exert control over autonomic, neuroendocrine, and behavioral 
responses to homeostatic threats via efferent projections to the mpPVN, central nucleus of the 
amygdala, periaqueductal gray, and numerous other brain regions (Gray and Magnuson, 1992; 
Dong et al., 2001; Walker et al., 2003; Crestani et al., 2013). Lesions or pharmacological 
inactivation of neurons within the vlBST decrease anxiety-like behavior (Walker and Davis, 
1997), decrease basal mpPVN CRH mRNA expression (Herman et al., 1994) and attenuate 
stress-induced increases in mpPVN cFos activation, plasma ACTH levels, and plasma CORT 
concentrations (Choi et al., 2007). The anterior vlBST – particularly the fusiform subnucleus – 
receives moderate innervation by GLP-1 neurons (Rinaman, 2010) and particularly dense 
innervation from PrRP+ A2 neurons (Forray and Gysling, 2004; Banihashemi and Rinaman, 
2006) (Figure 9). Further, neuroendocrine and anxiety-like responses to cognitive stress are 
mimicked and facilitated by central PrRP and NA signaling, including NA signaling targeted to 
the anterior vlBST (Cecchi et al., 2002; Cole and Sawchenko, 2002; Mera et al., 2006). 
Considering this, we hypothesized that fasting-induced "silencing" of GLP-1 and PrRP+ A2 
neurons would attenuate stress-induced activation of both mpPVN and anterior vlBST neurons. 
Although a main effect of feeding status on mpPVN cFos activation failed to reach statistical 
significance (p = 0.07), stress-induced activation of neurons within the anterior vlBST was 
significantly attenuated in fasted rats, consistent with fasting-induced suppression of excitatory 
inputs to the anterior vlBST that arise from GLP-1 and PrRP+ A2 neurons (Cecchi et al., 2002; 




Fasting Decreases Anxiety-like Behavior  
Acute overnight fasting significantly reduced anxiety-like behavior on the EPMZ, consistent 
with decreased cFos expression within the anterior vlBST and within hindbrain PrRP+ A2 and 
GLP-1 neurons. Ad lib-fed rats spent a majority of the 5 min test moving between the two closed 
arms, with very little open arm exploration. Fasted rats, however, displayed significantly 
increased open arm exploration, as evidenced by increased open arm time and entries compared 
to ad lib-fed rats. Our results are consistent with the hypothesis that the anxiolytic effects of 
caloric deficit permit increased exploration of the "anxiogenic" environment, i.e., the brightly lit 
open arms of the maze. There were no differences, however, between fasted and fed rats in the 
total number of arm entries or total distance traveled on the maze during the 5 min test, arguing 
against a general increase in locomotion after fasting.  These results are consistent with the 
hypothesis that fasting-induced suppression of GLP-1 and/or NA/PrRP signaling to the anterior 
vlBST contributes to the anxiolytic effects of caloric deficit. 
 
Fasting Increases CORT levels at Baseline and After Cognitive Stress  
Fasting elevated baseline plasma CORT levels, consistent with some (Kiss et al., 1994) but not 
all (Akana et al., 1994) previous reports. Regardless of feeding status, CORT levels after 
elevated platform exposure were lower than levels after restraint stress, evidence that restraint is 
the more "stressful" treatment. In ad lib-fed rats exposed to either stressor, CORT levels were 
significantly elevated 30 min after stress onset and markedly reduced 30 min after stress 
termination, consistent with previous reports (Bhatnagar and Dallman, 1998). Fasting, however, 
significantly increased peak CORT levels and delayed recovery after both stressors, particularly 
following restraint. These results validate previous reports that fasting increases peak CORT 
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levels after restraint stress (Akana et al., 1994; Kiss et al., 1994), and newly demonstrate that 
fasting also interferes with post-stress recovery of baseline CORT levels. CORT synthesis occurs 
within minutes of stressor onset (Sapolsky et al., 2000), and fasting has been reported to reduce 
plasma CORT degradation and clearance in rats (Herbst et al., 1960; Woodward et al., 1991; 
Kiss et al., 1994). Thus, even though fasting appears to reduce central drive to the HPA stress 
axis (i.e., to CRH neurons within the mpPVN), reduced CORT catabolism might explain the 
higher CORT levels measured at baseline and after stress in fasted rats.  
 
Central GLP-1 Signaling is Necessary for Cognitive Stress-Induced Hypophagia 
Central GLP-1 signaling has well-established hypophagic properties (Turton et al., 1996; 
Rinaman, 1999a), and previous reports using the GLP-1 receptor antagonist Ex9 indicate that 
central GLP-1 signaling is critical for the suppression of food intake by visceral stressors (i.e., 
lithium chloride and lipopolysaccharide) (Rinaman, 1999a; Grill et al., 2004). The present study 
provides the first evidence that central GLP-1 signaling also is necessary for the hypophagic 
effect of cognitive stress (i.e., restraint). Under baseline conditions, rats ate slightly less than 2% 
of their body weight in chow during the first hour of the dark period, with two-thirds of that 
intake occurring within the first 30 minutes. This intake pattern was not altered by i.c.v. 
administration of saline alone. However, i.c.v. saline followed by restraint significantly reduced 
intake by 70% during the first 30 min, and by 55% overall during the first hour. This finding is 
consistent with previous reports that restraint stress has anorectic effects (Krahn et al., 1986; 
Rybkin et al., 1997). The most important finding of our experiment was that the hypophagic 
response to restraint was abolished by i.c.v. pretreatment with Ex9, strongly supporting the 
hypothesis that endogenous GLP-1 receptor signaling contributes to (or mediates) cognitive 
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stress-induced hypophagia. Although we did not localize the central site(s) of action at which 
GLP-1 signaling suppresses food intake after restraint stress, a previous report indicates that 4th 
ventricular Ex9 attenuates hypophagia in rats after lipopolysaccharide administration (Grill et al., 
2004). Thus, a brainstem site of action appears likely. Although central PrRP signaling also 
suppresses food intake and may contribute to stress-induced hypophagia (Lawrence et al., 2000; 
Maniscalco et al., 2013), we did not evaluate this possibility given the current lack of 
pharmacological tools to antagonize PrRP receptors. 
 
Conclusions 
Results from the present study indicate that a single overnight fast markedly reduces the ability 
of cognitive stress to activate GLP-1 and PrRP+ A2 neurons within the cNTS. Fasting also 
reduces neuronal activation within the NA/PrRP terminal-rich vlBST, and decreases anxiety-like 
behavior. Our results also establish a critical role for endogenous GLP-1 receptor signaling in 
cognitive stress-induced hypophagia. We conclude that metabolic tuning of hindbrain GLP-1 and 
PrRP+ A2 neurons is a potential mechanism through which negative energy balance decreases 





4.0  GHRELIN RECEPTOR SIGNALING CONTRIBUTES TO FASTING-INDUCED 
SUPPRESSION OF HINDBRAIN NEURAL RESPONSES TO SYSTEMIC 
CHOLECYSTOKININ 
4.1 INTRODUCTION 
We recently reported that an overnight fast eliminates or markedly attenuates the ability of 
systemically administered cholecystokinin-8 (CCK) to activate cFos expression within hindbrain 
glucagon-like peptide-1 (GLP-1) neurons and noradrenergic (NA) A2 neurons that co-express 
prolactin-releasing peptide (PrRP) (Maruyama et al., 2001; Maniscalco and Rinaman, 2013). In 
ad libitum (ad lib)-fed rats, CCK increases the firing rate of gastrointestinal vagal sensory 
neurons that innervate the caudal (visceral) nucleus of the solitary tract (cNTS), activating GLP-
1, PrRP+ A2, and other cNTS neurons, thereby suppressing food intake (Smith et al., 1981; 
Raybould et al., 1988; Luckman, 1992; Schwartz et al., 1993; Monnikes et al., 1997; Rinaman, 
1999b; Lawrence et al., 2002; Rinaman, 2003a; Appleyard et al., 2007). In addition to eliciting 
satiety/hypophagia (Lawrence et al., 2000; Hayes et al., 2009), central GLP-1 and NA/PrRP 
signaling is strongly implicated in numerous physiological and behavioral components of energy 
balance and stress responses (Matsumoto et al., 2000; Cecchi et al., 2002; Kinzig et al., 2003; 
Maniscalco et al., 2013). Thus, the ability of food deprivation to decrease activation of GLP-1 
and PrRP+ A2 neurons may contribute to attenuations observed in both satiety 
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signaling/hypophagia and centrally mediated stress responses during periods of caloric deficit 
(Akana et al., 1994; Hanson et al., 1994; Lennie et al., 1995; Genn et al., 2003; Inoue et al., 
2004) (Chapter 3). Overnight fasting in rats, however, produces widespread metabolic and 
physical changes (Dallman et al., 1999), many of which might directly or indirectly affect 
hindbrain GLP-1 and PrRP+ A2 neurons. Identifying which components of fasting are 
responsible for altering activation of these neurons in response to systemic CCK will therefore 
clarify how satiety signaling and neural stress responses are reorganized during periods of 
negative energy balance.  
In fasted rats, reduced responsiveness of GLP-1 and PrRP+ A2 neurons to systemic CCK 
treatment could result from the loss of an excitatory signal that is present in ad lib-fed rats, the 
generation of an inhibitory signal associated with food deprivation, or both. Since CCK-induced 
activation of cNTS neurons depends on the integrity of glutamatergic vagal afferent signaling 
(Raybould et al., 1988; Monnikes et al., 1997; Appleyard et al., 2007), fasting-induced 
modulation of GLP-1 and PrRP+ A2 neuronal response to CCK could occur at the level of vagal 
afferents and/or within the cNTS itself. Considering this, we speculated that fasting-induced 
changes in leptin and/or ghrelin signaling are involved, as circulating levels of leptin and ghrelin 
reflect energy balance, and each hormone is poised to signal at vagal sensory neurons and within 
the cNTS. 
Leptin, the peptide product of the obese (Ob) gene, is released from adipose tissue and 
the gastric epithelium to signal long- and short-term caloric surfeit, respectively (Zhang et al., 
1994; Bado et al., 1998). Peripherally, leptin binds receptors on the vagus nerve (Buyse et al., 
2001; Burdyga et al., 2002) and depolarizes vagal afferents that synapse within the cNTS (Peters 
et al., 2006a). Following transport through the blood brain barrier (BBB) (Banks et al., 1996), 
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leptin acts directly on neurons of the cNTS, including PrRP+ A2 neurons (Hay-Schmidt et al., 
2001; Ellacott et al., 2002; Maniscalco and Rinaman, 2014). Since plasma leptin levels fall 
markedly in rats during overnight fasting (Dallman et al., 1999; Pico et al., 2002), reduced leptin 
signaling is a strong candidate factor underlying fasting-induced decreases in GLP-1 and PrRP+ 
A2 neuronal responses to exogenous CCK. Indeed, a substantial literature indicates that leptin 
signaling facilitates CCK-induced activation of cNTS neurons. Central leptin administration 
increases CCK-induced cFos expression within the cNTS (Emond et al., 1999) and A2 neurons 
(Williams et al., 2009), an effect that is recapitulated following peripheral leptin administration 
(Wang et al., 1998). The latter effect likely results, at least in part, from direct leptin signaling on 
vagal sensory neurons, since the majority of vagal afferents that are depolarized by leptin are 
also depolarized by CCK in vitro (Peters et al., 2006b), and co-administration of leptin enhances 
CCK-induced elevations in cytosolic calcium within cultured nodose neurons (Peters et al., 
2004). Thus, marked reductions in CCK-induced activation of GLP-1 and A2 neurons in fasted 
rats could result from reduced leptin signaling at the level of the vagus nerve, the cNTS, or both.  
Ghrelin is a potent orexigenic hormone produced by cells of the upper gastrointestinal 
(GI) tract (Kojima et al., 1999; Date et al., 2000; Toshinai et al., 2001). Unlike leptin and most 
GI hormones, plasma levels of ghrelin rise during fasting (Tschop et al., 2000; Bagnasco et al., 
2002), and a growing body of literature implicates ghrelin signaling in the suppression of 
vagally-mediated responses to CCK. Following release from the stomach, ghrelin acts at 
peripheral receptors expressed by CCK-sensitive vagal afferents to decrease their firing rate 
(Date et al., 2002; Date et al., 2005). Moreover, ghrelin pre-treatment prevents CCK-induced 
increases in vagal afferent spike frequency (Date et al., 2005), evidence that ghrelin signaling not 
only inhibits activation of vagal afferents and subsequent glutamate release in the cNTS 
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(Appleyard et al., 2007), but also prevents the otherwise robust activation of these afferents by 
CCK. Similar to leptin, ghrelin has direct central effects following transport across the BBB 
(Banks et al., 2002), the physiological importance of which is highlighted by the fact that ghrelin 
transport is facilitated during fasting (Banks et al., 2008). Within the cNTS, ghrelin acts directly 
on the synaptic terminals of vagal afferents to suppress glutamate release onto A2 cNTS neurons, 
resulting in decreased A2 firing rate (Cui et al., 2011). Interestingly, the ability of ghrelin to 
suppress glutamatergic vagal afferent signaling is enhanced in rats after an 18 hr overnight fast 
(Cui et al., 2011), suggesting that ghrelin’s signaling properties are more potent in fasted 
animals. Together, these findings strongly suggest that increased ghrelin signaling during periods 
of caloric deficit actively suppresses the ability of CCK to recruit hindbrain GLP-1 and PrRP+ 
A2 neurons. 
Considering the evidence presented above, we hypothesized that experimental 
manipulations to either increase circulating levels of leptin or to block ghrelin receptor signaling 
in fasted rats would rescue the ability of systemically administered CCK to activate GLP-1 and 
PrRP+ A2 neurons within the cNTS. 
4.2 MATERIALS & METHODS 
Animals 
Adult male Sprague-Dawley rats (Harlan, IN; 225-275g BW) were housed singly in hanging 
stainless steel wire mesh cages in a temperature-controlled room (20-22°C) on a 12/12 hr 
light/dark cycle (lights on at 0700 hr). Rats had ad libitum access to pelleted chow (Purina 5001) 
and water, except as noted. All experiments were conducted in accordance with the NIH Guide 
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for the Care and Use of Laboratory Animals and were approved by the University of Pittsburgh 
Institutional Animal Care and Use Committee. Rats were weighed one day prior to systemic drug 
treatments to determine proper dosage. Rats were returned to their home cage and deprived of 
food (but not water) for 16-18 hr overnight before injection. 
 
Experiment 1: Leptin co-administration with CCK 
On the day of the experiment rats were removed from their home cage between 0830 and 1030 
hr and injected intraperitoneally (i.p.) with 1.0 ml of sterile 0.15 M NaCl containing leptin alone 
(400 or 800 μg/kg BW; Sigma-Aldrich; L5037; n =4) or leptin plus sulfated CCK (3 μg/kg BW; 
Bachem; H-2080; n = 4). CCK and/or leptin were dissolved in vehicle just prior to injection, and 
rats were returned to their home cage immediately after injection. The 3 μg/kg BW dose of CCK 
elicits robust cFos activation in GLP-1 and A2 neurons in ad lib-fed rats, which is significantly 
reduced in fasted rats (Maniscalco and Rinaman, 2013). The 400 and 800 μg/kg BW doses of 
leptin each elicit a maximal pSTAT3 response in the cNTS in fasted rats (Maniscalco and 
Rinaman, 2014). Since there were no differences in the ability of the two leptin doses to alter 
hindbrain neural activation in the present study, data from rats receiving either dose were 
combined for statistical purposes.  
 
Experiment 2: Ghrelin antagonist pretreatment and CCK  
On the day of the experiment, rats (n = 20) were removed from their home cage between 0830 
and 1030 hr and received one of the following four i.p. treatments: 1) vehicle (0.15M NaCl), 2) 
vehicle containing ghrelin receptor antagonist (GRA; [D-Lys3]-GHRP-6; 3.3 mg/kg BW; Sigma-
Aldrich, G4535), 3) vehicle followed 30 min later by CCK (3 μg/kg BW), or 4) GRA followed 
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30 min later by CCK (n = 4-8 per treatment group). Pretreatment with GRA (or saline, to control 
for dual injections) was performed in order to achieve ghrelin receptor blockade before CCK 
treatment, and published data indicate that GRA robustly suppresses food intake in rats within 30 
minutes after i.p. administration (Asakawa et al., 2003). 
 
Perfusions & immunohistochemistry 
Ninety minutes after the first (or only) injection, rats were deeply anesthetized with pentobarbital 
sodium (39 mg/1.0 ml i.p., Fatal Plus Solution; Butler Schein) and perfused transcardially with a 
brief saline rinse followed by fixative (100 ml of 2% paraformaldehyde and 1.5% acrolein in 
0.1M phosphate buffer, followed by 100 ml of 2% paraformaldehyde alone). Brains were post-
fixed in situ overnight at 4°C, then removed from the skull and cryoprotected for 24-48 hr in 
20% sucrose. Brains were blocked and sectioned coronally (35μm) using a Leica freezing-stage 
sliding microtome. Tissue sections were collected in six serial sets, and stored at -20°C in 
cryopreservant solution (Watson et al., 1986) until immunohistochemical processing. Tissue sets 
from rats injected i.p. with CCK (3 μg/kg BW) and processed according to the same injection 
and perfusion protocol used here (n = 4 ad lib-fed; n = 4 DEP), were obtained from a recent 
study (Maniscalco and Rinaman, 2013). These tissue sets were processed for 
immunohistochemistry together with tissue sets from animals here, providing comparisons to 
treatment groups in experiments 1 and 2.  
Primary and secondary antisera were diluted in 0.1M phosphate buffer containing 0.3% 
Triton X-100 and 1% normal donkey serum. Two sets of tissue sections from each rat were 
incubated in a rabbit polyclonal antiserum against cFos (1:20,000; EMD Chemicals, PC38), 
followed by biotinylated donkey anti-rabbit IgG (1:500; Jackson ImmunoResearch). Sections 
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were then treated with Elite Vectastain ABC reagents (Vector) and reacted with 
diaminobenzidine (DAB) intensified with nickel sulfate to produce a blue-black nuclear cFos 
reaction product. To visualize cFos within hindbrain GLP-1 neurons, one set of cFos-labeled 
tissue sections was subsequently incubated in a rabbit polyclonal antiserum against GLP-1 
(1:10,000; Bachem, T-4363), followed by biotinylated donkey anti-rabbit IgG (1:500; Jackson 
ImmunoResearch), Elite Vectastain ABC reagents (Vector), and reacted with plain DAB to 
produce a brown cytoplasmic reaction product. To visualize cFos within PrRP+ A2 neurons in 
the cNTS, the second set of cFos-labeled tissue sections was incubated in rabbit anti-PrRP 
(1:1,000; Phoenix Pharmaceuticals, H-008-52). After rinsing, sections were incubated in Cy3-
conjugated donkey anti-rabbit IgG (1:300, Jackson ImmunoResearch) to produce a red 
fluorescent cytoplasmic signal.  
 
Imaging & quantification of cFos expression by GLP-1 neurons 
GLP-1 neurons were visualized using a light microscope and 20/40X objectives to determine the 
number of single-labeled GLP-1+ neurons, and the number of double-labeled GLP-1+/cFos+ 
neurons. Single- and double-labeled GLP-1 neurons were quantified bilaterally within the cNTS 
and adjacent reticular formation, and counts were made through the entire rostrocaudal extent of 
the GLP-1 cell group (i.e., from the cervical spinal cord through the NTS just rostral to the area 
postrema; ~15.46 mm to 13.15 mm caudal to bregma). Criteria for counting a neuron as GLP-1+ 
included clear cytoplasmic labeling and a visible nucleus. Criteria for counting a neuron as 
double-labeled included brown GLP-1 cytoplasmic labeling and a nucleus that contained visible 
blue-black cFos immunolabeling, regardless of intensity. In each analyzed case, cFos activated 
GLP-1 neurons were represented as a percent of total GLP-1 neurons. 
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Imaging & quantification of cFos expression by PrRP+ A2 neurons 
PrRP+ A2 neurons were imaged in the caudal NTS using a 20X objective on an Olympus 
microscope equipped for brightfield and epifluorescence, and photographed using a digital 
camera (Hamamatsu Photonics, Hamamatsu, Japan). Neurons were counted in photographic 
images using Adobe Photoshop CS4 image software. Criteria for counting a neuron as PrRP+ 
included clear cytoplasmic labeling and a visible nucleus. Neurons were considered cFos+ if their 
nucleus contained blue/black cFos immunoperoxidase labeling, regardless of intensity. Single- 
and double-labeled neurons were counted bilaterally through the rostrocaudal extent of the PrRP+ 
cell group (i.e., from the cervical spinal cord through the NTS at the level of the area postrema; 
~15.46 mm to 13.15 mm caudal to bregma). In each analyzed case, cFos activated PrRP+ neurons 
were represented as a percent of total PrRP+ neurons. 
 
Statistics 
Separate one-way ANOVAs were used to determine the effect of leptin co-administration or 
GRA pretreatment on CCK-induced cFos activation within hindbrain GLP-1 or PrRP+ A2 
neurons in fasted rats. When F values indicated a significant main effect of i.p. treatment, the 
ANOVA was followed by Fisher’s least significant difference post hoc analyses. Differences 




Experiment 1: Leptin co-administration with CCK 
Leptin co-administration did not increase the ability of CCK to activate cFos in hindbrain GLP-1 
or PrRP+ A2 neurons in fasted rats (Figure 13). ANOVA indicated a significant effect of 
treatment on the proportion of GLP-1 and PrRP+ A2 neurons that were activated to express cFos 
[GLP-1: F(3,12) = 153.173, p < .001; PrRP: F(3,12) = 63.683, p < .001]. Post hoc analyses for 
each ANOVA indicated that ad lib-fed rats treated with CCK displayed significantly higher 
proportions of cFos activated GLP-1 and PrRP+ A2 neurons compared to all other treatment 
groups. There were no other differences in GLP-1 or PrRP+ A2 neural activation between 





Figure 13. Leptin is not sufficient to rescue CCK-induced GLP-1 or PrRP+ A2 cFos activation in fasted rats 
A, color image depicting neuronal cFos expression (black nuclear label) and GLP-1+ neurons (brown cytoplasmic 
label) in the cNTS of a rat that received i.p. co-injection of CCK (3 μg/kg BW) and leptin (800 μg/kg BW). Despite 
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robust cNTS cFos activation, very few cFos+/GLP-1+ neurons are present. Inset, higher magnification view of 
several GLP-1+ neurons, none of which express cFos. B, color image depicting neuronal cFos expression (green 
nuclear label) and PrRP+ neurons (red cytoplasmic label) in the cNTS of a rat that received i.p. co-injection of CCK 
(3 μg/kg BW) and leptin (800 μg/kg BW). Despite robust cNTS cFos activation, very few cFos+/PrRP+ neurons are 
present. Inset, higher magnification view of several PrRP+ neurons, none of which express cFos. C, summary data 
illustrating the proportion of cFos+ hindbrain GLP-1 neurons (solid bars) or PrRP+ A2 neurons (striped bars). Within 
the same neuronal population (i.e., GLP-1 or PrRP), bar values with different letters are significantly different (p < 
.05). 
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Experiment 2: Ghrelin receptor antagonist pre-treatment and CCK 
GRA pretreatment in fasted rats partially rescued the ability of CCK to activate cFos expression 
in both GLP-1 and PrRP+ A2 neurons (Figure 14). ANOVA indicated a significant effect of 
treatment on the proportion of GLP-1 and PrRP+ A2 neurons that were cFos+ [GLP-1: F(5,22) = 
9.025, p < 0.001; PrRP: F(5,22) = 8.092, p < 0.001]. Post hoc analyses for each ANOVA 
indicated that ad lib-fed rats treated with CCK displayed a significantly higher proportion of 
GLP-1 and PrRP+ A2 neural activation, as compared to all other treatment groups. Additionally, 
fasted rats receiving GRA + CCK displayed significantly increased activation of GLP-1 and 
PrRP+ A2 neurons compared to fasted rats receiving CCK alone, saline vehicle alone, GRA 
alone, or vehicle + CCK.  GLP-1 and PrRP+ A2 neural activation was statistically similar 





Figure 14. Ghrelin receptor antagonism partially rescues CCK-induced cFos activation of GLP-1 and PrRP+ 
A2 neurons in fasted rats 
Ghrelin receptor antagonist pretreatment partially rescues CCK-induced cFos activation of hindbrain GLP-1 and 
PrRP+ A2 neurons in fasted rats. A, color image depicting neuronal cFos expression (black nuclear label) within 
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GLP-1+ neurons (brown cytoplasmic label) in the cNTS of a rat that received i.p. pretreatment with ghrelin receptor 
antagonist (3.3 mg/kg BW) prior to i.p. CCK (3 μg/kg BW). Inset, higher magnification view of several cFos+/GLP-
1+ neurons. B, color image depicting neuronal cFos expression (green nuclear label) within PrRP+ neurons (red 
cytoplasmic label) in the cNTS of a rat that received i.p. pretreatment with ghrelin receptor antagonist (3.3 mg/kg 
BW) prior to i.p. CCK (3 μg/kg BW). Inset, higher magnification view of several PrRP+ neurons, some of which 
express cFos. C, summary data illustrating the proportion of cFos+ hindbrain GLP-1 neurons (solid bars) or PrRP+ 
A2 neurons (lined bars). Within the same neuronal population (i.e., GLP-1 or PrRP), bar values with different letters 
are significantly different (p < .05). 
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4.4 DISCUSSION 
Overnight fasting substantially reduces or eliminates the ability of CCK to activate cFos 
expression within hindbrain A2 NA neurons and GLP-1 neurons (Maniscalco and Rinaman, 
2013). We also recently discovered that overnight fasting similarly blocks or attenuates the 
ability of cognitive stress to elicit cFos activation of GLP-1 and PrRP+ A2 neurons (Chapter 3). 
However, the mechanisms by which fasting tunes hindbrain neural sensitivity to vagal sensory 
and other neural inputs are unresolved. Here, we provide evidence that increased ghrelin 
signaling during overnight food deprivation suppresses CCK-induced activation of both GLP-1 
and PrRP+ A2 neurons. Conversely, leptin administration was insufficient to rescue neural cFos 
responses to CCK in fasted rats.  
 
Fasting decreases GLP-1 and PrRP+ A2 neural cFos activation 
Administration of 3 μg/kg BW CCK to ad lib-fed rats robustly activated cFos expression in 
hindbrain GLP-1 neurons and PrRP+ A2 neurons, consistent with previous reports (Rinaman, 
1999b; Lawrence et al., 2002; Maniscalco and Rinaman, 2013). Lawrence et al. (2002) reported 
that a high dose of CCK (i.e., 50 μg/kg BW) elicits ~85% activation of cNTS PrRP+ A2 neurons 
in fed rats, whereas an even higher dose (100 μg/kg BW) activated ~57% of GLP-1 neurons in 
fed rats (Rinaman, 1999b). While the much lower dose of CCK used in the present study (i.e., 3 
μg/kg BW) should more closely approximate levels resulting from postprandial release of 
endogenous CCK, it was sufficient to activate ~60% of GLP-1 and PrRP+ A2 neurons in ad lib-
fed rats, likely reflecting the importance of signaling from these neurons in satiety and stress 
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induced hypophagia (Rinaman, 1999a; Lawrence et al., 2002; Grill et al., 2004; Maniscalco et 
al., 2013). 
In contrast to the robust CCK-induced cFos activation of GLP-1 neurons in ad lib-fed 
rats, this population displayed little or no cFos response to CCK in fasted rats, consistent with 
our previous report (Maniscalco and Rinaman, 2013). Although GLP-1 neurons appear to be 
highly desensitized to stimulus input during fasting, they are not completely refractory, as the 
strong stimulus of a gastric balloon distention is sufficient to increase activation of these neurons 
in fasted rats (Vrang et al., 2003). Similar to the GLP-1 population, fasting nearly eliminated 
CCK-induced activation of PrRP+ A2 neurons, a novel result indicating substantial metabolic 
sensitivity in the PrRP+ subset of A2 neurons. This finding is particularly interesting when 
interpreted in light of a previous report that quantified cFos activation in all A2 neurons (i.e., 
both PrRP+ and PrRP- subsets) of fed and fasted rats. In that study, a substantial proportion of 
total A2 neurons was activated by CCK in fasted rats (Maniscalco and Rinaman, 2013). 
Considering that nearly all PrRP+ A2 neurons are refractory to CCK-induced cFos activation 
during fasting (Figure 13), activation of the total A2 population during fasting must result nearly 
entirely from recruitment of PrRP- neurons. While this has yet to be determined empirically, it 
suggests a dichotomy in the metabolic sensitivity of PrRP+ and PrRP- A2 neural subsets, the 
importance of which is currently unknown. 
 
Ghrelin receptor antagonism partially rescues CCK-induced activation of GLP-1 and PrRP+ A2 
neurons in fasted rats 
CCK-mediated recruitment of cNTS neurons occurs via activation of glutamatergic vagal 
afferent fibers (Raybould et al., 1988; Monnikes et al., 1997; Appleyard et al., 2007), and ghrelin 
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signaling inhibits vagal afferent activation and central vagal glutamate release (Date et al., 2002; 
Cui et al., 2011). Since circulating ghrelin levels rise during fasting (Tschop et al., 2000), we 
hypothesized that ghrelin signaling inhibits vagal afferent input to cNTS neurons during an 
overnight fast, thereby preventing CCK-induced activation of GLP-1 and PrRP+ A2 neurons. 
Indeed, ghrelin receptor antagonism in fasted rats partially rescued CCK-induced cFos activation 
in GLP-1 and PrRP+ A2 neurons, confirming our hypothesis. On average, GRA pretreatment 
rescued slightly less than 50% of the cFos activation observed in ad lib-fed rats. In fasted rats, no 
change in cFos activation occurred following saline treatment alone or saline pretreatment prior 
to CCK, indicating that the handling and stress associated with each injection procedure does not 
alter cFos activation of these hindbrain neurons. Importantly, GRA administration alone was also 
not sufficient to increase cFos activation in either neural population, indicating that antagonism 
of ghrelin signaling permits stimulus-induced activation of GLP-1 and PrRP+ A2 neurons 
without activating the neurons per se. Together, this evidence strongly implicates ghrelin 
signaling in the metabolic tuning of GLP-1 and PrRP+ A2 neurons. As GRA was administered 
systemically, we are unable to identify its specific site of action; however, it is possible that 
antagonism of ghrelin receptors influenced vagal afferent signaling at both peripheral (Date et 
al., 2002) and central (Cui et al., 2011) sites.  
Despite producing a significant increase in CCK-induced cFos activation in hindbrain 
GLP-1 and PrRP+ A2 neurons, GRA pretreatment did not fully restore cFos activation to levels 
observed in ad lib-fed rats. It is possible that the 30-minute latency between pretreatment and 
CCK administration did not provide sufficient time for GRA to reach target receptors. This time 
point was chosen based on previous work showing that i.p. GRA administration markedly 
reduces food intake within 30 minutes (Asakawa et al., 2003). However, ghrelin’s hyperphagic 
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effects occur – at least in part – via the hypothalamic arcuate nucleus (Andrews, 2011). Thus, it 
is possible that GRA’s effects within the arcuate nucleus (and subsequently on food intake) occur 
more rapidly than GRA’s effects on brainstem/vagal afferent neurons. If so, a longer latency 
between pretreatment and CCK injection may enhance the efficacy of GRA at vagal 
afferent/brainstem receptors. It is also possible that the suppressive effects of ghrelin signaling 
on hindbrain neurons occur in conjunction with increases in another inhibitory signal or 
decreases in an excitatory signal, resulting in a partial (but not full) rescue of neural cFos 
activation when ghrelin signaling is manipulated in isolation.  
 
Leptin co-administration is insufficient to rescue CCK-induced activation of hindbrain GLP-1 & 
PrRP+ A2 neurons in fasted rats 
A growing body of histological (Wang et al., 1998; Williams et al., 2009) and 
electrophysiological evidence (Peters et al., 2004; Peters et al., 2006a) indicates that both central 
and peripheral leptin signaling enhance the ability of CCK to activate neurons within the cNTS. 
As leptin levels fall markedly during an overnight fast (Dallman et al., 1999), we hypothesized 
that exogenous leptin (i.p.) in fasted rats would rescue CCK-induced activation of hindbrain 
GLP-1 and PrRP+ A2 neurons. However, neither leptin administration alone nor leptin co-
administration with CCK was sufficient to increase cFos activation of either hindbrain neural 
population.  
It is unlikely that higher doses of systemic leptin are required to alter hindbrain neural 
sensitivity to CCK, as the doses used here elicit robust pSTAT3 responses within the cNTS 
(Maniscalco and Rinaman, 2014), and lower doses are sufficient to enhance CCK-mediated 
transcriptional events in vagal afferents (de Lartigue et al., 2010), decrease food intake 
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(Campfield et al., 1995; Barrachina et al., 1997; de Lartigue et al., 2010), inhibit gastric 
emptying (Cakir et al., 2007), and increase sympathetic nervous system activation and lipolysis 
(Shen et al., 2007). It is possible, however, that pretreatment (versus co-administration) of leptin 
is necessary to permit CCK-induced activation of GLP-1 and PrRP+ A2 neurons in fasted rats. 
The current study employed a leptin and CCK co-administration strategy based on evidence that 
leptin directly depolarizes vagal afferent neurons and enhances CCK-mediated calcium influx 
within seconds of application (Peters et al., 2004; Peters et al., 2006a). Those findings, however, 
were obtained in vitro, and it is possible that the kinetics of leptin diffusion and/or transport 
following i.p. injection preclude immediate effects on CCK-induced vagal depolarization. In 
sum, while our results suggest that decreased leptin signaling during fasting does not play a 
critical role in reducing GLP-1 and PrRP+ A2 neural sensitivity to CCK, additional work is 
needed to strengthen this conclusion. 
 
Conclusion 
The results of this study indicate that increased endogenous ghrelin signaling is an important (but 
not the sole) factor underlying fasting-induced suppression of hindbrain GLP-1 and PrRP+ A2 
neuronal responses to CCK. By reducing the ability of sensory signals to activate these hindbrain 
neurons, fasting-mediated increases in ghrelin signaling may alter numerous central processes in 
which GLP-1 and PrRP+ A2 neurons are implicated. For example, A2 neurons (Rinaman, 2003a) 
and central GLP-1 signaling (Chapter 3) are required for CCK- and restraint-induced suppression 
of food intake, respectively, and evidence suggests that the ability of stressful stimuli to decrease 
food intake is attenuated during periods of negative energy balance (Lennie et al., 1995; 
Youngblood et al., 1997; McMinn et al., 2000). It is tempting to speculate that this may be due, 
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at least in part, to ghrelin-mediated suppression of PrRP+ A2 and GLP-1 neuronal activation. 
Additional work is needed to examine this possibility. 
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5.0  GENERAL DISCUSSION 
5.1 SUMMARY AND INTERPRETATION OF FINDINGS 
5.1.1 Summary 
Periods of caloric deficit substantially attenuate many centrally mediated responses to stress, 
including neural drive to the HPA axis, anxiety-like behavior, and stress-induced suppression of 
food intake (i.e., stress hypophagia). It is posited that this reorganization of stress responses 
reduces anxiety and promotes food intake during periods of negative energy balance, increasing 
the likelihood of finding food and repleting energy stores. The mechanisms by which caloric 
deficit alters central stress responses, however, remain unclear. Brainstem GLP-1 neurons and 
PrRP+ A2 neurons are stress-sensitive, responsive to changes in the interoceptive environment 
(including those indicative of food intake and metabolic status), and have been implicated 
anatomically and functionally in HPA axis activation, anxiety-like behavior, and stress 
hypophagia. Considering this, we proposed that the ability of caloric deficit to attenuate each of 
these stress responses depends on reduced signaling from PrRP+ A2 neurons and hindbrain GLP-




1. Demonstrate the ability of overnight fasting to reduce visceral and cognitive stress-
induced activation within hindbrain and forebrain regions integral to HPA axis activation, 
anxiety-like behavior, and stress hypophagia. 
2. Determine whether overnight fasting reduces anxiety-like behavior. 
3. Assess the contribution of GLP-1 signaling to cognitive stress-induced hypophagia. 
4. Identify specific components of fasting that contribute to reductions in stress-induced 
neural activation of GLP-1 and PrRP+ A2 neurons. 
 
In Chapter 2, we hypothesized that overnight food deprivation would attenuate the ability of 
CCK, a visceral stressor, to activate cFos within NA A2 and hindbrain GLP-1 neurons as well as 
mpPVN neurons. This study demonstrated that: 
 
1. In ad lib-fed rats, CCK dose-dependently increased cFos activation within A2 neurons, 
while the stress of i.p. injection  maximally increased GLP-1 neuronal activation.  
2. In fasted rats, the ability of i.p. injection and CCK to elicit cFos activation was 
significantly reduced in A2 neurons and nearly eliminated in GLP-1 neurons, indicating 
that recruitment of each population is dependent on metabolic state. 
3. Overnight fasting attenuated cFos activation in the mpPVN, which correlated 
significantly with both brainstem GLP-1 and A2 neuronal activation.  
 
Overall, these results support our overarching hypothesis, demonstrating that caloric deficit 
reduces visceral stimulus-driven recruitment of stress responsive hindbrain and hypothalamic 
neurons. Therefore, in Chapter 3, we hypothesized that overnight fasting attenuates the ability of 
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cognitive stress to activate cFos within hindbrain GLP-1 and PrRP+ A2 neurons as well. We also 
proposed that fasting would attenuate cFos activation within the vlBST and mpPVN – two 
regions implicated in HPA axis activation and anxiogenesis – in conjunction with decreased 
anxiety-like behavior. Furthermore, as fasting “uncouples” neurally-mediated stress responses 
from adrenocortical CORT responses (Akana et al., 1994; Dallman et al., 1999; Genn et al., 
2003), we hypothesized that fasting would increase plasma CORT responses to cognitive 
stressors. Lastly, since cognitive stressors activate brainstem neurons (Section 1.6.1; Chapter 3) 
and GLP-1 signaling is critical for visceral stress-induced hypophagia (Rinaman, 1999a; Grill et 
al., 2004), we hypothesized that GLP-1 signaling is also necessary for cognitive stress-induced 
hypophagia. Our results indicated that: 
 
1. In ad lib-fed rats, cognitive stressors robustly activated GLP-1 and PrRP+ A2 neurons, 
consistent with previous reports on PrRP+ A2 neurons (Morales and Sawchenko, 2003; 
Zhu and Onaka, 2003) and providing novel evidence that cognitive stressors recruit 
hindbrain GLP-1 neurons. 
2. Overnight fasting eliminated cognitive stress-induced activation in hindbrain GLP-1 and 
PrRP+ A2 neurons at baseline and in response to cognitive stress, bolstering our previous 
report of the metabolic sensitivity of these populations. 
3. Overnight fasting decreased anxiety-like behavior and cognitive stress-induced activation 
of the vlBST, providing novel evidence that overnight food deprivation decreases 
behavioral anxiety (perhaps via reductions in vlBST output). Fasting-mediated reductions 
in mpPVN cFos activation approached, but did not reach, significance.  
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4. Fasting increased plasma CORT levels at baseline and in response to cognitive stress, 
consistent with previous reports (Akana et al., 1994; Chacon et al., 2005). We newly 
demonstrate that fasting interferes with post-stress recovery of baseline CORT levels, 
indicative of a reduction in plasma CORT degradation and clearance (Herbst et al., 1960; 
Woodward et al., 1991; Kiss et al., 1994). 
5. I.c.v. pretreatment with a GLP-1 receptor antagonist abolished RES stress-induced 
hypophagia in ad lib-fed rats, providing the first evidence that hindbrain GLP-1 neurons 
are critical for suppression of food intake by cognitive stressors.  
 
In sum, the results of this study support our overarching hypothesis, demonstrating that overnight 
fasting reduces the ability of cognitive stressors to activate cFos expression within hindbrain and 
forebrain neurons implicated in HPA axis activation and anxiety. Furthermore, attenuated neural 
responses occurred in conjunction with decreased anxiety-like behavior and increased plasma 
CORT levels, substantiating the neural and adrenal “uncoupling” effect documented previously 
(Akana et al., 1994; Dallman et al., 1999). This study also provides the first evidence that a 
cognitive stressor requires recruitment of hindbrain GLP-1 neurons to suppress food intake. As 
GLP-1 neurons appear to be “silenced” at rest and in response to stimulus-driven input during 
fasting, it is likely that reduced GLP-1 signaling contributes to fasting-mediated reductions in 
stress hypophagia.  
Considering the impact of a single overnight fast on neural, neuroendocrine, and 
behavioral responses to stress, it was of interest to identify which components of fasting are 
responsible for reducing activation of hindbrain neurons. To address this, the experiments in 
Chapter 4 tested the hypothesis that fasting-mediated attenuations in GLP-1 and PrRP+ A2 neural 
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activation in response to CCK result from either decreased leptin signaling, increased ghrelin 
signaling, or both. Our results indicate that: 
 
1. Systemic leptin co-administration with CCK (i.p.) is insufficient to rescue hindbrain cFos 
activation in fasted rats.  
2. Pretreatment with systemic ghrelin receptor antagonist partially rescues (~50%) CCK-
induced cFos activation of both GLP-1 and PrRP+ A2 neurons. 
 
The results from this study support the hypothesis that increased ghrelin signaling during an 
overnight fast plays an integral role in suppressing activation of hindbrain neurons, while 
challenging the hypothesis that fasting-mediated decreases in plasma leptin attenuate hindbrain 
neural activation. 
5.1.2 Metabolic tuning of neural, neuroendocrine, and behavioral responses to stress: a 
working model 
The results of my dissertation project support a working model in which brainstem neurons 
integrate peripheral signals of metabolic status into neurally mediated stress responses. Based on 
our work and the work of others, we propose that:  
In an ad lib-fed animal, circulating ghrelin levels are low, permitting tonic and stimulus-
induced activation of the vagus nerve and glutamate release within the cNTS. This results in 
moderate baseline activation of both GLP-1 and PrRP+ A2 neurons. Following a visceral stressor 
(e.g., CCK), vagal afferent firing rate increases and glutamate release drives neural activation 
within cNTS neurons. Following a cognitive stressor, descending inputs (of unidentified 
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chemical phenotype) increase neural activation within cNTS neurons. Stress-induced activation 
of these neurons increases GLP-1, PrRP, NE, and glutamate release at axonal target sites, 
including the mpPVN, the vlBST, and brainstem reticular neurons. This transmitter signaling 
(both pre- and postsynaptically) contributes to robust HPA axis activation, anxiety-like behavior, 
and stress-induced hypophagia (Figure 1).   
Conversely, in a fasted animal, circulating ghrelin levels are high, inhibiting tonic and 
stimulus-induced activation of the vagus nerve and glutamate release within the cNTS, 
consequently abolishing baseline activation in both GLP-1 and PrRP+ A2 neurons. Increased 
ghrelin signaling also prevents visceral stress-induced vagal afferent activation and glutamate 
release, preventing recruitment of cNTS neurons. Following a cognitive stressor, GLP-1 and 
PrRP+ A2 neural activation is also substantially reduced, possibly due to a direct inhibitory effect 
of ghrelin on cNTS neurons. Alternatively, it is possible that ghrelin-mediated reductions in tonic 
vagal afferent activation remove a normally permissive glutamatergic excitatory signal to GLP-1 
and PrRP+ A2 neurons, preventing neural activation in response to any input source. Regardless 
of the exact cause, in the absence of stress-induced activation of these neurons, GLP-1, PrRP, 
NE, and glutamate are not released at target sites. This reduction of signaling results in reduced 
drive to the HPA axis, decreased anxiety-like behavior, and attenuation of hypophagic responses 
to real or anticipated homeostatic threats (Figure 1). 
While our findings support this proposed model, it is necessary to address a number of 
limitations and caveats. First, our results suggest that changes in ghrelin signaling are not the 
only mechanism by which fasting influences neural stress responses (Chapter 4). It is likely that 
additional vagally- and non-vagally-mediated signals of metabolic status influence neurons of 
the cNTS (Sawchenko et al., 2000; Potes and Lutz, 2010). It is also possible that the integration 
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of metabolic information into central stress signaling is conducted by the cNTS in coordination 
with other brain regions that are responsive to changes in interoceptive state, including numerous 
hypothalamic subnuclei (Schwartz et al., 2000; Dhillon et al., 2006). Thus, this model can and 
should be modified/updated based on the results of future experiments. Second, the ability of 
fasting-mediated increases in ghrelin signaling to suppress cognitive stress-induced activation of 
GLP-1 and PrRP+ A2 neurons is speculative. Based on our results in rats treated with CCK, 
however, the impact of systemic GRA on cognitive stress-induced cNTS recruitment should be 
tested empirically. Finally, and most importantly, while our findings strongly suggest that 
fasting-mediated reductions in GLP-1 and PrRP+ A2 neural activation attenuate downstream 
neural, neuroendocrine, and behavioral stress responses (Chapters 2 & 3), we present no causal 
evidence to support this. It is important that future studies address this (Section 5.3). 
5.2 OBSERVATIONS AND CONSIDERATIONS 
5.2.1 Additional neurophysiological changes that may contribute to fasting-mediated 
alterations in central stress responses 
Although our work has focused on the contribution of brainstem neurons in fasting-mediated 
reductions of central stress responses, fasting likely influences additional brain regions that can 
alter central stress circuits, including the arcuate nucleus of the hypothalamus (ARC). Neurons of 
the ARC, including those expressing neuropeptide Y/agouti-related protein (NPY/AgRP), are 
sensitive to changes in metabolic state (Schwartz et al., 2000). Furthermore, overnight fasting 
increases activation of NPY/AgRP neurons (Yang et al., 2011; Liu et al., 2012) and stimulates 
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hypothalamic NPY mRNA expression (Hanson et al., 1997; Hahn et al., 1998; Dallman et al., 
1999). These results strongly suggest that NPY is released at target sites – including the mpPVN 
and central extended amygdala (Liposits et al., 1988; Broberger et al., 1998) – during overnight 
food deprivation. Thus, fasting-mediated increases in NPY signaling could contribute to the 
changes in food intake, anxiety-like behavior, and HPA axis activation observed in fasted rats.   
Indeed, food intake is robustly increased by central administration of NPY (Stanley and 
Leibowitz, 1984; Dallman et al., 1993) or selective pharmacological/optogenetic stimulation of 
NPY/AgRP neurons (Aponte et al., 2011; Krashes et al., 2011). Conversely, selective inhibition 
of these neurons decreases dark-onset food intake (Krashes et al., 2011), and lesions of 
NPY/AgRP neurons result in marked and persistent decreases in food intake and body weight 
(Luquet et al., 2005). Thus, in an overnight fasted rat, increased signaling from hypothalamic 
NPY/AgRP neurons is well suited to complement reductions in activation of satiety-mediating 
brainstem neurons to elicit both an increased drive for food and larger meals. 
Increased NPY signaling may also contribute to the attenuation of behavioral anxiety in 
fasted rats (Bowers et al., 2012), as central administration or overexpression of NPY mitigates 
anxiety-like behavior (Heilig et al., 1989; Broqua et al., 1995; Thorsell et al., 2000), while 
genetic deletion of NPY enhances anxiety-like behavior (Bannon et al., 2000). Furthermore, 
evidence indicates that the NPY’s anxiolytic effects are due – in part – to signaling within the 
amygdala (Sajdyk et al., 1999), and very likely result from antagonistic effects on anxiogenic 
CRH signaling within the vlBST (Lee and Davis, 1997; Kash and Winder, 2006).  
Although increased NPY signaling is well positioned to drive food intake and reduce 
anxiety in the fasted state, it does not appear to contribute to reduced neural drive of the HPA 
axis. In fact, NPY signaling appears to have the converse effect. Within the mpPVN, NPY 
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signaling stimulates CRH mRNA expression and increases ACTH release (Inoue et al., 1989; 
Hanson and Dallman, 1995; Seal et al., 2002). Thus, fasting-mediated increases in NPY 
signaling would be expected to enhance drive to the HPA axis in fasted rats, contrary to previous 
reports (Akana et al., 1994; Hanson et al., 1994). At this point it is unclear how to reconcile these 
findings.  
Together, these studies indicate that increases in NPY signaling may contribute to 
fasting-mediated anxiolysis and drive for food intake. It is possible that signaling from brainstem 
GLP-1 and PrRP+ A2 neurons interacts with and/or influences the NPY system, as GLP-1 and 
A2 neurons project to the ARC (Rinaman, 2010, 2011) and central GLP-1 administration 
significantly reduces NPY-stimulated food intake in rats (Turton et al., 1996). Continued 
anatomical and functional characterization of the effects of caloric deficit on these systems will 
lead to a more holistic understanding of the impact of metabolic state on neurally mediated stress 
responses. 
5.2.2 Elucidating ghrelin’s mechanism of action 
In Chapter 4, we demonstrate that ghrelin receptor antagonism partially rescues CCK-induced 
activation of GLP-1 and PrRP+ A2 neurons in fasted rats (Figure 14). Although the mechanisms 
by which ghrelin inhibits activation of cNTS neurons during overnight fasting remain unclear, 
numerous studies implicate ghrelin in the suppression of CCK-induced activation of vagal 
afferents at either peripheral or central sites. Peripheral ghrelin signaling decreases the spike 
frequency of vagal afferent neurons (Date et al., 2002) and inhibits CCK-induced increases in 
vagal afferent activation (Date et al., 2005), while central ghrelin signaling suppresses glutamate 
release from CCK-sensitive vagal afferent terminals, resulting in decreased postsynaptic spike 
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frequency of cNTS neurons (Cui et al., 2011). Together, these studies provide strong mechanistic 
evidence that fasting-mediated increases in ghrelin suppress hindbrain GLP-1 and PrRP+ A2 
neural cFos activation, in part, via inhibition of vagal afferents. 
As vagal afferents innervate many cNTS subnuclei and phenotypically-distinct neural 
populations (Altschuler et al., 1992), it might be expected that fasting-mediated reductions in 
vagal afferent activation would attenuate cFos expression in many or all cNTS neural 
populations. Our qualitative observations, however, indicate that this does not appear to be the 
case (at least following CCK administration), since robust cFos expression is present within the 
cNTS of fasted rats despite the complete loss of cFos within GLP-1 neurons (Figure 3). 
However, quantification of total cFos within the cNTS is necessary to address this possibility. A 
decrease in total cNTS cFos following CCK administration in fasted rats would support the 
hypothesis that ghrelin-mediated reductions in vagal glutamatergic input contribute substantially 
to decreased activation of cNTS neurons. Based on our observations, however, we hypothesize 
that total cNTS cFos will not be significantly altered, suggesting that ghrelin signaling acts 
somewhat selectively on the GLP-1 and PrRP+ A2 populations, perhaps due to dynamic 
regulation or selective expression of the ghrelin receptor within these neurons (Lin et al., 2004; 
Zigman et al., 2006). 
Understanding the mechanisms by which ghrelin signaling inhibits cNTS neural 
activation in response to CCK will provide insight into the potential role of ghrelin signaling in 
attenuation of cognitive stress-induced activation of GLP-1 and PrRP+ A2 neurons. Since 
cognitive stressors recruit medullary neural activation via descending projections from the 
forebrain (Figure 1) (Dayas and Day, 2001; Dayas et al., 2004), reductions in vagal afferent input 
may not influence the ability of these stressors to recruit hindbrain neural activation. However, it 
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is also possible that excitatory input from vagal afferent neurons is permissive for recruitment of 
GLP-1 and PrRP+ A2 neurons, regardless of the input source, in which case ghrelin signaling 
would be expected to influence cognitive stress-induced activation of these neurons as well. 
Assessing the impact of GRA on total cNTS cFos following CCK as well as the ability of GRA 
to rescue cFos activation in response to cognitive stressors will provide strong first steps in 
clarifying ghrelin’s influence and mechanisms of action. 
5.2.3 Additional factors that may contribute to reduced hindbrain neural activation 
during fasting 
Our observation that GRA only partially rescued CCK-induced activation of GLP-1 and PrRP+ 
A2 neurons in fasted rats (Chapter 4) suggests that the suppressive effect of ghrelin signaling on 
hindbrain neurons occurs in conjunction with increases in another inhibitory signal or decreases 
in an excitatory signal. Although overnight fasting elicits a myriad of physiological changes that 
might directly or indirectly contribute to attenuation of cNTS cFos activation (Dallman et al., 
1999), fasting-mediated changes in circulating glucose, gastric distention, and CORT synthesis 
are three mechanisms worth considering here. 
Although tightly regulated, even during periods of food deprivation, plasma glucose 
levels fall during an overnight fast (Dallman et al., 1999). Our unpublished observations indicate 
that plasma glucose levels decrease significantly, from ~90mg/dL in ad lib-fed rats to ~70mg/dL 
in fasted rats (p < .05). Previous studies indicate that cNTS A2 neurons and ventrolateral medulla 
A1 neurons are glucose sensitive and recruitment of these neurons is necessary for hyperphagic 
and HPA axis responses to glucoprivation (Ritter et al., 2001; Ritter et al., 2003). Therefore, it is 
possible that both GLP-1 and PrRP+ A2 neurons are sensitive to blood glucose levels, and that a 
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decrease in plasma glucose contributes to reductions in GLP-1 and PrRP+ A2 neural activation 
during fasting. Our preliminary work, however, suggests that this is not the case. The stressor 
treatments used in Chapters 2-4 (i.e., EP, i.p. saline injection, and i.p. CCK injection) each 
increase blood glucose levels above those of ad lib-fed rats, presumably as a result of SNS and/or 
CORT responses to stress (unpublished data). Despite increases in blood glucose, these stressors 
remain insufficient to increase GLP-1 or PrRP+ A2 neural activation in fasted rats. These 
observations suggest that the mild drop in blood glucose during fasting does not contribute to 
changes in hindbrain neural activation. However, glucose homeostasis and signaling is a 
dynamic and complex process (Watts and Donovan, 2010; Jokiaho et al., 2014), and it is possible 
that a transient increase in blood glucose resulting from stress exposure has markedly different 
effects than persistently elevated glucose resulting from ad lib food intake.  
Gastric distention is a necessary consequence of food intake and results in rapid and 
sustained discharges of mechanosensitive vagal afferent nerves (Schwartz et al., 1991a). Thus, 
gastric distention generates an excitatory (i.e., vagal glutamatergic) signal to cNTS GLP-1 and 
PrRP+ A2 neurons in ad lib-fed rats, and this signal is likely lost during fasting. Furthermore, as 
gastric distention and systemic CCK administration have synergistic effects to activate vagal 
afferents (Schwartz et al., 1991a; Schwartz et al., 1993), reduced gastric distention is poised to 
have a particularly strong influence on cNTS neural activation in response to systemic CCK 
(Chapters 2 & 4). Indeed, gastric balloon distention in fasted rats increases cFos activation within 
A2 neurons (~10% activation) (Willing and Berthoud, 1997) and GLP-1 neurons (~30% 
activation) (Vrang et al., 2003). While this represents a significant increase as compared to near-
0% activation in controls, it is not possible to interpret the degree to which gastric distention 
“rescued” ad lib-fed baseline neural activation, as this was not assessed. However, in light of our 
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observations that, in ad lib-fed rats, baseline cFos activation of GLP-1 and PrRP+ A2 neurons is 
~30%, reduced gastric distention appears likely to play a major role in fasting-mediated 
reductions of GLP-1 and PrRP+ A2 neural activation. It is interesting to consider that decreased 
gastric distention and increased ghrelin signaling may be responsible for a substantial proportion 
of decreased cNTS neural activation in fasted rats, and an empirical assessment of this possibility 
is warranted.  
During overnight fasting, circulating CORT levels increase significantly in a pattern that 
corresponds to the missed meals (Akana et al., 1994; Dallman et al., 1999). These large increases 
are sufficient to allow CORT access to GRs throughout the brain (Spencer et al., 1990), 
including those expressed by neurons of the NTS (Herman, 1993). As CORT signaling at 
numerous central sites elicits a “negative feedback” effect on the HPA axis (to prevent excessive 
neuroendocrine responses) (Herman and Cullinan, 1997), it is possible that overnight elevations 
in CORT are partially responsible for reduced neural activation in GLP-1 and PrRP+ A2 neurons.  
A role for hindbrain GLP-1 neurons in CORT negative feedback has previously been 
proposed based on evidence that both acute stress and chronic variable stress decrease PPG 
mRNA in the cNTS (Zhang et al., 2009; Zhang et al., 2010). In these studies, the ability of stress 
to decrease PPG mRNA was attenuated or abolished by adrenalectomy, and reduced PPG mRNA 
expression could be recapitulated by acute or chronic exogenous CORT administration. In both 
cases, reduced PPG mRNA expression was accompanied by reduced immunoreactivity of GLP-1 
terminals within the mpPVN. Together, these findings indicate that CORT negative feedback 
inhibits central GLP-1 synthesis and decreases GLP-1 protein in mpPVN terminals, possibly 
reducing the ability of GLP-1 to drive neuroendocrine stress responses. More recently, the 
functional implications of hindbrain CORT negative feedback were directly assessed using cNTS 
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implantation of micropellets containing CORT or a GR antagonist. cNTS CORT pellets 
significantly reduced HPA axis responses to acute RES, while GR antagonist pellets increased 
HPA axis responses to RES as well as anxiety-like behavior on the EPMZ (Ghosal et al., 2014). 
These results indicate that CORT indeed has negative feedback effects on cNTS neurons, 
including the GLP-1 subset (Zhang et al., 2009), which result in decreased anxiety-like behavior 
and HPA axis responses to cognitive stress (Ghosal et al., 2014). The ability of CORT negative 
feedback to suppress baseline and stimulus-induced cFos activation of hindbrain GLP-1 and 
PrRP+ A2 neurons is not known. However, experiments utilizing adrenalectomy/CORT 
replacement or CORT micropellet implantation would allow for a clearer understanding of this 
possibility. 
5.2.4 The importance of reticular GLP-1 neurons 
A noteworthy result from Chapter 3 is our observation that reticular GLP-1 neurons contribute 
substantially to the entire GLP-1 population (i.e., ~44% of total GLP-1 neurons). Although 
numerous studies have noted the presence of GLP-1 neurons within the medullary reticular 
formation (Larsen et al., 1997b; Rinaman, 1999b), these neurons have been given little 
consideration. We reported that in ad lib-fed rats reticular GLP-1 neurons are equally as 
responsive to cognitive stressors as those in the cNTS (Table 4), and a number of important 
considerations arise from these findings.  
First, the afferent inputs activating reticular and cNTS GLP-1 neurons following 
cognitive stress have not yet been established. Evidence suggests that descending inputs from 
hypothalamic and limbic forebrain regions convey cognitive stress information to A2 neurons 
(Dayas and Day, 2001; Dayas et al., 2004), and it seems likely that these inputs drive cognitive 
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stress-induced cNTS GLP-1 recruitment as well. It is not clear, however, whether these same 
descending inputs directly innervate reticular GLP-1 neurons, if a parallel set of descending 
circuits innervates the reticular population, or if reticular GLP-1 neural activation results from 
relayed signaling via the cNTS.  
Second, it is not known whether the axonal projections of reticular GLP-1 neurons are 
similar to those arising from cNTS GLP-1 neurons. A previous report from our laboratory found 
complete overlap between brain regions receiving GLP-1 axonal input and those containing 
fibers labeled with anterograde tracer following injection into the medial cNTS (Rinaman, 2010). 
Although these results demonstrate that projections from reticular GLP-1 neurons do not 
innervate regions distinct from projections arising from cNTS neurons as a whole, this study was 
not able to characterize differences in projections arising from reticular versus cNTS GLP-1 
neurons specifically. Therefore, while it appears likely that reticular and cNTS GLP-1 neurons 
give rise to axons innervating the same target regions, this has not been established empirically, 
and the possibility remains that reticular GLP-1 axons innervate targets distinct from those 
innervated by cNTS GLP-1 neurons. Furthermore, even in brain regions that receive innervation 
from both reticular and cNTS GLP-1 neurons, it is possible that the strength of axonal input from 
these two populations of GLP-1 neurons differs. Thus, characterizing the axonal topography of 
reticular versus cNTS GLP-1 neurons, as well as the strength of projections arising from each 
population within specific target regions, will establish essential anatomical evidence for the 
homo- or heterogeneity between reticular and cNTS GLP-1 neural populations. This can be 
achieved through systematic injection of retrograde tracers into GLP-1 terminal plexuses and 
quantification of the number of cNTS versus reticular GLP-1 neurons projecting to each region. 
Moreover, by exposing tracer-injected rats to visceral or cognitive stressors prior to sacrifice, it is 
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possible to identify stress-induced cFos activation of reticular versus cNTS GLP-1 neurons that 
project to a given target nucleus. These experiments will provide a wealth of functional and 
anatomical information about brainstem GLP-1 neurons, greatly expanding the results presented 
in Chapters 2-4. 
Third, characterizing cNTS versus reticular GLP-1 neural activation in response to 
diverse visceral/cognitive stressors will provide clues regarding the functional role of these 
neurons. Considering the predominant roles of the vagus nerve and cNTS in visceral sensory 
processing (Section 1.4.1), we hypothesize that many visceral stressors will preferentially recruit 
cNTS GLP-1 neurons. Consistent with this, unpublished observations from our laboratory 
indicate that intake of a large meal, a visceral stimulus that recruits vagal afferent signaling (Grill 
and Hayes, 2012), preferentially activates GLP-1 neurons within the cNTS. Conversely, a recent 
study demonstrated that i.p. injection of the endotoxin LPS (a visceral stressor) preferentially 
activates reticular GLP-1 neurons (Gaykema et al., 2009). This is somewhat surprising, as the 
vagus nerve is poised to transmit signals associated with peripheral LPS exposure (Goehler et al., 
1997; Hosoi et al., 2005; Wieczorek and Dunn, 2006), and vagal mediation of this signal would 
be expected to elicit increased activation within the cNTS (Appleyard et al., 2007). It is possible, 
however, that the immune response associated with LPS injection elicited activation of reticular 
neurons by a non-vagal route that involves signaling via endothelial and perivascular cells 
(Sawchenko et al., 2000). Considering these complexities, a better understanding of the stimuli 
that activate reticular GLP-1 neurons in the fed and fasted state – as well as investigation of the 
mechanisms by which these neurons are activated – is warranted. 
Lastly, the development of RNA interference to disrupt PPG mRNA expression provides 
a promising route by which to selectively and chronically manipulate signaling from GLP-1 
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neurons (Barrera et al., 2011). However, in addition to the challenge of targeting the substantial 
rostrocaudal distribution of GLP-1 neurons with viral delivery of short-hairpin RNA, it is 
unlikely that this technique can be used effectively to knockdown PPG expression in the widely-
distributed GLP-1 reticular neural population. A major benefit of targeting the cNTS GLP-1 
neurons with RNA interference is the ability to explore and identify a selective contribution of 
these neurons to neural, physiological, and behavioral outcomes. This benefit, however, comes 
with the significant interpretive challenge associated with negative results, as reticular GLP-1 
neurons remain intact.  
5.2.5 Understanding the cause of increased circulating CORT during fasting 
In Chapter 3, fasting significantly increased peak CORT levels and delayed recovery after both 
RES and EP. These results validate previous reports that fasting increases peak CORT responses 
to RES stress (Akana et al., 1994; Kiss et al., 1994), and newly demonstrate that fasting also 
interferes with post-stress recovery of baseline CORT levels. The mechanism(s) by which fasting 
augments stress-induced plasma CORT levels in the face of attenuated pituitary ACTH output 
remain unclear (Akana et al., 1994). Multiple factors, however, might increase adrenocortical 
sensitivity to ACTH (Bornstein et al., 2008), potentiating stress-induced CORT synthesis despite 
reduced hypothalamic outflow. For example, stressors increase sympathetic drive to the adrenal 
gland, which can subsequently increase adrenocortical steroidogenic response to ACTH 
(Engeland and Gann, 1989; Edwards and Jones, 1993). Thus, it is possible that fasting enhances 
sympathetic drive to the adrenal gland following cognitive stress, resulting in elevated 
circulating CORT levels despite reduced ACTH output. The likelihood of this mechanistic 
explanation, however, is not clear: while removal of adrenal sympathetic innervation reduces 
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both circadian and dehydration stress-induced increases in plasma CORT levels (Ulrich-Lai and 
Engeland, 2002; Ulrich-Lai et al., 2006), it does not appear to affect RES stress-induced plasma 
CORT levels in ad lib-fed rats (Strausbaugh et al., 1999). While this suggests that SNS 
innervation of the adrenal gland does not impact the magnitude of CORT responses in ad lib-fed 
rats, it remains possible that adrenal sympathetic innervation is recruited selectively during 
fasting. 
Alternatively, adrenal sensitivity to ACTH and adrenal steroidogenic response to 
stressors may each remain unchanged during overnight fasting, despite increases in circulating 
CORT. As CORT synthesis occurs within minutes of stressor onset (Sapolsky et al., 2000) and 
fasting reduces plasma CORT degradation and clearance in rats (Herbst et al., 1960; Woodward 
et al., 1991; Kiss et al., 1994), it is possible that reduced CORT catabolism could explain the 
higher peak CORT levels and reduced post-stress CORT recovery observed in Chapter 3. 
5.2.6 Consequences of increased circulating CORT 
In Chapter 3, we discussed the likelihood that fasting-mediated elevations in plasma CORT may 
serve to increase peripheral energy mobilization and utilization, allowing for the maintenance of 
glucose-dependent processes despite the absence of caloric intake (Dallman et al., 1999; 
Sapolsky, 2004). It is also possible that increased CORT levels contribute to the stimulation of 
feeding in fasted rodents. Substantial evidence indicates that increases in glucocorticoid levels 
are associated with increased food intake, and that administration of glucocorticoids can elicit 
increases in caloric consumption (Maniam and Morris, 2012), particularly in the presence of low 
insulin levels (Dallman et al., 1993). Considering that insulin levels quickly fall at the outset of 
an overnight fast, and remain significantly decreased through the following morning (Dallman et 
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al., 1999), this evidence implicates elevated glucocorticoid signaling in the drive for food intake 
during caloric deficit. Finally, increased CORT levels during fasting may have direct or indirect 
negative feedback effects to suppress central stress responses that produce consequences that are 
“maladaptive” in the fasted state (i.e., anxiety-like behavior and stress-induced hypophagia). 
Recent evidence indicates that this type of CORT negative feedback may involve direct GR 
signaling in the cNTS (Section 5.2.3). 
5.2.7 Using ACTH as a measure of hypothalamic outflow 
In Chapters 2 & 3, we utilized cFos expression within the mpPVN to understand the strength of 
neural drive to the HPA axis. While this provides a useful quantitative measure of neural 
activation (and a measure that can be directly correlated with changes in cFos activation within 
other brain regions), this method has less quantitative resolution than other available techniques. 
A more accurate estimation of HPA axis activity would result from identification of cFos 
expression selectively within mpPVN CRH+ neurons, as these neurons are directly responsible 
for HPA axis activation (Section 1.2). However, in our hands, technical challenges have 
prevented immunolabeling of a sufficient number of mpPVN CRH neurons to allow accurate 
quantification. Measurement of plasma ACTH levels arguably represents the most quantitatively 
rigorous index of “hypothalamic outflow,” as circulating ACTH levels are dictated by neural 
drive to the HPA axis and directly stimulate CORT synthesis in the adrenal cortex (Section 1.2; 
Figure 1). Furthermore, the use of radioimmunoassay or enzyme immunoassay allows for 
quantification of the absolute concentration of ACTH in the blood, obviating much of the 
subjectivity inherent in cFos quantification and more readily allowing for direct comparison of 
results between studies. As an understanding of the metabolic regulation of HPA axis activation 
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has become a predominant focus of our work, ensuring that we are using adequately sensitive 
and quantitatively rigorous measures is imperative.  
5.2.8 Fasting does not decrease the number of immunoreactive PrRP neurons 
In addition to their role in centrally mediated stress responses, PrRP+ A2 neurons have been 
implicated in satiation and the maintenance of energy homeostasis (Section 1.6.4) (Onaka et al., 
2010; Maniscalco et al., 2013). Interestingly, results from previous studies indicate that periods 
of negative energy balance, such as lactation or a 48 hr fast, decrease PrRP mRNA expression 
and reduce the number of cNTS neurons that express detectable PrRP immunoreactivity 
(Lawrence et al., 2000; Morales and Sawchenko, 2003). These findings suggest that periods of 
negative energy balance attenuate PrRP expression to thereby reduce the anorexic effect of PrRP 
signaling (Lawrence et al., 2000; Lawrence et al., 2002) and allow for repletion of energy stores. 
In light of this, we examined whether a shorter, overnight fast was sufficient to reduce the 
number of cNTS neurons immunolabeled for PrRP (Chapter 3). However, we observed no effect 
of fasting or stress treatment on the number of PrRP+ neurons (or GLP-1 neurons) (Table 3). 
These discordant results may be due to the brevity of an overnight fast as compared to the 
protracted state of negative energy balance produced by lactation or a 48-hour fast.  
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5.3 ESTABLISHING A CAUSAL ROLE FOR BRAINSTEM NEURONS IN 
FASTING-MEDIATED ATTENUATION OF STRESS RESPONSES 
Substantial evidence demonstrates that NA/GLP-1 receptor antagonism or selective lesion of NA 
(and likely PrRP+) hindbrain neurons attenuates anxiety-like behavior (Cecchi et al., 2002; 
Kinzig et al., 2003), stress-induced HPA axis activation (Kinzig et al., 2003; Schiltz and 
Sawchenko, 2007; Bienkowski and Rinaman, 2008), and stress-induced hypophagia (Rinaman, 
1999a; Grill et al., 2004) (Chapter 3)2. These studies provide strong evidence that loss of 
signaling from cNTS neurons may result in attenuated neuroendocrine and behavioral stress 
responses during fasting. It will be difficult, however, to substantiate the claim that reduced 
signaling from GLP-1 or PrRP+ A2 neurons causes changes in these stress responses during 
overnight fasting, as this requires physiologically relevant restoration of neurotransmitter 
signaling in the fasted state. I.c.v or local parenchymal administration of receptor agonists in 
fasted rats provides a possible experimental route by which to address this hypothesis. However, 
a number of inherent limitations detract from the utility of this approach: 
 
1. Although agonist administration provides strong foundational evidence of involvement of 
central receptor signaling in a given process/function, it is exceedingly difficult to both 
quantify and replicate endogenous neurotransmitter concentrations. Thus, the 
physiological relevance of agonist administration is questionable and will not provide 
conclusive causal evidence. 
                                                 
2 There are currently no available pharmacological antagonists for the PrRP receptor (GPR10), 
precluding a clear understanding of the role of endogenous PrRP in these processes. 
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2. As NE and PrRP are expressed in numerous central nuclei, many of which innervate 
overlapping regions, agonist administration prevents an understanding of the cell groups 
contributing to any effects observed. 
3. Co-localization of vGlut2 in both A2 (Stornetta et al., 2002) and GLP-1 neurons (Zheng 
& Rinaman, submitted) indicates that these neurons are also glutamatergic, and the use of 
pharmacological agonists would not recapitulate the dual transmitter release that likely 
occurs following their activation. 
 
Considering this, additional strategies to replicate endogenous signaling from cNTS GLP-1 and 
PrRP+ A2 neurons are worth considering. The use of optogenetics or designer receptors 
exclusively activated by designer drugs (DREADD) technology each provide the ability to 
selectively activate neurons in the fasted state, and it may be possible to adjust/titrate activation 
to generate physiologically relevant neural output.  
Optogenetics involves ectopic expression of light-sensitive ion channels within the CNS, 
enabling depolarization or hyperpolarization of neural populations with high temporal resolution 
(Fenno et al., 2011). Using an optogenetic approach in rats, it is possible to inject a lentivirus or 
adeno-associated virus that expresses channelrhodopsin-2 (ChR2) – a nonspecific cation channel 
– into the cNTS. By exposing transfected neurons to a blue light (via an implanted optic fiber), it 
would be possible to drive cNTS neural depolarizations in a fasted rat and observe the 
consequences of selective “restoration” of signaling from this region on HPA axis activation, 
anxiety-like behavior, and stress-induced hypophagia (Zalocusky and Deisseroth, 2013). 
Furthermore, by utilizing opsins engineered to promote membrane trafficking to axon terminals, 
light activation at specific terminal targets of cNTS neurons may be achieved (e.g., mpPVN, 
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vlBST, CeA, etc.). This provides a powerful technique by which to uncover the impact of cNTS 
neural input within specific target nuclei.  
A major current limitation to the use of optogenetics in rats is the challenge associated 
with viral transfection of opsins under the promotion of cell-subtype specific promoters, as these 
genetic regions are generally too large to package into viral genomes (Zalocusky and Deisseroth, 
2013). This limitation currently prevents viral targeting of ChR2 selectively within GLP-1 or 
PrRP+ A2 neurons, and significantly limits the usefulness of this approach. However, the 
development of a transgenic rat line that expresses the protein Cre recombinase under the control 
of the endogenous TH promoter (TH:Cre rats) may circumvent this limitation (Witten et al., 
2011). In these animals, Cre is expressed in all catecholaminergic neurons, including the A2 
neurons of the cNTS (presumably, this has not yet been demonstrated empirically). By using 
TH:Cre rats, it is possible to generate specific ChR2 expression in A2 neurons through delivery 
of viruses in which opsin expression is dependent on the cellular presence of Cre (Fenno et al., 
2011). Thus, viral injections into the cNTS would allow for selective ChR2 expression within A2 
neurons and subsequent, temporally controlled stimulation of these neurons in a fasted rat.  
DREADD technology provides another route by which to selectively activate cNTS 
neurons in fasted rats. DREADD involves the use of a mutated muscarinic receptor that can only 
be activated by an otherwise pharmacologically inert synthetic ligand (Armbruster et al., 2007; 
Ferguson et al., 2011). Thus, by coupling the DREADD receptor with a stimulatory Gq protein 
and virally targeting expression of the receptor to neurons of the cNTS, this technique would 
allow for neural depolarization following administration of the synthetic ligand (Armbruster et 
al., 2007; Alexander et al., 2009). A major benefit of DREADD – as opposed to optogenetics – is 
the ability to systemically administer the synthetic excitatory ligand, obviating the need for 
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chronic implantation of an optic fiber and thus increasing the tractability of many behavioral and 
neurophysiological experiments. Use of DREADD, however, is also subject to the challenges 
associated with viral transfection of the receptor. That is, viral packaging can preclude the 
incorporation of many larger cell-subtype specific promoters. Thus, the DREADD technique 
does not allow for specific stimulation of hindbrain GLP-1 or PrRP+ A2 neurons at present. 
While both optogenetic and DREADD stimulation have the potential to clarify the role of GLP-1 
or PrRP+ A2 neural signaling in fasted rats, technological limitations limit the efficacy of these 
approaches at present.  
Considering the limitations associated with these currently available techniques, it will be 
challenging to establish the causal role of hindbrain GLP-1 neurons and PrRP+ A2 neurons in 
fasting-mediated changes in central stress responses. Each technology, however, is evolving 
rapidly and it is possible that development of novel transgenic rat lines will allow for GLP-1- or 
PrRP-specific neural stimulation through the use of Cre-dependent opsin or DREADD 
expression in the future. Thus, immediate future directions of this research should be aimed at 
developing a comprehensive and thorough understanding of 1) the role of brainstem GLP-1 and 
PrRP+ A2 neurons in central stress responses, and 2) the ability of metabolic state to alter the 
function of these neurons. 
5.4 CONCLUSIONS AND FUTURE DIRECTIONS 
The research contributing to this dissertation has identified hindbrain GLP-1 neurons and PrRP+ 
A2 neurons as a node for the metabolic tuning of centrally mediated stress responses. However, 
our current understanding of the interaction between metabolic state and stress responsiveness is 
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far from complete. While much work remains to be done, a number of immediate future 
directions will significantly extend current knowledge. First, it is imperative to better understand 
the functional role of brainstem neurons in generating central stress responses, which can be 
achieved through numerous lines of experimentation: 
 
1. In Chapter 3, we discovered that antagonism of central GLP-1 signaling prevents 
cognitive stress-induced hypophagia (Figure 12). Based on previous neuroanatomical and 
functional work, we hypothesize that this effect is mediated by neurons in the brainstem 
(Figure 1). By utilizing 4th ventricular administration of GLP-1 receptor antagonist, it can 
be determined whether cognitive stress-induced hypophagia results from GLP-1 signaling 
within the hindbrain. 
2. With the addition of results presented in Chapter 3, central GLP-1 receptor antagonist has 
been demonstrated to attenuate anxiety-like behavior, HPA axis activation, and stress-
induced hypophagia. Furthermore, GLP-1 signaling within the CeA and mpPVN has 
been shown to elicit anxiety-like behavior and HPA axis activation, respectively. Despite 
axonal input to the vlBST, it is unknown whether GLP-1 receptor signaling within this 
region contributes to anxiety-like behavior or HPA axis activation, and this should be 
tested directly using local stereotaxic injections of GLP-1 receptor agonists or 
antagonists. 
3. The lack of pharmacological antagonists for PrRP receptors has prevented a clear 
understanding of the role of endogenous PrRP signaling in central stress responses. One 
approach to address this dearth of knowledge is the use of RNA interference technology 
to disrupt either PrRP mRNA expression in A2 neurons or expression of its receptor 
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(GPR10) within specific brain sites (e.g., mpPVN and vlBST). The use of RNA 
interference to decrease cNTS PPG mRNA expression has recently been demonstrated 
(Barrera et al., 2011), providing a platform by which to guide development of this 
technique. 
 
Second, results from Chapter 4 indicate that ghrelin receptor antagonism is sufficient to partially 
rescue visceral stress-induced activation of hindbrain GLP-1 neurons and PrRP+ A2 neurons in 
fasted rats. Considering this, it will be important to: 
 
1. Identify and characterize other contributing factors to fasting-mediated reductions in 
brainstem neural activation, including gastric distention and CORT signaling (Section 
5.2.3). 
2. Assess the ability of GRA administration to rescue activation of GLP-1 and PrRP+ A2 
neurons in response to cognitive stress exposure in fasted rats. 
3. Determine whether GRA administration reverses fasting-mediated reductions in 
mpPVN/vlBST neural activation or anxiety-like behavior, two effects predicted by our 
working model. 
 
Lastly, a more thorough and comprehensive characterization of the metabolic tuning of hindbrain 
GLP-1 and PrRP+ A2 neural stress responses is warranted, including: 
 
1. Examination of the metabolic sensitivity of neural activation in response to additional 
stressors, including those with differing stimulus intensity, modality, and duration.  
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2. Clarification of the role of the vagus nerve in metabolic tuning. Our working hypothesis 
posits that metabolic tuning occurs, at least in part, via the vagus nerve. It might be 
possible to empirically test this using subdiaphragmatic vagotomy (however, this could 
only be used to assess metabolic tuning of cognitive stress exposure, as visceral stressors 
require vagal integrity to elicit central responses)3. 
3. Assessment of metabolic tuning of cNTS neurons by different types of changes in 
metabolic state, such as chronic food restriction, changes in diet composition, and diet-
induced or genetic obesity. 
 
Periods of caloric deficit alter neural, neuroendocrine, and behavioral responses to stress, and it 
is believed that these alterations represent an adaptive shift in stress responses during periods of 
negative energy balance. The results of my dissertation work support the hypothesis that 
metabolic tuning of hindbrain GLP-1 and PrRP+ A2 neurons is a mechanism through which 
negative energy balance decreases central drive to the HPA axis, promotes anxiolysis, and 
attenuates hypophagic responses to acute stress. This current working model is likely far from 
complete, and numerous lines of future investigation are essential to improve our understanding 
of the neural mechanisms responsible for metabolic tuning of central stress responses. 
                                                 
3 A major caveat of this approach, however, is that vagotomy would also remove a substantial 
amount of non-metabolic sensory feedback that may shape centrally mediated stress responses. 
These studies would therefore require carefully designed control groups and conservative 
interpretation of results.   
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APPENDIX A 
SYSTEMIC LEPTIN DOSE-DEPENDENTLY INCREASES STAT3 
PHOSPHORYLATION WITHIN HYPOTHALAMIC AND HINDBRAIN NUCLEI4 
A.1 INTRODUCTION 
Leptin, the peptide product of the obese (Ob) gene, is released from adipose tissue and the gastric 
epithelium to signal long- and short-term caloric surfeit, respectively (Zhang et al., 1994; Bado et 
al., 1998). In this capacity, leptin acts as a hormonal feedback signal to promote negative energy 
balance (Friedman and Halaas, 1998), in part by increasing sensitivity to satiation signals 
(Emond et al., 1999; Schwartz and Moran, 2002; Peters et al., 2004; Peters et al., 2005; Peters et 
al., 2006a) to decrease meal size (Flynn et al., 1998; Kahler et al., 1998; Flynn and Plata-
Salaman, 1999; Morton et al., 2005; Kanoski et al., 2012). The strong influence of leptin 
signaling on energy balance as well as reproductive, autonomic, and other physiological systems 
has been clearly demonstrated in rodents with recessive mutations in the gene encoding leptin 
                                                 
4 The entirety of the work presented in Appendix A is from “Systemic leptin dose-dependently 
increases STAT3 phosphorylation within hypothalamic and hindbrain nuclei,” by J.W. 
Maniscalco and L. Rinaman, 2014, American Journal of Physiology: Regulatory, Integrative and 
Comparative Physiology, 306, p. R576-R585. Copyright (2014) by the American Physiological 
Society. Reprinted with permission. 
 141 
[ob/ob mice (Ingalls et al., 1950)] or its receptor [db/db mice (Hummel et al., 1966) & fa/fa rats 
(Chua et al., 1996; Iida et al., 1996; Phillips et al., 1996)]. These rodent strains display marked 
obesity, hyperphagia, autonomic nervous system dysfunction, infertility, and disruption of 
hypothalamic-pituitary hormonal signaling (Ingalls et al., 1950; Zucker LM, 1961; Zucker and 
Zucker, 1963; Hummel et al., 1966; Giachetti, 1978; Young and Landsberg, 1983; Chehab et al., 
1996; Durham and Truett, 2006). 
Leptin exerts its behavioral, metabolic, and hormonal effects, at least in part, via direct 
action within the central nervous system (CNS). Following peripheral release, leptin is 
unidirectionally transported into the CNS (Banks et al., 1996) where it can directly access leptin 
receptors expressed by cells within numerous CNS regions. Leptin receptors are abundantly 
expressed within the arcuate nucleus of the hypothalamus (ARC), the ventromedial nucleus of 
the hypothalamus (VMH), and the nucleus of the solitary tract (NTS) (Schwartz et al., 1996; 
Elmquist et al., 1998a; Grill et al., 2002; Scott et al., 2009), three regions that play integral roles 
in food intake, body weight regulation, glucose homeostasis, and energy metabolism (Minokoshi 
et al., 1999; Schwartz et al., 2000; Sternson et al., 2005; Dhillon et al., 2006; Rinaman, 2011; 
Grill and Hayes, 2012; Maniscalco et al., 2013). Indeed, acute central administration of leptin is 
sufficient to robustly decrease food intake and body weight (Campfield et al., 1995; Schwartz et 
al., 1996; Grill et al., 2002), facilitate glucose homeostasis (Minokoshi et al., 1999), and increase 
sympathetic nerve activity (Dunbar et al., 1997; Casto et al., 1998). Furthermore, central leptin 
signaling is necessary for normal regulation of body weight and adiposity, since neuronal 
deletion of leptin receptors results in obesity (Cohen et al., 2001), and CNS-specific rescue of 
leptin receptors in db/db mice ameliorates obesity (Kowalski et al., 2001). 
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Histological identification of leptin-responsive cells in the CNS can provide a wealth of 
information regarding the specific cellular phenotypes and neural circuits through which leptin 
signaling modulates physiology and behavior. The long form of the leptin receptor is a member 
of the cytokine receptor family, and is coupled to the janus kinase/signal transducer and activator 
of transcription (JAK-STAT) pathway (Tartaglia, 1997). Leptin binding to this receptor results in 
phosphorylation of signal transducer and activator of transcription 3 (pSTAT3) (Vaisse et al., 
1996), making pSTAT3-immunoreactivity (ir) a useful proxy for identifying cells directly 
responsive to leptin. Centrally administered leptin increases pSTAT3 immunolabeling within the 
ARC, VMH, and NTS (Hubschle et al., 2001). However, given that endogenous leptin is secreted 
from peripheral tissues, the physiological relevance of centrally administered leptin is unclear. 
 A robust literature indicates that – similar to central leptin administration – 
systemic administration of leptin has pronounced effects on food intake, body weight, glucose 
homeostasis, reproductive function, and sympathetic activity (Barash et al., 1996; Dryden et al., 
1999; Niimi et al., 1999; Lin et al., 2001; Wetzler et al., 2004). While most studies have used 
large intraperitoneal or intravenous doses of leptin (i.e., >1 mg/kg BW) to observe these effects, 
systemic leptin doses ranging from 10-130 μg/kg BW are sufficient to decrease food intake 
(Campfield et al., 1995; Barrachina et al., 1997; de Lartigue et al., 2010), inhibit gastric 
emptying (Cakir et al., 2007), and increase sympathetic nervous system (SNS) activity and 
lipolysis (Shen et al., 2007). Western blot and gel-shift assays indicate that peripheral doses of 
leptin as low as 50-100 μg/kg BW are sufficient to increase STAT3 phosphorylation centrally 
(Vaisse et al., 1996; El-Haschimi et al., 2000); however, these techniques do not permit 
identification of leptin-sensitive cellular populations or circuits. Studies that have identified 
central pSTAT3-positive cells following systemic leptin administration have used doses ranging 
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from 1-15 mg/kg BW (Hosoi et al., 2002; Munzberg et al., 2003; Levin et al., 2004; Ellacott et 
al., 2006; Huo et al., 2007; Huo et al., 2008; Roth et al., 2008; Becskei et al., 2010; Turek et al., 
2010; Bouret et al., 2012; Ha et al., 2013), much higher than doses required for behavioral, 
metabolic, and hormonal responses. Central pSTAT3 immunolabeling following systemic leptin 
doses below 1 mg/kg BW has not been reported. Considering this, we utilized 
immunohistochemical antigen retrieval techniques (Munzberg et al., 2003; Levin et al., 2004; 
Ellacott et al., 2006; Becskei et al., 2010) to reveal pSTAT3-ir within anatomically- and 
phenotypically-identified populations of CNS cells in rats after peripheral administration of 
leptin at doses ranging from 50-800 μg/kg BW. 
A.2 MATERIALS & METHODS 
Animals 
Adult male Sprague-Dawley rats (Harlan, IN; 225-275g BW; n = 34) were housed singly in 
hanging stainless steel wire mesh cages in a temperature-controlled room (20-22°C) on a 12/12 
hr light/dark cycle (lights on at 0700 hr). Rats had ad libitum access to pelleted chow (Purina 
5001) and water, except as noted. All experiments were conducted in accordance with the NIH 
Guide for the Care and Use of Laboratory Animals and were approved by the University of 
Pittsburgh Institutional Animal Care and Use Committee. 
 
Injections & Perfusions 
Rats were weighed one day before leptin administration to determine proper dosage. Rats were 
deprived of food (but not water) for 16-18 hours overnight before leptin or vehicle treatment, 
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since food deprivation increases central responsiveness to systemically administered leptin in 
mice (Becskei et al., 2010). On the day of the experiment rats were removed from their home 
cage between 0830 and 1030 hr and injected intraperitoneally (i.p.) with 1.0 ml of sterile 0.15M 
NaCl containing recombinant rat leptin (Sigma-Aldrich; L5037) as follows: 0 μg/kg BW (n = 4); 
50 μg/kg BW (n = 3); 100 μg/kg BW (n = 8); 200 μg/kg BW (n = 6); 400 μg/kg BW (n = 7); 800 
μg/kg BW (n = 6). Leptin was dissolved in vehicle just before injection, and rats were returned to 
their home cage immediately after injection.  
Ninety minutes after i.p. injection, rats were deeply anesthetized with pentobarbital 
sodium (39 mg/1.0 ml i.p., Fatal Plus Solution; Butler Schein) and perfused transcardially with a 
brief saline rinse followed by fixative (100 ml of 2% paraformaldehyde and 1.5% acrolein in 
0.1M phosphate buffer, followed by 100 ml of 2% paraformaldehyde alone)(McLean and 
Nakane, 1974). Brains were post-fixed in situ overnight at 4°C, then removed from the skull and 
cryoprotected for 24-48 hr in 20% sucrose. Brains were blocked and sectioned coronally (35μm) 
using a Leica freezing-stage sliding microtome. Sections were collected in six serial sets, and 






Immunohistochemical identification of pSTAT3 was used to measure direct leptin signaling in 
the brain, following a protocol adapted from those described previously (Munzberg et al., 2003; 
Huo et al., 2004; Levin et al., 2004; Ellacott et al., 2006; Becskei et al., 2010; Bouret et al., 
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2012). Free-floating tissue sections were removed from cryoprotectant storage and rinsed 
thoroughly in 0.02M phosphate buffer (PB). Importantly, our pilot studies indicate that this 
buffer molarity is essential for optimal pSTAT3-ir. Following rinses, tissue was treated with 
0.5% sodium borohydride (20 minutes), 0.3% NaOH + 0.3% H2O2 (20 minutes), 0.3% glycine 
(10 minutes), and 0.03% SDS (10 minutes; all in 0.02M PB). Nonspecific binding was prevented 
with a 20-minute incubation in blocking solution (0.02M PB containing 4% normal donkey 
serum, 0.4% Triton-X 100, and 1% BSA) before antibody incubation.  
Primary and secondary antisera were diluted in blocking solution. Tissue sections were 
incubated in rabbit anti-pSTAT3 (1:1,000; Cell Signaling, D3A7). The specificity and selectivity 
of this commercially available antibody has been reported (Tripathi and McTigue, 2008; Caron 
et al., 2010). Tissue was incubated in biotinylated donkey anti-rabbit IgG (1:500; Jackson 
ImmunoResearch), treated with Elite Vectastain ABC reagents (Vector), and reacted with 
diaminobenzidine (DAB) intensified with nickel sulfate to produce a blue-black pSTAT3 
reaction product.  
 
ARC and NTS Neural Phenotypes 
To begin determining the chemical phenotypes of neurons demonstrating pSTAT3-ir following 
these relatively low doses of leptin, we assessed pSTAT3-ir within ARC neurons expressing the 
anorexigenic peptide, cocaine- and amphetamine-regulated transcript (CART) (Kristensen et al., 
1998). We also assessed pSTAT3-ir within noradrenergic NTS neurons expressing dopamine-β-
hydroxylase (DβH) alone or together with prolactin-releasing peptide (PrRP), and in NTS 
neurons expressing glucagon-like peptide-1 (GLP-1).  CART, DβH/PrRP, and GLP1 neurons 
 146 
were selected for examination because each population has been implicated in central control of 
body energy balance (Kristensen et al., 1998; Rinaman, 2011; Maniscalco et al., 2013).  
To identify pSTAT3-ir within neurons of the ARC that express CART, pSTAT3-labeled 
forebrain sections from some cases were subsequently incubated in rabbit anti-CART (1:10,000, 
Phoenix Pharmaceuticals, H-003-62) followed by AlexaFluor 488-conjugated donkey anti-rabbit 
IgG (1:300, Jackson ImmunoResearch) to produce a green fluorescent cytoplasmic signal.  
To localize pSTAT3 within DβH- and PrRP-positive neurons of the NTS, pSTAT3-
labeled brainstem sections from some cases were incubated in a cocktail of mouse anti-DβH 
(1:5,000; Millipore, MAB308) and rabbit anti-PrRP (1:1,000; Phoenix Pharmaceuticals, H-008-
52). After this, tissue sets were incubated in a cocktail of Cy3-conjugated donkey anti-rabbit IgG 
(1:300, Jackson ImmunoResearch) and AlexaFluor 488-conjugated donkey anti-mouse IgG 
(1:300, Jackson ImmunoResearch) to produce red and green fluorescent cytoplasmic signals, 
respectively.  
To localize pSTAT3 within NTS GLP-1-positive neurons, pSTAT3-labeled brainstem 
sections were incubated in rabbit anti-GLP-1 (1:10,000; Bachem, T-4363) followed by 
biotinylated donkey anti-rabbit IgG (1:500, Jackson ImmunoResearch), Elite Vectastain ABC 
reagents, and plain DAB to produce a brown cytoplasmic reaction product. 
 
Imaging & Quantification 
 
Quantification of pSTAT3-Expressing Cells in the ARC, dorsomedial (dm)VMH, and NTS 
pSTAT3-labeled tissue was visualized using a 20X objective on an Olympus microscope 
equipped for brightfield and fluorescent optics, and was photographed using a digital camera 
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(Hamamatsu Photonics, Hamamatsu, Japan). For all anatomical regions, pSTAT3-positive 
profiles were quantified on images using Adobe Photoshop CS4 image software. The criterion 
for counting a cell as pSTAT3-positive was the presence of visible blue-black nuclear 
immunolabeling, regardless of intensity. 
pSTAT3-ir was quantified bilaterally at two rostrocaudal levels of the ARC 
(approximately 2.00mm and 2.45mm caudal to bregma) and bilateral counts were averaged per 
section. Within the dmVMH, pSTAT3-labeled profiles were quantified bilaterally at a single 
rostrocaudal level (approximately 2.45mm caudal to bregma). This level represents the core of 
the nucleus and contained the most robust pSTAT3-ir after our highest peripheral dose of leptin. 
Within the NTS, pSTAT3-labeled cells were quantified bilaterally at two rostrocaudal levels 
(approximately 14.36mm and 14.16mm caudal to bregma; see Figure 17) and bilateral counts 
were averaged per section. In all cases, distance from bregma was approximated based on tissue 
comparison to a standard rat brain atlas (Swanson, 2004). 
 
Qualitative Assessment of pSTAT3-ir in Phenotypically-Identified ARC and NTS Neurons 
pSTAT3-labeled sections co-labeled for CART, DβH/PrRP, or GLP-1 were viewed on the 
Olympus photomicroscope described above. Using a 20X objective, photographic images were 
captured from a single selected rostrocaudal level of the ARC (approximately 2.00mm caudal to 
bregma) or the NTS (approximately 14.36mm caudal to bregma). Neurons were identified using 
Adobe Photoshop CS4 image software. Criteria for identifying a neuron as CART-, DβH/PrRP-, 
or GLP-1-positive included clear cytoplasmic labeling and a visible nucleus. Neurons were 
considered pSTAT3-positive if the nucleus contained pSTAT3 immunolabeling, regardless of 




Separate one-way ANOVAs were used to determine the effect of leptin dose (0, 50, 100, 200, 
400, and 800 μg/kg BW) on the number of pSTAT3-positive profiles within the ARC, dmVMH, 
and NTS. When F-values indicated a significant effect, the ANOVA was followed by Fisher’s 
LSD post hoc analyses. Differences were considered significant when p < 0.05. 
 
Preparation of Images 
Using Adobe Photoshop software, photographic images were adjusted for optimal brightness and 
contrast. Images that included both immunoperoxidase and immunofluorescence were altered to 
generate Figure 19B-C (i.e., blue-black NiDAB pSTAT3 labeling photographed in the green 
color channel was inverted, giving it the appearance of a fluorescent signal). The presence or 
absence of immunolabeling in images was not digitally manipulated. 
A.3 RESULTS 
The presence of leptin-induced pSTAT3-ir was assessed throughout the full rostrocaudal extent 
of the brain, from the upper cervical spinal cord through the prefrontal cortex. Systemically 
administered leptin elicited robust pSTAT3-ir within the ARC, dmVMH, and NTS. Other brain 





pSTAT3 Labeling within the ARC 
ANOVA indicated a significant effect of all leptin doses on the number of pSTAT3-positive 
profiles within the ARC [F (5,28) = 35.712, p < .001; Figure 15D]. While some pSTAT3-ir was 
observed in the ARC of vehicle-treated rats, all doses of i.p. leptin significantly increased 





Figure 15. Representative images and summary data of pSTAT3 labeling within the ARC 
Representative images of pSTAT3 labeling within the ARC after i.p. injection of (A) saline vehicle, (B) 200 μg/kg 
BW leptin, or (C) 800 μg/kg BW leptin. Images depict the ARC approximately 2.85 mm caudal to bregma. D, bar 
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graph illustrating the number of pSTAT3-positive cells within the ARC bilaterally after i.p. leptin at doses from 0-
800 μg/kg BW. All doses significantly increased ARC pSTAT3 labeling compared to saline vehicle. Bars with 
different letters are significantly different (p < .05). 3V = third ventricle; ARC, arcuate nucleus of the hypothalamus; 
ME = median eminence. Scale bar in A = 100 μm, applies also to B and C.  
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pSTAT3 Labeling within the dmVMH 
In contrast to the binary pattern of STAT3 phosphorylation observed in the ARC (i.e., similar 
increases in pSTAT3-ir after all leptin doses), the dmVMH displayed a leptin dose-dependent 
increase in pSTAT3 labeling (Figure 16A-C). ANOVA indicated a significant effect of leptin 
dose on the number of pSTAT3-ir profiles within the dmVMH [F (5,28) = 78.057, p < .001].  
pSTAT3-ir was negligible in vehicle-treated rats and in rats treated with 50 or 100 μg/kg BW 






Figure 16. Representative images and summary data of pSTAT3 labeling within the dmVMH 
Representative images of pSTAT3 labeling within the dmVMH after i.p. injection of (A) saline vehicle, (B) 200 
μg/kg BW leptin, or (C) 800 μg/kg BW leptin. Images depict the dmVMH approximately 2.45 mm caudal to 
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bregma. D, bar graph illustrating the number of pSTAT3-positive cells within the dmVMH after i.p. leptin at doses 
from 0-800 μg/kg BW. Leptin dose-dependently increased dmVMH pSTAT3 labeling. Bars with different letters are 
significantly different (p < .05). 3V = third ventricle; ARC, arcuate nucleus of the hypothalamus; dmVMH, 
dorsomedial subregion of the ventromedial hypothalamus; cVMH, central subregion of the ventromedial 
hypothalamus; vlVMH, ventrolateral subregion of the ventromedial hypothalamus. Scale bar in A = 100 μm, applies 
also to B and C.  
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pSTAT3 Labeling within the NTS 
The rostrocaudal extent of the NTS was examined for pSTAT3-ir to evaluate subregional effects 
of systemic leptin. Even in rats receiving the highest leptin dose (800 μg/kg BW), pSTAT3-ir 
within the NTS was largely limited to the medial subnucleus of the caudal “visceral” NTS, with 
peak immunolabeling at the rostrocaudal level of the area postrema (Figure 17).  In each rat, 
STAT3 phosphorylation was quantified in two tissue sections through this level of the NTS (i.e., 
approximately 14.36 and 14.16mm caudal to bregma) (Figure 17). ANOVA indicated a 
significant effect of leptin dose on the number of pSTAT3-ir profiles within the NTS at this 
rostrocaudal level [F (5,28) = 11.282, p < .001]. pSTAT3-ir was negligible in vehicle-treated 
rats, whereas systemic leptin elicited a dose-dependent increase in pSTAT3-ir that reached a 





Figure 17. Images of pSTAT3 labeling through the rostrocaudal extent of the caudal NTS after i.p. leptin  
Images of pSTAT3 labeling through the rostrocaudal extent of the caudal NTS in a representative rat after i.p. leptin 
at a dose of 800 μg/kg BW. pSTAT3 immunoreactivity was located primarily within the medial subnucleus of the 
caudal NTS. Numbers in each panel represent relative distance from bregma. AP = area postrema; DMX = dorsal 






Figure 18. Representative images and summary data for pSTAT3 labeling within the NTS 
Representative images and summary data for pSTAT3 labeling within the NTS after i.p. injection of (A) saline 
vehicle, (B) 200 μg/kg BW leptin, or (C) 800 μg/kg BW leptin. Images depict the caudal NTS approximately 14.36 
mm caudal to bregma. D, bar graph illustrating the number of pSTAT3-positive cells within the mNTS after i.p. 
leptin at doses from 0-800 μg/kg BW. Leptin dose-dependently increased NTS pSTAT3 labeling. Bars with different 
letters are significantly different (p < .05). CC = central canal; mNTS = medial subnucleus of the nucleus of the 
solitary tract; DMX = dorsal motor nucleus of the vagus. Scale bar in A = 100 μm, applies also to B and C.  
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pSTAT3 Immunolabeling in Phenotypically Identified Neurons 
Consistent with a previous report using peripheral leptin administration in rats (Huo et al., 2008), 
pSTAT3 within the NTS was not co-localized in any GLP-1 neurons (Figure 19A). pSTAT3-ir 
was co-localized in a subset of DβH- and DβH/PrRP-positive neurons of the caudal NTS (Figure 
19B). However, qualitative assessment indicated that the majority of DβH- and DβH/PrRP-
positive neurons did not co-localize pSTAT3, and vice versa. Within the ARC, many CART-
expressing neurons were also pSTAT3-positive (Figure 19C), consistent with reports that 





Figure 19. Images of pSTAT3 and phenotypically-identified neurons in the brainstem and hypothalamus 
Representative color images of pSTAT3 and phenotypically-identified neurons within the brainstem and 
hypothalamus. A, pSTAT3 (blue-black) is not colocalized in GLP-1-positive (brown) NTS neurons in rats after any 
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dose of leptin (this image is from a rat treated with leptin at 200 μg/kg BW; 14.36 mm caudal to bregma). B, 
pSTAT3 (green) is colocalized in some DβH-positive (blue) and DβH/PrRP-positive (purple-pink) neurons within 
the caudal NTS after leptin treatment (800 μg/kg BW; approximately 14.36 mm caudal to bregma). The majority of 
DβH- and DβH/PrRP-positive neurons did not co-localize pSTAT3, and vice versa. Arrows indicate 
pSTAT3+DβH/PrRP-positive neurons; the arrowhead indicates a pSTAT3+DβH-positive neuron that is not 
immunolabeled for PrRP. C, pSTAT3 (green) is co-localized with many CART-positive ARC neurons (red) after i.p. 
leptin (400 μg/kg BW; approximately 2.45 mm caudal to bregma). Inset, higher magnification view of several 
double-labeled ARC neurons. Scale bar in A = 100 μm. Scale bars in B and C = 50 μm. 
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pSTAT3 Immunolabeling within Neural Processes 
We observed dose-dependent increases in cytoplasmic pSTAT3-ir within neural processes in the 
ARC, dmVMH, and NTS. Labeling within the ARC appeared to remain within the anatomic 
boundaries of the nucleus. Conversely, pSTAT3-positive dmVMH processes projected radially 
in all directions away from the core of the nucleus, with particularly prominent labeling located 
ventral to the dmVMH within the internuclear area separating the VMH from the ARC (Figure 
16C). Labeling of neural processes within the NTS was most prevalent within the medial 
subnucleus, but was also observed within the commissural subnucleus and extending into the 
area postrema (Figure 17 & Figure 18B-C). 
A.4 DISCUSSION 
Leptin plays a critical role in regulating energy balance and other physiological functions 
(Moschos et al., 2002; Gautron and Elmquist, 2011; Carlton et al., 2012), and leptin signaling 
pathways that underlie these effects include direct activation of leptin receptors in brainstem and 
hypothalamic nuclei (Satoh et al., 1997; Minokoshi et al., 1999; Hayes et al., 2010). In order to 
better understand how systemically released leptin acts on the brain to modulate physiology and 
behavior, it is necessary to localize and phenotypically identify leptin-responsive cells within the 
CNS.  The present study is the first to immunohistochemically visualize pSTAT3 in rats after 
relatively low doses of systemic leptin. Doses used in the present study are known to elicit 
behavioral and physiological effects after systemic administration (Campfield et al., 1995; Cakir 
et al., 2007; Shen et al., 2007), and are much lower than systemic doses used previously to 
induce central pSTAT3 labeling. We report pSTAT3-ir after peripheral doses of leptin as low as 
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50 μg/kg BW, well within the range of leptin doses that alter physiology and behavior 
(Campfield et al., 1995; Cakir et al., 2007; Shen et al., 2007). We also conducted the first 
reported dose-response assessment of leptin-induced pSTAT3 in several brain regions, providing 
new information regarding leptin sensitivity within and between central nuclei. Our results 
demonstrate that i.p. leptin at doses ranging from 50-800 μg/kg BW elicit unique and dose-
dependent patterns of STAT3 phosphorylation in the ARC, dmVMH, and NTS.  
 
Arcuate Nucleus of the Hypothalamus 
It is well established that the ARC plays a critical role in energy balance by transducing 
circulating signals, including the adiposity signal leptin, into neural responses (Elias et al., 2000; 
Cone et al., 2001; Cowley et al., 2003). Leptin receptors are abundantly expressed within the 
ARC, and numerous studies have reported dense ARC pSTAT3-ir in rodents after high 
peripheral doses of leptin (Levin et al., 2004; Becskei et al., 2010; Turek et al., 2010). However, 
our study is the first to assess leptin-induced pSTAT3-ir within the ARC after leptin doses lower 
than 1mg/kg BW. Our results demonstrate that the ARC displays moderate pSTAT3-ir in 
vehicle-treated rats, presumably the result of endogenous leptin or other signaling factors that 
phosphorylate STAT under these conditions. Interestingly, the number of pSTAT3-positive ARC 
cells increased to maximal levels following the lowest leptin dose used in the present study (50 
μg/kg BW) – a dose 100-300 times lower than those previously shown to be effective (Hosoi et 
al., 2002; Levin et al., 2004; Turek et al., 2010). Higher leptin doses elicited no further increase 
in pSTAT3-ir. These results support the view that the ARC is unusually sensitive to systemically 
administered leptin, probably due to high rates of peripheral-to-central leptin transport at this site 
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(Banks et al., 2000b), and likely tied to the ARCs critical role in controlling body energy 
homeostasis. 
Since leptin receptor activation within the ARC decreases food intake and body weight 
(Satoh et al., 1997), we investigated the ability of peripheral leptin to phosphorylate STAT3 
within ARC neurons that have a known anorexigenic role. ARC neurons that express both pro-
opiomelanocortin (POMC) and CART (Elias et al., 1998) drive anorexigenic responses to leptin 
via downstream central targets (Kristensen et al., 1998; Balthasar et al., 2005; Aponte et al., 
2011). As predicted, many CART-positive ARC neurons co-localized pSTAT3 after 400 μg/kg 
BW leptin. This finding is consistent with evidence that POMC/CART neurons contribute to the 
decreased food intake (Campfield et al., 1995), inhibition of gastric motility (Cakir et al., 2007), 
and increased sympathetic outflow (Shen et al., 2007) observed following peripheral doses of 
leptin similar to those used here. 
Within the ARC, maximal pSTAT3-ir was observed in rats that received the lowest leptin 
dose (i.e., 50 μg/kg BW). It will be important in future studies to identify the threshold dose for 
increased STAT3 phosphorylation within the ARC, and to explore dose-related pSTAT3 
responses among phenotypically identified neural populations.   
 
Ventromedial Nucleus of the Hypothalamus 
The VMH has long been implicated in the control of feeding and energy balance (Hetherington 
and Ranson, 1940), and recent evidence indicates that it does so in part through direct leptin 
signaling. The VMH expresses the leptin receptor (Schwartz et al., 1996; Elmquist et al., 1998a), 
and intra-VMH leptin injection facilitates blood glucose homeostasis (Minokoshi et al., 1999), 
increases sympathetic outflow (Satoh et al., 1997), and decreases food intake (Jacob et al., 1997). 
 164 
Moreover, genetic deletion of the leptin receptor within a subset of VMH neurons that express 
steroidogenic factor-1 (SF-1) results in increased body weight and susceptibility to diet-induced 
obesity (Dhillon et al., 2006). The downstream targets through which VMH neurons modulate 
energy balance remain under investigation (Elmquist et al., 1998b; Sternson et al., 2005). 
Following peripheral administration of leptin, dose-dependent increases in pSTAT3-ir 
were observed within the VMH. pSTAT3-ir was present predominantly within the dorsomedial 
subregion of the VMH, although labeling was also observed in the central and ventrolateral 
subregions. Within the dmVMH, doses of leptin at or below 100 μg/kg BW elicited negligible 
pSTAT3-ir, whereas dose-related increases in STAT3 phosphorylation were observed after 
administration of leptin at 200, 400, and 800 μg/kg BW. The significant response to leptin at the 
200 μg/kg dose is especially noteworthy, as this dose is 25 times lower than the lowest 
peripheral dose previously reported to increase pSTAT3-ir within the VMH (Turek et al., 2010). 
No plateau in pSTAT3-ir was observed within the VMH in the present study, suggesting that 
higher doses of leptin might induce additional STAT3 phosphorylation in this brain region.   
The chemical phenotypes of VMH neurons sensitive to leptin at these doses is unclear, 
although they likely include SF-1 neurons that co-localize pituitary adenylate cyclase-activating 
polypeptide, based on evidence that these neurons mediate some of leptin’s hypophagic effects 
(Dhillon et al., 2006; Hawke et al., 2009).  
  
Nucleus of the Solitary Tract 
A growing literature has implicated neurons of the NTS in the changes in energy balance 
produced by central leptin signaling [for review, see (Grill, 2010)]. Recent studies show that 
leptin signaling in the NTS is not only sufficient to decrease food intake and body weight (Grill 
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et al., 2002) but is necessary for maintenance of normal energy balance in freely-feeding rats 
(Hayes et al., 2010). Previous reports indicate that systemic leptin doses between 1-5 mg/kg BW 
are sufficient to elicit STAT3 phosphorylation within the NTS (Munzberg et al., 2003; Ellacott et 
al., 2006; Huo et al., 2008; Turek et al., 2010). No study, however, had investigated whether low 
doses of leptin – sufficient to alter autonomic, physiological, and behavioral output (Campfield 
et al., 1995; Barrachina et al., 1997; Cakir et al., 2007; Shen et al., 2007) – act directly on 
neurons of the NTS.  
The present results demonstrate significantly elevated STAT3 phosphorylation within the 
NTS in rats after peripheral administration of leptin at doses as low as 100 μg/kg, which is 10-50 
times lower than doses used previously. pSTAT3-ir within the NTS displayed a leptin dose-
response effect that was intermediate to effects observed within the ARC and the dmVMH. 
Some baseline pSTAT3-ir was present within the NTS in vehicle-treated rats, and the ability of 
leptin to increase pSTAT3-ir reached a plateau at the 200 μg/kg BW dose. Increased pSTAT3-ir 
was confined to the caudal “visceral” NTS, a region known for its role in satiation and visceral 
sensory processing (Maniscalco et al., 2013). Consistent with a previous report using systemic 
leptin administration (Huo et al., 2008), most of the pSTAT3-ir observed in the present study 
was located within the medial subnucleus (mNTS), which receives digestive-related vagal 
sensory input (Altschuler et al., 1989; Miselis et al., 1991). Intra-mNTS leptin injections 
suppress food intake and motivation for food seeking (Grill et al., 2002; Kanoski et al., 2013), 
while virus-mediated knockdown of mNTS leptin receptors increases food intake, meal size, 
body weight, and adiposity (Hayes et al., 2010; Kanoski et al., 2012). However, the neural 
circuits underlying these effects remain unclear.   
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The majority of pSTAT3-ir within the caudal NTS was localized in phenotypically 
unidentified neurons. We were somewhat surprised to observe relatively few DβH- and 
DβH/PrRP-positive neurons among those expressing pSTAT3-ir, because these neurons together 
comprise the A2 noradrenergic cell group, which contributes importantly to food intake and meal 
size control in rats (Rinaman, 2011; Maniscalco et al., 2013). GLP-1 neurons were never 
pSTAT3-positive, consistent with a previous report in rats, but in contrast to histological and 
electrophysiological results in mice (Huo et al., 2008; Hisadome et al., 2010). This is not to say, 
however, that leptin does not affect A2 or GLP-1-expressing neurons in rats. Leptin exerts a 
strong depolarizing effect on glutamatergic vagal afferents that synapse directly onto neurons of 
the NTS (Peters et al., 2004; Peters et al., 2006c; Appleyard et al., 2007), providing a potential 
route through which leptin receptors might modulate visceral afferent signaling to caudal NTS 
neurons, including A2 and GLP-1 neurons. 
 
Dose Response Summary 
To our knowledge, this report is the first to describe differential dose-related sensitivity of 
central pSTAT3-ir responses to leptin. The ARC displayed the greatest sensitivity, with maximal 
pSTAT3 labeling observed after the lowest leptin dose administered (i.e., 50 μg/kg BW), while 
pSTAT3-ir within the NTS did not reach maximal levels until rats were dosed with leptin at 200 
μg/kg BW. Both the ARC and the NTS displayed leptin dose-related plateaus in pSTAT3-ir, 
evidence that higher doses would be unlikely to further increase pSTAT3-ir in these regions. 
Phosphorylation of STAT3 within the dmVMH, however, increased progressively through the 
highest dose administered (i.e., 800 μg/kg BW) without reaching an evident plateau, suggesting 
that higher doses might produce additional increases in pSTAT3-ir within the VMH.  
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Cytoplasmic pSTAT3 Immunoreactivity 
In addition to nuclear labeling, strong pSTAT3-ir was present within neural processes. Leptin 
receptors are expressed on both proximal and distal dendrites, where STAT3 phosphorylation 
occurs before translocation to the nucleus (Banks et al., 2000a; Villanueva and Myers, 2008; Ha 
et al., 2013). Thus, neuritic labeling likely represents dendritic pSTAT3 that has yet to undergo 
nuclear translocation. Since pSTAT3 accumulates in the cell’s nucleus but not in the cytoplasm, 
it is likely that visualization of dendritic pSTAT3-ir requires more sensitive 
immunohistochemical and optic techniques than are commonly used (Ha et al., 2013). Our report 
is not the first to show dendritic pSTAT3 labeling (Hubschle et al., 2001; Hosoi et al., 2002; 
Roth et al., 2008; Ha et al., 2013), but immunolabeling in the present study is significantly more 
pronounced than previously documented.  
Importantly, the dendritic pSTAT3 labeling in our material closely matches established 
dendritic patterns of neurons within each brain region. Golgi staining reveals that ARC neuronal 
dendrites remain largely within the anatomical boundaries of the ARC (Millhouse, 1979), 
whereas VMH neuronal dendrites radiate in all directions, including ventrally-directed dendritic 
branches that extend into the internuclear area separating the ARC from VMH (Millhouse, 1973, 
1979). These dendritic patterns precisely match the pSTAT3 labeling we observed within the 
medial hypothalamus. Within the NTS, dendritic pSTAT3 immunolabeling was confined 
predominantly to the medial subnucleus, but was also observed in processes extending medially 
into the commissural subnucleus and dorsally into the area postrema. This pattern of labeling 
reflects the organization of NTS neuronal dendrites (Ellacott et al., 2006), and is consistent with 
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dendritic pSTAT3 labeling reported within the NTS of rats that received a much higher systemic 
dose of leptin (Hosoi et al., 2002; Ha et al., 2013).  
 
Perspectives and Significance 
Since its discovery 20 years ago, much has been learned about leptin and leptin receptor-
mediated regulation of physiology and behavior. However, much remains to be discovered 
regarding the structure and function of neural circuits through which leptin elicits its diverse 
effects. The present study documents STAT3 phosphorylation within the rat CNS after systemic 
doses of leptin that are up to 300 times lower than those used previously to generate pSTAT3-ir. 
Furthermore, this study provides the first dose-response assessment of leptin-induced STAT3 
phosphorylation within the ARC, VMH, and NTS, providing new information regarding leptin 
sensitivity within and between these nuclei. Additional studies will be necessary to further 
characterize the neurochemical phenotypes and axonal projections of central neurons in which 
STAT3 is phosphorylated by systemic leptin. Further characterization of central leptin-sensitive 
neurons and circuits will lead to a better understanding of how peripherally-derived leptin acts 




SATIATION AND STRESS-INDUCED HYPOPHAGIA:  EXAMINING THE ROLE OF 
HINDBRAIN NEURONS EXPRESSING PROLACTIN-RELEASING PEPTIDE (PRRP) 
OR GLUCAGON-LIKE PEPTIDE 1 (GLP-1)5 
B.1 INTRODUCTION 
Factors that increase or decrease food intake do so by altering meal size, meal frequency, or both 
(Smith, 1998; Smith, 2000, 2004).  Satiation – the natural process that ends a meal – is a 
brainstem-mediated phenomenon in which food intake is terminated as a consequence of intake 
within that meal, thus influencing meal size.  In contrast, satiety is a post-ingestive state that 
precludes initiation of a meal, thereby influencing meal frequency. Satiation occurs in adult 
decerebrate rats in which the brainstem is surgically isolated from the hypothalamus and the rest 
of the forebrain (Grill and Norgren, 1978; Seeley et al., 1994; Grill and Kaplan, 2002; Grill, 
                                                 
5 The entirety of the work presented in Appendix B is from “Satiation and stress-induced 
hypophagia: Examining the role of hindbrain neurons expressing prolactin-releasing peptide or 
glucagon-like peptide 1,” by J.W. Maniscalco, A.D. Kreisler, and L. Rinaman, 2013, Frontiers in 
Neuroscience, 6:199. Copyright (2013) by Maniscalco, Kreisler, and Rinaman. This is an open-
access article distributed under the terms of the Creative Commons Attribution License, which 
permits use, distribution and reproduction in other forums, provided the original authors and 
sources are credited and subject to any copyright notices concerning any third-party graphics etc. 
Reprinted with permission. 
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2010), and in neonatal rats with functionally immature forebrain-brainstem connections (Hall 
and Bryan, 1980; Hall and Swithers-Mulvey, 1992; Rinaman et al., 1994).  Satiation depends on 
peripherally-generated “satiety signals”, which decrease activity in brainstem circuits that 
maintain ingestive licking/chewing/swallowing behaviors, and/or increase activity in brainstem 
circuits that suppress these behaviors (Smith, 1998; Smith, 2000, 2004).  Although the brainstem 
is sufficient for satiation, the amount of food consumed before a meal is voluntarily terminated is 
powerfully modulated by neural signals from the forebrain and hormonal factors that increase or 
decrease the behavioral potency of satiety signals (Grill and Hayes, 2012).  Some of these signals 
and factors act directly on the brainstem components of ingestive control circuits, while others 
act indirectly by engaging hypothalamic and limbic forebrain regions that influence the activity 
of brainstem ingestive control circuits via descending projections (Smith, 1998; Smith, 2000; 
Grill and Kaplan, 2002; Luckman and Lawrence, 2003; Smith, 2004; Grill and Hayes, 2009; 
Grill, 2010).  Satiety signals and other feedback about the quality and quantity of food consumed 
are delivered to brainstem and forebrain regions that coordinate a host of feeding-related 
processes, including anticipatory and reflexive metabolic, endocrine, and autonomic adjustments, 
preference and avoidance learning, appetitive motivation, and behavioral state control (Grill and 
Kaplan, 2002; Luckman and Lawrence, 2003; Smith, 2004; Grill and Hayes, 2009; Grill, 2010; 
Rinaman, 2010; Berthoud et al., 2011; Grill and Hayes, 2012).   
Satiation and satiety are normal, everyday processes.  However, consuming a satiating 
meal can be stressful, especially if food intake occurs at an unusual (i.e., unpredicted) time, or if 
the meal is unusually large or calorically dense.  Food intake presents an immediate 
physiological challenge to homeostasis (Woods, 1991), and there is evidence that feeding 
activates the neuroendocrine hypothalamic-pituitary-adrenal (HPA) axis to increase circulating 
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levels of glucocorticoids (i.e., cortisol in humans, corticosterone in rats and mice) (Shiraishi et 
al., 1984; Dallman et al., 2004).  The HPA axis is primarily involved in energy storage and 
mobilization under baseline conditions and in response to homeostatic challenge (Dallman et al., 
2004), and stressors are commonly defined as internal or external stimuli that increase HPA axis 
activity above baseline circadian-modulated levels.  Meals are fundamentally disruptive to 
homeostasis because they cause significant changes in a variety of important physiological 
parameters that are under constant surveillance and regulation, such as gastrointestinal 
distension, liver temperature, osmotic pressure, and blood glucose (Woods, 1991; Woods and 
Ramsay, 2000).  Viewed from this perspective, it is reasonable to propose that there is a very fine 
line between central circuits that inhibit food intake during satiation and satiety, and those that 
inhibit intake during acute stress.  The idea that satiety signals and hypophagic stressors might 
recruit a common set of neurons and circuits is not new [e.g., see (Ritter et al., 1999; Seeley et 
al., 2000; Calvez et al., 2011)], but the putatively shared circuits whose recruitment results in 
decreased meal size and/or frequency remain to be identified.   
The present review discusses evidence that inhibition of food intake by satiety signals 
and by hypophagic stressors is mediated, at least in part, by recruitment of two phenotypically 
distinct but anatomically intermingled populations of hindbrain neurons.  The first population 
comprises noradrenergic (NA) neurons within the caudal nucleus of the solitary tract (cNST; A2 
cell group), a majority of which express prolactin-releasing peptide (PrRP; Maruyama et al., 
2001).  PrRP was identified as an endogenous ligand for the human orphan G-protein-coupled 
receptor hGR3/GPR10, and earned its name because it induces prolactin secretion from anterior 
pituitary cells in vitro (Hinuma et al., 1998).  However, PrRP is absent from the external layer of 
the median eminence, and there is no evidence that endogenous PrRP plays any physiological 
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role in prolactin release.  Instead, mRNA for PrRP receptor (hGR3/GPR10) is expressed in 
multiple brainstem and forebrain regions implicated in feeding, behavioral, and physiological 
responses to stress (Roland et al., 1999; Lawrence et al., 2000; Yamada et al., 2009).  PrRP 
mRNA is expressed exclusively by a subset of caudal medullary NA neurons, and by a small 
number of neurons in a ventral region of the caudal dorsomedial hypothalamic nucleus (Iijima et 
al., 1999; Roland et al., 1999; Onaka et al., 2010).  The second group of hindbrain neurons with a 
proposed role in both satiation and stress-induced hypophagia synthesize glucagon-like peptide 1 
(GLP-1).  Despite the largely overlapping hindbrain distribution of PrRP and GLP-1 neurons, the 
latter are a completely distinct population of non-adrenergic neurons that expresses mRNA for 
preproglucagon (PPG), the protein precursor of GLP-1.  Within the brain, PPG mRNA 
expression is limited to the olfactory bulb, the cNST, and the caudal medullary reticular 
formation (Larsen et al., 1997b; Merchenthaler et al., 1999)6.  Since PPG-expressing neurons 
within the olfactory bulb are interneurons with very short axons, GLP-1 fibers and terminals 
throughout the rest of the CNS can be assumed to originate from hindbrain PPG-expressing 
neurons. 
Results from many published reports indicate that food intake in rats and mice is reduced 
after central infusions of PrRP, GLP-1, or their synthetic analogs (Tang-Christensen et al., 1996; 
Turton et al., 1996; Imeryuz et al., 1997; McMahon and Wellman, 1997; Asarian et al., 1998; 
McMahon and Wellman, 1998; Thiele et al., 1998b; Lawrence et al., 2000; Kinzig et al., 2002; 
Lawrence et al., 2002; Schick et al., 2003; Grabauskas et al., 2004; Lawrence et al., 2004; 
                                                 
6 Amoeboid microglia also contain GLP-1 immunoreactive material, at least when activated in 
culture (Iwai et al., 2006), suggesting that under certain pathological conditions activated 
microglia may release GLP-1 to access receptors in brain sites not normally targeted by the 
axons of hindbrain GLP-1 neurons. 
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Bechtold and Luckman, 2006; Nakade et al., 2006; Takayanagi et al., 2008; Holmes et al., 2009; 
Takayanagi and Onaka, 2010; Hayes et al., 2011; Alhadeff et al., 2012).  Such studies are 
important, and provide a strong foundation for the hypothesis that both neural populations drive 
hypophagia.  However, delivery of synthetic peptides or their analogs into the brain is a poor 
model for understanding whether stimulus-induced release of endogenous PrRP or GLP-1 
contributes to satiation or stress-induced hypophagia.  The present review focuses on results 
from a smaller number of studies providing evidence that satiety signals and acute stress inhibit 
food intake by recruiting endogenous PrRP and GLP-1 signaling pathways.  Before reviewing 
those data, we first review the anatomical location, neurochemical features, and circuit 
connections of hindbrain PrRP and GLP-1 neurons. 
B.2 ANATOMY OF THE DORSAL VAGAL COMPLEX AND ITS RESIDENT PRRP 
AND GLP-1 NEURONS 
PrRP-immunopositive neurons and non-adrenergic GLP-1-immunopositive neurons are co-
distributed in the hindbrain near the medullary-spinal junction, within caudal levels of the NST 
and the nearby medullary reticular formation (Figure 20). The cNST is the “visceral” NST, 
distinct from the more rostral “gustatory” NST (Lundy-Jr. and Norgren, 2004). The cNST is a 
key component of the dorsal vagal complex (DVC), which also includes the area postrema (AP) 
and dorsal motor nucleus of the vagus (DMV).  The DVC is remarkable for being perhaps the 
smallest circumscribed brain region whose destruction is incompatible with life.  It is a critical 
central node for autonomic and endocrine functions, relaying interoceptive visceral, hormonal, 
and somatic feedback from body to brain, tuning stress responsiveness, and regulating glucose 
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homeostasis and other aspects of energy balance (Zagon et al., 1999; Rinaman, 2003b; Berthoud 
et al., 2006; Rinaman, 2007; Grill and Hayes, 2009; Grill, 2010; Rinaman, 2010; Zhang et al., 
2010; Rinaman, 2011; Grill and Hayes, 2012).  The AP and a significant portion of the subjacent 
cNST contain fenestrated capillaries, allowing blood-borne factors to affect neurons in this 
region (Yamamoto et al., 2003).  As recently reviewed (Grill and Hayes, 2009; Grill, 2010; 
Rinaman, 2010, 2011), AP neurons innervate the subjacent cNST (Shapiro and Miselis, 1985a; 
Kachidian and Pickel, 1993; Cunningham-Jr. et al., 1994), and cNST neurons innervate other 
NST neurons (including those located in the more rostral “taste” area) as well as gastrointestinal 
and pancreatic vagal preganglionic parasympathetic motor neurons whose cell bodies occupy the 
DMV and whose dendrites ramify widely within the overlying cNST (Shapiro and Miselis, 





Figure 20. Location of PrRP and GLP-1 neurons in the rat hindbrain 
Location of PrRP and GLP-1 neurons in the rat hindbrain.  A, Schematics illustrating the location of the cNST 
(highlighted in blue), adapted from Swanson (2004).  The red line in the mid-sagittal brain schematic at upper left 
illustrates the rostrocaudal level of all coronal sections depicted in Figure 1 images.  B, In this image, dopamine beta 
hydroxylase (DbH) immunopositive NA neurons are green, while GLP-1-immunopositive neurons are red.  The two 
intermingled populations are distinct, with no colocalization of immunolabeling.  C, GLP-1 immunoperoxidase-
labeled neurons.  D, DbH immunoperoxidase-positive NA neurons of the A2 cell group.  E, In this image, all PrRP-
positive neurons are double-labeled for DbH, rendering them yellow/orange (NA/PrRP neurons).  Some 
intermingled NA neurons (green) are PrRP-negative.  cc, central canal. 
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In addition to inputs from the AP, cNST neurons receive sensory feedback from 
cardiovascular, respiratory, and alimentary systems (Kalia and Sullivan, 1982).  Visceral sensory 
inputs arrive predominantly via glutamatergic glossopharyngeal and vagal afferents whose 
central axons converge in the solitary tract before synapsing with the dendrites and somata of 
cNST neurons, including GLP-1 and NA neurons, the latter of which undoubtedly includes the 
PrRP-positive majority subpopulation (Altschuler et al., 1989; Rinaman et al., 1989; Spyer, 
1990; Bailey et al., 2006; Appleyard et al., 2007; Hisadome et al., 2010, 2011).  In the mouse in 
vitro slice preparation, glutamatergic visceral afferent signals produce tightly synced, large-
amplitude excitatory postsynaptic currents in NA and GLP-1 neurons within the cNST, 
providing high-fidelity transmission of sensory nerve activity.  Other visceral and somatic 
sensory inputs are relayed to the cNST from the spinal cord, trigeminal and related nuclei, and 
reticular formation (Menétrey and Basbaum, 1987; Arbab et al., 1988; Altschuler et al., 1989; 
Menétrey and dePommery, 1991; deSousaBuck et al., 2001).  
Given the diversity of sensory signals they are positioned to receive, it is not surprising 
that GLP-1 and NA neurons, including PrRP neurons, respond to a broad array of interoceptive 
signals that can suppress food intake and also drive the HPA axis, including hormonal, thermal, 
osmotic, gastrointestinal, cardiovascular, respiratory, and inflammatory signals (Sawchenko and 
Swanson, 1981; Luckman, 1992; Rinaman et al., 1993; Chan and Sawchenko, 1994; Rinaman et 
al., 1997; Chan and Sawchenko, 1998; Rinaman et al., 1998; Dayas et al., 2001b; Hollis et al., 
2004; Rinaman, 2004; Myers et al., 2005; Myers and Rinaman, 2005; Duale et al., 2007; 
Gaykema et al., 2007; Bienkowski and Rinaman, 2008; Kasparov and Teschemacher, 2008; 
Takayanagi et al., 2008; Bonnet et al., 2009; Rinaman, 2010). In these cited studies and many 
others, stimulus-induced “activation” of NA, PrRP, and/or GLP-1 neurons generally is 
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characterized by double immunolabeling to localize nuclear cFos, the protein product of the 
immediate-early response gene, c-fos, together with cytoplasmic proteins identifying the 
chemical phenotype of activated neurons. As a binary index of neural activation, the presence or 
absence of cFos immunolabeling does not index the magnitude or duration of a neuron’s 
presynaptic inputs, or its resulting spike frequency. However, quantitative and regional analyses 
of neural cFos expression permit assessment of stimulus-induced activation across multiple 
populations of phenotypically-identified neurons under control and experimental conditions, 
making it an ideal approach for testing hypotheses regarding neural sensitivity and/or function.  
The collective results of studies utilizing cFos indicate that NA, PrRP, and GLP-1 neurons are 
consistently activated by stimuli that present actual or anticipated threats to bodily homeostasis 
(see below).  
PrRP and GLP-1 neurons participate in reciprocal connections with the medullary 
reticular formation, including the caudal ventrolateral medulla (cVLM), and other regions of the 
pons, diencephalon, and telencephalon that are implicated in food intake and body energy 
balance (Rinaman, 2010; Grill and Hayes, 2012).  Direct descending projections from the cortex, 
limbic forebrain, and hypothalamus to cNST regions where PrRP and GLP-1 neurons reside 
provide a route through which emotional and cognitive events can modulate visceral and 
ingestive responses to diverse threats and opportunities to which the organism is exposed, 
including conditioned responses that are based on past experience (Sawchenko, 1983; Li et al., 
1996; Li and Sawchenko, 1998; Woods and Ramsay, 2000; Dayas and Day, 2001; Taché et al., 
2001; Buller et al., 2003; Dayas et al., 2004; Price, 2005; Blevins and Baskin, 2010).  In turn, 
ascending projections from GLP-1 and NA neurons, including PrRP neurons, provide a route 
through which interoceptive feedback from the gastrointestinal tract and other organ systems can 
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shape hypothalamic and limbic forebrain functions (Sawchenko, 1983; Loewy, 1990; Onaka et 
al., 1995; Blessing, 1997; Rinaman and Schwartz; Onaka et al., 2010). 
 
Beyond the cNST.   
Many reports cited in the present review leave open the possibility that functions ascribed to 
central signaling by PrRP and/or GLP-1 neurons include signaling from neurons located not 
within the cNST, but within the nearby medullary reticular formation. PrRP-positive neurons 
comprise a subset of the cVLM A1 noradrenergic cell group (Chen et al., 1999), whereas GLP-1 
neurons are scattered in regions somewhat dorsal and medial to the A1 cell group (Vrang et al., 
2007; Vrang and Grove, 2011).  However, limited evidence suggests that PrRP and GLP-1 
neurons within the cNST are functionally distinct from those located within the reticular 
formation.  For example, NA and GLP-1 neurons within the cNST receive direct visceral sensory 
input (Appleyard et al., 2007; Hisadome et al., 2011), whereas those in the medullary reticular 
formation do not.  This may explain why A2 NA neurons within the cNST are recruited to 
express cFos in meal-entrained rats that consume a large scheduled meal, whereas cVLM A1 
neurons are not activated (Rinaman et al., 1998). PrRP neurons within the cNST also are 
activated in mice after a single cycle of 24-hr food deprivation followed by re-feeding, whereas 
PrRP neurons in the reticular formation are not (Takayanagi et al., 2008).  In addition, the ability 
of hypoglycemia to increase food intake apparently is mediated by NA neurons within the VLM, 
and not by neurons within the cNST A2 cell group (Li et al., 2009). There is no published 
evidence that GLP-1 neurons within the cNST vs. reticular formation project to different brain 
areas or maintain separate functions, although this possibility should be examined.  It’s relevant 
to note here that non-NA projections from the cNST to the cVLM (Hermes et al., 2006) allow 
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visceral signals to recruit neurons of the A1 cell group (Tucker et al., 1987; Yamashita et al., 
1989; Kawano and Masuko, 1996; Bailey et al., 2006; Hermes et al., 2006), and the axons of 
many A1 neurons (including PrRP-positive neurons) join the ventral noradrenergic ascending 
bundle along with the axons of cNST neurons that project rostrally from the hindbrain 
(Sawchenko and Swanson, 1981, 1982; Chan et al., 1995).  In the absence of specific evidence to 
discriminate between PrRP or GLP-1 neurons within the cNST vs. medullary reticular formation, 
a conservative approach dictates that projections and functions ascribed to chemically distinct 
neurons in either region should be considered likely to be shared by neurons in the other region.   
 
Other neurochemical features of PrRP and GLP-1 neurons.   
PrRP neurons are phenotypically distinguished by mRNA expression and positive 
immunolabeling for PrRP as well as tyrosine hydroxylase (TH), the rate-limiting enzyme for 
dopamine synthesis, together with dopamine beta hydroxylase (DbH), the enzyme that converts 
dopamine to norepinephrine (NE) (Armstrong et al., 1982) (see Figure 20 for colocalization of 
PrRP and DbH immunolabeling within the cNST).  A1 and A2 neurons do not express 
phenylethanolamine N-methyltransferase, the enzyme that converts NE to epinephrine and 
identifies adrenergic neurons of the C1, C2, and C3 cell groups (Dahlström and Fuxe, 1964), 
which do not express PrRP (Morales et al., 2000).  When considering the functional role of PrRP 
neurons and their axonal projections, it’s important to keep in mind that these neurons release 
additional signaling molecules from their axon terminals and varicosities.  In rats, at least 80% of 
A2 neurons express mRNA for a homolog of the vesicular glutamate transporter-2 (Stornetta et 
al., 2002), suggesting that the majority (perhaps all) of PrRP neurons release glutamate along 
with NE and PrRP from their axon terminals. In addition, subpopulations of catecholaminergic 
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NST neurons are immunopositive for neuropeptide Y (Sawchenko et al., 1985; Everitt and 
Hökfelt, 1989), nesfatin-1 (Bonnet et al., 2009), dynorphin (Ceccatelli et al., 1992), neurotensin 
(Riche et al., 1990), and/or pituitary adenylate cyclase-activating polypeptide (Das et al., 2007).  
The extent to which cNST PrRP neurons co-express these additional signaling molecules 
remains unclear.   
After posttranslational processing by the prohormone convertases PC1/3 and PC2, PPG-
expressing neurons generate GLP-1 and several additional peptides for which GLP-1 neurons are 
immunopositive, including GLP-2, glicentin, intervening peptide-2, and oxyntomodulin (Schafer 
et al., 1993; Baggio and Drucker, 2007; Vrang and Larsen, 2010). Indirect evidence suggests that 
beyond PPG-encoded peptides, GLP-1 neurons also are immunopositive for met-enkephalin, 
somatostatin, and inhibin-β (Sawchenko et al., 1988; Sawchenko et al., 1990; Sawchenko and 
Pfeiffer, 1995).  Apparently, none of these signaling molecules are expressed by cNST PrRP 
neurons (because none are expressed by NA neurons), and none of the neuropeptides that 
potentially are co-expressed by PrRP neurons (see previous section) have been localized to GLP-
1 neurons.  Another notable difference exists between PrRP and GLP-1 neurons in their 
expression of leptin receptors (Hay-Schmidt et al., 2001).  Evidence for direct neuronal 
sensitivity to leptin has only been presented by one study, in which leptin directly depolarized 
identified GLP-1 neurons in brainstem slice preparations from transgenic mice (Hisadome et al., 
2010).  In mice, leptin receptor mRNA is expressed by GLP-1 neurons but not by NA or PrRP-
positive cNST neurons (Garfield et al., 2012).  Conversely, in rats, NA (and PrRP) neurons 
express leptin receptor immunolabeling (Ellacott et al., 2002) and exhibit pSTAT3 induction 
after ip leptin administration (Huo et al., 2008), evidence for direct leptin sensitivity.  Rat GLP-1 
neurons do not exhibit pSTAT3 induction after ip leptin (Huo et al., 2008), but it is not known 
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whether rat GLP-1 neurons express leptin receptors. Thus, not only do PrRP and GLP-1 neurons 
appear to display differential leptin sensitivity, their sensitivity appears to be reversed between 
rats and mice.   
 
Brainstem and forebrain targets of PrRP and GLP-1 neurons.   
PrRP and GLP-1 neurons are well-positioned to participate in vago-vagal reflexes that modulate 
gastrointestinal motility, pancreatic hormone release, and other digestive-related autonomic 
processes associated with satiation and stress-induced hypophagia.  GLP-1 and NA neurons, 
including PrRP neurons, project locally within the DVC and medullary reticular formation, and 
also to the spinal cord, comprising a subset of pre-autonomic hindbrain neurons implicated in 
autonomic control of cardiovascular and digestive functions (Fukuda et al., 1987; Rogers et al., 
2003; Martinez-Peña-y-Valenzuela et al., 2004; Hermann et al., 2005; Travagli et al., 2006; 
Duale et al., 2007; Pearson et al., 2007; Llewellyn-Smith et al., 2011; Llewellyn-Smith et al., 
2013).  Pancreatic and gastric vagal motor neurons express GLP-1R in rats (Wan et al., 2007; 
Holmes et al., 2009), and the ability of restraint stress to impact intestinal motility is blocked by 
central GLP-1R antagonism (Gulpinar et al., 2000).  Intra-DVC or 4th ventricular microinjection 
of PrRP or GLP-1 has pronounced effects on vagally-mediated gastric motility, and results from 
in vitro slice preparations suggest that PrRP regulates gastric motor function by modulating the 
efficacy of excitatory synaptic inputs to vagal motor neurons (Grabauskas et al., 2004).   
Axons and varicosities arising from PrRP and GLP-1 neurons also occupy regions of the 
spinal cord and pontine and medullary reticular formation that contain the pattern generators, 
pre-motor neurons, and motor neurons that control ingestive consummatory behaviors (i.e., 
licking/chewing/swallowing) (Norgren, 1978; Travers et al., 1997; Chen et al., 2001; Yano et al., 
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2001; Grill and Kaplan, 2002; Travers and Rinaman, 2002; Chen and Travers, 2003; Grill, 
2010).  Thus, PrRP and/or GLP-1 neurons may control the behavioral output of ingestive circuits 
to thereby induce or shape satiation and stress-induced hypophagia (Figure 21).  Additional 
support comes from a transneuronal viral tracing study demonstrating that cNST neurons provide 
synaptic input to oral pre-motor or motor neurons (Travers and Rinaman, 2002) with 
demonstrated importance for feeding control (Travers et al., 1997; Travers et al., 2010).  It 
remains to be determined whether PrRP and GLP-1 neurons are among the cNST neurons that 





Figure 21. Summary schematic of our working hypothesis 
Summary schematic of our working hypothesis.  Cognitive stressors originate from conditioned and unconditioned 
cues that are processed through the cortex, hippocampus, and/or limbic forebrain before engaging the HPA axis and 
cNST.  Visceral stressors typically are unconditioned stimuli that first engage cNST neurons (including PrRP and 
GLP-1 neurons) that innervate hypothalamic and limbic forebrain targets to recruit the HPA axis.  Neurons within 
the cNST engage brainstem targets to organize ingestive motor output.  
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Dual-labeling retrograde tracing and fiber lesion studies indicate that NA neurons, 
including PrRP-positive neurons, and GLP-1 neurons also project to multiple higher brain 
regions implicated in behavioral and physiological components of food intake (Morales et al., 
2000; Renner et al., 2010; Rinaman, 2010, 2011; Renner et al., 2012).  PrRP- and GLP-1-
positive fibers have been localized to every medullary, pontine, mesencephalic, diencephalic, 
and limbic forebrain region that receives axonal input from the cNST.  Subsets of A2 neurons, 
presumably including PrRP neurons, have axon collaterals that innervate two or more forebrain 
targets (Petrov et al., 1993; Banihashemi and Rinaman, 2006; Schiltz and Sawchenko, 2007; 
Bienkowski and Rinaman, 2008). One study reported that 11-20% of hindbrain GLP-1 neurons 
were retrogradely labeled after either PVN or DMH tracer injections, but relatively few (i.e., 15-
25%) of the tracer-labeled neurons projected to both hypothalamic nuclei (Vrang et al., 2007).  
On the other hand, 30-40% of all hindbrain GLP-1 neurons reportedly innervate the midbrain 
ventral tegmental area (VTA) or the ventral striatal nucleus accumbens (NAcc) (Alhadeff et al., 
2012), indicating that subsets of GLP-1 neurons probably send collateralized axonal projections 
to multiple brain regions.   Some individual A2 neurons have axons that collateralize to regions 
of the medullary reticular formation as well as to the limbic forebrain (Reyes and Bockstaele, 
2006).  Interestingly, however, individual A2 neurons appear to target either the pons or the 
VLM, but not both (Hermes et al., 2006), suggesting a higher degree of anatomical specificity 
for projections within the brainstem vs. projections to the hypothalamus and limbic forebrain.   
Regarding hypothalamic projections, of particular relevance to the present review is 
evidence that PrRP and GLP-1 axonal projections target the medial parvocellular subregion of 
the paraventricular nucleus of the hypothalamus (mpPVN), where they form synaptic contacts 
with corticotropin releasing hormone (CRH)-positive neurons (Liposits et al., 1986a; Matsumoto 
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et al., 2000; Sarkar et al., 2003b) at the apex of the HPA axis.  CRH is the principal and obligate 
hypophysiotropic peptide driving the HPA axis under basal conditions and in response to 
homeostatic challenge (Plotsky et al., 1989; Watts, 1996), and PrRP acts synergistically with NE 
to activate CRH neurons and the HPA axis (Maruyama et al., 2001; Seal et al., 2002; Uchida et 
al., 2010).  Lesions that decrease NA input to the mpPVN markedly attenuate CRH neuronal 
cFos activation responses to interoceptive signals (Li et al., 1996; Fraley and Ritter, 2003; 
Rinaman, 2003a; Ritter et al., 2003; Rinaman and Dzmura, 2007; Schiltz and Sawchenko, 2007; 
Bienkowski and Rinaman, 2008).  Central administration of PrRP or GLP-1 activates cFos in the 
large majority of CRH-positive mpPVN neurons, and also increases plasma levels of 
corticosterone (Turton et al., 1996; Rowland et al., 1997; Kinzig et al., 2003; Mera et al., 2006). 
Although these cFos results by themselves do not prove that CRH neurons are activated directly 
by PrRP, NE, or GLP-1 receptor-mediated stimulation, bath application of GLP-1 to mouse 
hypothalamic slices increase spike frequency in a majority of PVN neurons (Acuna-Goycolea et 
al., 2004).  Evidence for a mediating role of endogenously released GLP-1 comes from 
experiments demonstrating that the ability of stress to activate the HPA axis is markedly 
attenuated in rats after third ventricular administration of a GLP-1 receptor (GLP-1R) antagonist 
(Kinzig et al., 2003).  Interestingly, however, GLP-1R -/- mice display paradoxically increased 
plasma corticosterone levels in responses to acute stress (MacLusky et al., 2000), suggesting that 
one role of endogenous GLP-1R signaling (at least in mice) may be to restrain or limit stress 
hormone secretion.  This is consistent with the idea that GLP-1 signaling may serve a protective 
role to limit stress responses in the face of threat, e.g., to limit fever after immune challenge 
(Rinaman and Comer, 2000), and perhaps to guard against the overconsumption of unanticipated 
and/or excessively large meals. 
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As discussed in the Introduction, the HPA axis is activated by real or perceived 
homeostatic threats, including ad libitum (ad lib) or deprivation-induced food intake.  By virtue 
of their synaptic inputs to CRH neurons, we hypothesize that PrRP and GLP-1 neurons may 
drive HPA axis responses to food intake, because PrRP and GLP-1 neurons drive HPA axis 
responses to some (but not all) experimental stressors (Rinaman, 2010, 2011).7  In the mature, 
intact brain, PrRP and GLP-1 neurons innervate not only brainstem but also hypothalamic and 
limbic forebrain regions that control parallel autonomic, endocrine, and behavioral aspects of 
satiation and stress-induced hypophagia.  In this regard, we view HPA axis activation as 
occurring in parallel with, but relatively independent from, the brainstem-mediated behavioral 
processes of satiation and hypophagia, which do not depend on neural connections between the 
brainstem and forebrain (Grill and Norgren, 1978; Hall and Bryan, 1980; Hall and Swithers-
Mulvey, 1992; Rinaman et al., 1994; Seeley et al., 1994; Grill and Kaplan, 2002). The following 
section reviews evidence that PrRP and GLP-1 signaling pathways participate in satiation, and 
the final section reviews evidence that similar signaling pathways contribute to stress-induced 
hypophagia. 
B.3 POTENTIAL ROLE OF PRRP AND GLP-1 NEURONS IN SATIATION 
To examine whether endogenous NA and/or GLP-1 signaling pathways contribute to normal 
feeding-induced satiation, a few studies have examined whether phenotypically identified NA or 
GLP-1 neurons within the cNST, the former presumably including PrRP-positive neurons, are 
                                                 
7 HPA axis recruitment by PrRP and GLP-1 signaling pathways is discussed further below.   
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differentially activated to express cFos in rats that have recently consumed a large satiating meal, 
a smaller non-satiating meal, or no meal (Rinaman et al., 1998; Rinaman, 1999b; Gaykema et al., 
2009; Kreisler and Rinaman, 2012).  In other studies, pharmacological and genetic manipulations 
have been used to investigate whether rats or mice consume more food when the central 
receptor-mediated effects of endogenously released PrRP or GLP-1 are attenuated or eliminated 
[e.g., (Schick et al., 2003; Takayanagi et al., 2008; Hayes et al., 2009; Barrera et al., 2011; 
Dossat et al., 2011; Alhadeff et al., 2012; Dickson et al., 2012)].  These general experimental 
approaches are among the best currently available for testing hypotheses about the endogenous 
central neural underpinnings of satiation and/or stress-induced hypophagia.  However, the results 
of such studies must be interpreted within their own unique experimental context, with particular 
attention paid to the feeding paradigm utilized and any requisite surgical manipulations and 
handling.   
 
Feeding-induced activation of PrRP and GLP-1 neurons.   
In the absence of experimental manipulations, the cNST displays very low levels of neuronal 
cFos expression in ad lib-fed (presumably satiated) adult rats that are killed during the first few 
hours of the light cycle.  Under such conditions, identified PrRP and NA neurons rarely express 
cFos in rats or mice (Takayanagi et al., 2008; Maniscalco et al., 2012). Conversely, in alternate 
tissue sections from the same satiated rats, approximately 20% of identified GLP-1 neurons 
express cFos (Maniscalco et al., 2012).  This moderate level of “baseline” GLP-1 activation is 
markedly reduced (i.e., from ~20% to less than 4%) if rats are not allowed to eat for 16-24 hours 
before sacrifice (Kreisler and Rinaman, 2012; Maniscalco et al., 2012).  Insofar as neuronal 
sensitivity is revealed by cFos labeling, these findings suggest that GLP-1 neurons are more 
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sensitive than PrRP neurons to signals associated with post-prandial satiety in non-manipulated, 
ad lib-fed rats.   Post-prandial satiety signals, which may be distinct from signals that promote 
satiation within a meal, could include gastrointestinal/colonic distension, post-absorptive 
nutrient levels, and circulating factors such as GLP-1, leptin, insulin, or ghrelin, for which 
plasma levels differ significantly in satiated rats and mice compared to levels measured after 
food deprivation (Mizuno et al., 1999; Kmiec et al., 2005; Kmiec et al., 2006; Johansson et al., 
2008). 
Under ad lib feeding conditions, laboratory rats typically maintain their body weight by 
consuming a large number (e.g., 10-15) of small meals each day, with ~80% of daily food intake 
occurring nocturnally, and the largest meals predictably consumed near the beginning and end of 
the dark phase of the photoperiod (Kissileff, 1970; Strubbe et al., 1986; Collier and Johnson, 
1990; Woods, 2002).  With few exceptions, published studies examining central cFos responses 
to feeding-induced signals use paradigms in which rats are acclimated over the course of several 
days or longer to a repeating schedule of food deprivation followed by re-feeding, in order to 
train them to voluntarily consume a meal that is unusually large compared to the typical size of 
an ad lib meal.  Over the course of a week or two, through a Pavlovian process of classical 
conditioning, the animal learns to anticipate how much food can be safely consumed during the 
re-feeding period (including the approximate caloric and macronutrient composition of the 
meal) as it learns to initiate appropriately-timed cephalic phase responses (e.g., increased insulin 
release, gastric relaxation, digestive enzyme secretion) to ensure that larger meals can be safely 
consumed (Woods and Ramsay, 2000; Woods, 2002).  As pointed out in the Introduction (1.0), 
these anticipatory adjustments are vitally important, because the energetic benefits of eating are 
counterbalanced by the energetic cost of homeostatic challenge (Woods, 1991, 2002).  
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Progressive meal-induced recruitment of visceral sensory “satiety” signals from the 
gastrointestinal tract to the hindbrain serve to constrain meal size during both ad lib and 
scheduled meal feeding, thereby limiting the stressful effects of food intake (Smith, 1998; 
Woods, 2002) through a process termed “meal tolerance” (Woods and Ramsay, 2000).   
When experimentally naïve rats are food deprived for 24 hr and then re-fed for the very 
first time on chow or palatable liquid diet early in the dark cycle, both NA and GLP-1 neuronal 
populations are activated to express cFos in direct proportion to the gastric distension produced 
by the meal (Kreisler and Rinaman, 2012), suggesting that both PrRP and GLP-1 neurons might 
contribute to meal-induced satiation in this experimental context.  Although the PrRP-positive 
subpopulation of NA neurons has not yet been examined for feeding-induced activation in rats, 
first-time re-feeding after a 24-hr fast does activate PrRP neurons in experimentally naïve mice 
(Takayanagi et al., 2008).  After several days of acclimation to a repeating schedule of overnight 
food deprivation followed by a predictable solid or liquid morning meal, rats voluntarily 
consume an even larger amount, and cNST NA neurons, presumably including PrRP neurons, 
still are acutely activated in proportion to the gastric distension produced by the meal (Rinaman 
et al., 1998).  However, in the same rats, GLP-1 neurons are not activated (Rinaman, 1999b).  
Considered together, these findings suggest that NA and PrRP neurons contribute to meal-
induced satiation in both experimental contexts, whereas GLP-1 neurons adapt or acclimate to 
signals such as gastric distension, elevated blood glucose, or insulin secretion that are 
predictably generated by a large scheduled meal.  Indeed, the hypothesized acclimation of GLP-
1 neurons during scheduled meal feeding may be part of the Pavlovian process through which 
meal-entrained rats learn to tolerate the stress of consuming larger meals.  In other words, a lack 
of GLP-1 neuronal recruitment may represent attenuation or removal of a “brake” on intake that 
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would otherwise constrain meal size via engagement of GLP-1 receptors in the caudal 
brainstem, which reduces meal size (Hayes et al., 2008; Grill and Hayes, 2009; Hayes et al., 
2009).  If so, then GLP-1 neural recruitment by food intake in rats that are food-deprived and 
then re-fed for the very first time may help explain why these rats consume a smaller meal 
compared to acclimated, meal-entrained rats.    
 
Increased food intake after pharmacological blockade of endogenous PrRP and GLP-1 
signaling.   
There currently are no available pharmacological tools with which to antagonize PrRP 
(hGR3/GPR10) receptors.  However, central administration of a monoclonal anti-PrRP antibody 
in rats was reported to increase meal size but not meal frequency, and to increase total food 
intake compared to the effects of a control antibody (Takayanagi et al., 2008).  These results 
support the hypothesis that endogenous PrRP signaling participates in meal-induced satiation, 
but it is unclear where in the brain the proposed signaling occurs or whether satiation can be 
attributed to hindbrain populations of PrRP neurons as opposed to those located in the 
dorsomedial hypothalamus.  It also is unclear whether meal size and total food intake measured 
in control rats after central injection of control antibody was reduced compared to similar 
measures in non-manipulated rats.  The importance of including non-manipulated controls is 
discussed further, below.  
Central GLP-1 signaling can be effectively disrupted by central administration of 
Exendin-9 (Ex-9), a specific GLP-1R antagonist.  Daily intraventricular administration of Ex-9 
produces daily increases in food intake compared to intake by rats after vehicle administration 
(Barrera et al., 2011), although it’s not clear whether this effect depends on increased meal size 
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(supporting a role in satiation), meal frequency (supporting a role in appetite/motivation), or 
both.   Parenchymal administration of Ex-9 into subregions of the mesolimbic reward system, 
i.e., the VTA or NAcc, increases short-term intake of chow, palatable high fat diet, and sucrose 
in rats (Dossat et al., 2011; Alhadeff et al., 2012; Dickson et al., 2012), suggesting that GLP-1 
signaling in these regions may normally act to suppress reward-driven intake.  Ex-9 targeted to 
the lateral hypothalamus enhances short-term food intake in ad lib-fed rats, but has no effect on 
food intake in 24-hr food deprived rats (Schick et al., 2003), perhaps because intake in deprived 
rats already is quite high.  Conversely, Ex-9 injections targeted to the 4th ventricle or cNST 
increase the amount of food consumed by rats after gastric distension, but not after intestinal 
nutrient infusions (Hayes et al., 2009).  Results from these studies support the view that 
endogenous GLP-1 signaling suppresses or limits food intake across a variety of experimental 
conditions, and the cNST/hindbrain may be an especially sensitive site of action for this effect 
(Grill and Hayes, 2012).  Indeed, the hypothalamus and forebrain are not required for the ability 
of GLP-1 signaling to suppress gastric emptying and food intake in rats, as these responses are 
preserved in chronic supracollicular decerebrate rats (Hayes et al., 2008). 
 A potential interpretational problem in the studies cited above is the typical comparison 
of data from surgically-manipulated and/or drug-infused rats with data from control rats 
subjected to sham surgery and/or infused with vehicle.  While these are appropriate 
experimental controls, they are incomplete.  The manipulations employed in these studies are 
often complex, requiring one or more surgical sessions (e.g., to equip animals with chronic brain 
cannulas or intravenous catheters), and acute handling for central or systemic drug injection.  
Such manipulations are themselves likely to promote some degree of stress-induced hypophagia, 
such that “baseline” food intake measured in animals after central or systemic vehicle treatment 
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may be less than intake that would be observed under non-manipulated conditions. Accordingly, 
the ability of centrally administered Ex-9 or anti-PrRP antibody to increase food intake could be 
interpreted as evidence that central GLP-1 or PrRP signaling attenuates stress-induced 
hypophagia.  Some experiments have attempted to address this issue by pre-exposing animals to 
experimental handling and drug infusion conditions in order to habituate them to the potentially 
stressful aspects of those conditions.  However, results in “habituated” animals rarely are 
compared to results obtained in non-manipulated animals, making it unclear whether or how the 
habituation procedure affected results.  It will be important for future studies to include 
additional comparative data from non-manipulated controls. 
 
Increased food intake after genetic manipulation of PrRP and GLP-1 signaling.  
To better understand the role of endogenous GLP-1 signaling in satiation and long-term energy 
balance, one research group used a knockdown strategy in which short hairpin RNA was 
microinjected into the cNTS of adult rats to suppress endogenous PPG expression; this produced 
a significant and long-lasting increase in daily food intake and body weight compared to control 
rats (Barrera et al., 2011).  However, it might be argued that the brainstem surgery itself in that 
study had a marked and long-lasting effect to reduce food intake and body weight growth, and 
that knockdown of PPG expression merely attenuated the deleterious effects of surgery.   
Evidence challenging a physiological role for GLP-1 signaling in daily food intake control 
comes from research using GLP-1R -/- mice, which are lean and consume a similar number of 
daily calories compared to wild-type mice (Scrocchi et al., 1996).  In considering this apparent 
discrepancy in results, a recent review (Vrang and Larsen, 2010) pointed out that GLP-1R -/- 
mice display an apparent disturbance in satiation, such that termination of food intake is delayed 
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early in the dark period, thereby prolonging the initial nocturnal meal.  This is followed by a later 
suppression of intake to achieve caloric compensation [see Figure 5A in (Scrocchi et al., 2000)].   
GPR10 (PrRP receptor)-deficient mice display hyperphagia under ad lib feeding 
conditions, but not in a one-time 16 hr fasting/re-feeding protocol (Gu et al., 2004).  In addition, 
GPR10 is required for the ability of exogenously administered PrRP and CCK to inhibit food 
intake in mice (Bechtold and Luckman, 2006). PrRP-deficient mice also display hyperphagia and 
increased body weight when maintained either on normal chow or on a high-fat diet (Mochiduki 
et al., 2010). In another study, PrRP-deficient mice displayed increased meal size (but not 
frequency) under ad lib feeding conditions, increased intake after deprivation, and reduced 
responsiveness to the feeding-suppressive effects of exogenous cholecystokinin octapeptide 
(CCK) and leptin (Takayanagi et al., 2008), which endogenously function as satiety signals.  
Interestingly, a polymorphism in the GPR10 gene that abolishes binding of PrRP in brain slices 
does not affect the ability of exogenously administered PrRP to suppress food intake in rats 
(Ellacott et al., 2005), suggesting that the hypophagic effects of the endogenous peptide could 
also be mediated through another, as yet unidentified, receptor signaling mechanism in rats.  
Additional studies will be required to examine this issue.  However, there is compelling evidence 
that a natural mutation of the GPR10 receptor (in addition to mutation of CCK-1 receptors) in the 
Otsuka Long-Evans Tokushima Fatty (OLETF) rat underlies its obese phenotype, and OLETF 
rats are insensitive to the hypophagic effects of exogenously administered PrRP (Watanabe et al., 
2005). 
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B.4 POTENTIAL ROLE OF PRRP AND GLP-1 NEURONS IN STRESS-INDUCED 
HYPOPHAGIA 
To the extent that it has been examined, GLP-1, PrRP, and NA neurons within the cNST express 
cFos in every experimental situation in which food intake is acutely inhibited and the HPA axis 
is activated (Bouton and Bolles, 1980; Callahan and Rinaman, 1998; Rinaman et al., 1998; 
Rinaman, 1999b, 2003a; Vrang et al., 2003; Zhu and Onaka, 2003; Onaka, 2004; Rinaman, 
2004; Mera et al., 2006; Gaykema et al., 2007; Gaykema et al., 2008; Bonnet et al., 2009; 
Gaykema et al., 2009; Jelsing et al., 2009; Uchoa et al., 2009; Rinaman, 2010).  As if to 
emphasize the close relationship between brainstem neural recruitment and endocrine responses 
to hypophagic stressors, systemically administered amylin reduces meal size but does not 
activate NA or GLP-1 neurons, and amylin does not activate the HPA axis (meaning it is not 
stressful) (Potes and Lutz, 2010).  Acute stressors that activate cNST NA and GLP-1 neurons, 
inhibit food intake, and activate the HPA axis also inhibit gastric emptying, likely via direct or 
indirect NA-, PrRP-, and GLP-1-mediated effects on autonomic outflow (Callahan and Rinaman, 
1998; Hellstrom and Naslund, 2001; Rinaman, 2003a; Rogers et al., 2003; Grabauskas et al., 
2004; Rinaman, 2004; Nakade et al., 2006; Balcita-Pedicino and Rinaman, 2007; Seto et al., 
2008; Hayes et al., 2009).  
States of threatened homeostasis are met by a complex but generally predictable 
repertoire of physiological and behavioral stress responses (Chrousos, 1998; Kyrou and Tsigos, 
2009), including suppression of food intake (Dess and Vanderweele, 1994; Calvez et al., 2011).  
Stress responses are adaptive in the short term, because they shift the allocation of behavioral 
and physiological resources away from procuring and storing energy, and towards mobilizing 
energy and altering behavior to cope with the homeostatic threat.  Experimental stressors are 
 195 
diverse in nature and magnitude, but can be categorized as either visceral (a.k.a. 
interoceptive/physiological), or cognitive (a.k.a. neurogenic/psychological). Visceral stressors 
typically comprise unconditioned stimuli that present a direct challenge to physiological 
homeostasis, such as dehydration, toxemia, infection, or gastrointestinal stimulation.  Their 
ability to activate the HPA axis largely depends on direct and relayed projections from spinal and 
hindbrain viscerosensory neurons to CRH neurons within the mpPVN, including projections 
from PrRP and GLP-1 neurons (Figure 21).  Cognitive stressors originate from conditioned and 
unconditioned cues that are processed through the cortex and hippocampus before engaging the 
limbic forebrain and hypothalamus (Figure 21).  Cognitive stressors in rats and mice include 
predator cues, open illuminated spaces, restraint/immobilization, and conditioned stimuli 
previously associated with an interoceptive or cognitive stressor.  Thus, cognitive stressors 
predict an impending challenge to homeostasis, including the challenge of a large meal, which 
can be a visceral stressor.  At least some cognitive stressors (i.e., mild footshock and restraint) do 
not require hindbrain inputs to the mpPVN in order to activate the HPA axis. However, GLP-1, 
PrRP, and NA neurons are activated by these and other cognitive stressors (Li et al., 1996; 
Morales and Sawchenko, 2003; Zhu and Onaka, 2003; Maniscalco et al., 2012), likely due to 
recruitment of descending inputs to the cNST that arise from stress-sensitive regions of the 
hypothalamus and limbic forebrain (Dayas and Day, 2001; Buller et al., 2003; Dayas et al., 2004; 
Blevins and Baskin, 2010) (Figure 21).  Our working hypothesis is that, similar to satiation, 
stress-induced hypophagia depends on the recruitment of PrRP and GLP-1 neurons that 
participate in stressor-induced decreases in meal size (Morley et al., 1985).  We propose that 
PrRP and GLP-1 neurons participate in satiation and stress-induced hypophagia regardless of 
whether these neurons are recruited directly via interoceptive/viscerosensory inputs to the cNST, 
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or indirectly via descending projections from the hypothalamus and limbic forebrain (Figure 21).  
However, the potential role of PrRP or GLP-1 neurons in mediating stress-induced hypophagia 
has thus far been examined in only a small number of experimental models.  The following 
paragraphs highlight these relatively limited findings, which cumulatively support the view that 
the ability of stressors to recruit PrRP and/or GLP-1 neurons contributes importantly to their 
ability to suppress food intake. 
 
Cholecystokinin octapeptide.   
CCK was the first peptide hormone proposed to act as a physiological within-meal satiety signal 
(Gibbs et al., 1973).  Endogenous CCK is released from the upper intestine by nutrient 
stimulation during and after a meal, binding to peripheral CCK receptors to thereby increase the 
activity of glutamatergic vagal sensory inputs to the cNST (Bednar et al., 1994).  Without 
challenging the role of endogenous CCK as a satiety factor, synthetic CCK also has been used as 
a pharmacological tool to activate central neural circuits that respond to gastric vagal stimulation.  
Such studies have demonstrated that systemic CCK dose-dependently decreases meal size (West 
et al., 1984) and elicits cFos activation of cNST neurons (Zittel et al., 1999), including NA 
neurons (Maniscalco et al., 2012) that presumably co-express PrRP .  Moderate to high doses of 
CCK (i.e., 10-100 µg/kg BW) activate GLP-1 and NA neurons, including PrRP neurons 
(Luckman, 1992; Rinaman et al., 1993; Rinaman et al., 1995; Verbalis et al., 1995; Lawrence et 
al., 2002; Bechtold and Luckman, 2006; Babic et al., 2009) that project to the PVN (Rinaman et 
al., 1995) and activate CRH and oxytocin neurons (Verbalis et al., 1991).  Systemic CCK at 
doses of ~1-3 µg/kg BW, which many researchers would argue are within the physiological 
range, are “stressful” in that they elevate plasma levels of adrenocorticotropic hormone (ACTH) 
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in rats (Kamilaris et al., 1992); higher CCK doses produce larger HPA axis responses.  CCK 
delivered at a lower dose (i.e., 0.5 µg/kg BW) does not activate the HPA axis (Kamilaris et al., 
1992). Although hypophagic effects of lower doses of CCK (i.e., ≤ 0.5μg/kg BW) have been 
reported using various systemic routes of administration and dietary conditions, to our 
knowledge there are no reports of parallel HPA axis activation under these conditions.  As the 
hypothalamus and the entire forebrain are unnecessary for the ability of CCK to inhibit intake 
(Grill and Smith, 1988), it follows that HPA axis activation also is unnecessary for CCK-induced 
hypophagia.  However, in the absence of evidence indicating otherwise, exogenous CCK-
induced hypophagia appears to be accompanied by HPA axis activation, presumably because 
exogenous CCK activates hindbrain neurons that inhibit food intake and neurons that activate 
hypothalamic CRH neurons. 
A2 neurons, including PrRP neurons, are necessary for the ability of a moderate to high 
dose of CCK to reduce meal size, and also are necessary for CCK-induced activation of neurons 
within the PVN (Rinaman, 2003a).  Interestingly, DbH -/- mice (which cannot convert dopamine 
to NE) show no deficiencies in the ability of CCK to reduce food intake (Cannon and Palmiter, 
2003), suggesting that PrRP rather than NE is the principal mediator of CCK-induced 
hypophagia, at least in mice.  Indeed, a later study confirmed that PrRP signaling is necessary for 
the ability of exogenous CCK to suppress food intake in mice (Bechtold and Luckman, 2006).  
CCK activates cFos expression by GLP-1 neurons (Maniscalco & Rinaman, 2012; Rinaman, 
1999), but GLP-1 neuronal recruitment appears to be insufficient to support CCK hypophagia in 
rats with A2 neuronal loss, which would include loss of cNST PrRP neurons (Rinaman, 2003a). 
However, there are no published reports indicating whether GLP-1R signaling is necessary for 
CCK-induced hypophagia in either rats or mice.  
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Lithium Chloride (LiCl).   
Peripheral administration of the nauseogenic agent LiCl, an experimental model of toxemia, 
potently increases plasma corticosterone and inhibits food intake in rats (McCann et al., 1989).  
Unlike satiation, LiCl reduces food intake in rats by reducing feeding frequency, without 
reducing meal size (West et al., 1987).  While LiCl treatment activates cFos within A2 and GLP-
1 neurons in rats and mice (Rinaman, 1999a, b; Lachey et al., 2005; Rinaman and Dzmura, 
2007), one report indicates that a hypophagic dose of LiCl in rats does not activate the PrRP-
positive subpopulation of A2 neurons (Lawrence et al., 2002).   This result suggests that LiCl 
suppresses food intake through non-PrRP signaling pathways, and that only stimuli related to 
normal satiation are sufficient to recruit PrRP neurons, as hypothesized previously (Luckman 
and Lawrence, 2003). Pharmacological blockade of central GLP-1 receptors or selective lesions 
that destroy A2 neurons, likely including PrRP neurons, attenuates (but does not abolish) the 
ability of LiCl to inhibit food intake in rats (Rinaman, 1999a; Seeley et al., 2000; Kinzig et al., 
2002; Rinaman and Dzmura, 2007), and central GLP-1R antagonism blunts LiCl-induced 
activation of the HPA axis (Kinzig et al., 2003).  Central GLP-1R antagonism also decreases 
LiCl-induced cFos in the rat cNST (Thiele et al., 1998a), evidence that GLP-1R signaling 
contributes to LiCl-induced recruitment of cNST neurons. Conversely, although LiCl activates 
GLP-1 neurons in mice, neither GLP-1R antagonism in wild type mice nor the absence of GLP-
1R signaling in GLP-1R -/- mice attenuates the hypophagic effects of LiCl (Lachey et al., 2005).  
These disparate findings in rats and mice suggest important species differences in the role of 
GLP-1 signaling in responses to toxemia and other nauseogenic treatments.   
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Immune challenge.    
Experimental models of infection, including systemic lipopolysaccharide (LPS; the major outer 
membrane component of gram-negative bacteria), promote the release of pro-inflammatory 
cytokines, elevate plasma levels of ACTH and corticosterone (Sapolsky et al., 1987; Hansen et 
al., 2000; Serrats and Sawchenko, 2006), and dose-dependently suppress food intake (Uehara et 
al., 1989; Kaneta and Kusnecov, 2005). Bacterial infections, LPS administration, and cytokines 
drive central stress responses via receptors located on vagal afferent terminals (Watkins et al., 
1995; Fleshner et al., 1998; Goehler et al., 1999; Hosoi et al., 2005) and/or on endothelial and 
perivascular cells (Sawchenko et al., 2000; Zhang and Rivest, 2003), and signaling through both 
routes engages cNST neurons.  LPS administered into the brain ventricles in rats reduces food 
intake primarily by reducing meal size (Plata-Salaman and Borkoski, 1993).  Conversely, 
systemic administration of LPS reduces intake by reducing meal frequency (Langhans et al., 
1990; Langhans et al., 1993), suggesting that central and peripheral routes of administration 
engage different feeding control circuits.  Systemic LPS increases hindbrain PrRP gene 
expression (Mera et al., 2006), and activates A2 neurons, GLP-1 neurons, and PVN neurons to 
express cFos (Rinaman, 1999b).  PVN and HPA axis activation in response to immune challenge 
is significantly attenuated in rats after unilateral transection of ascending projections from the 
cNST to the PVN that interrupt both PrRP and GLP-1 signaling pathways (Li et al., 1996), or by 
selective neurochemical lesions of NA neurons (likely including PrRP neurons) that innervate 
the PVN (Bienkowski and Rinaman, 2008).  Grill and colleagues (Grill et al., 2004) 
demonstrated that LPS-induced hypophagia is dependent on hindbrain, but not forebrain, GLP-
1R signaling.  However, hypophagic (and HPA axis) responses to LPS are intact in GPR10 -/- 
mice (Bechtold and Luckman, 2006), evidence that PrRP signaling is unnecessary for stress-
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induced hypophagia in this species. Taken together, these studies suggest that the hypophagic 
and HPA axis responses to bacterial infection and proinflammatory cytokines depend in large 
part on the recruitment of NA and GLP-1 neurons, while the role of PrRP signaling has been 
challenged in mice, and not yet explored in rats.  
 
Immobilization/restraint 
One of the most commonly used models of cognitive stress is physical restraint, which activates 
the HPA axis and suppresses food intake (Rybkin et al., 1997; Kinzig et al., 2008; Seto et al., 
2008; Calvez et al., 2011).  A recent study investigated whether restraint and forced swim stress 
inhibited food intake in rats by reducing meal size, meal number, or both.  Similar to satiation, 
restraint and forced swim stress both reduced food intake by reducing meal size and duration 
(Calvez et al., 2011), supporting the view that these stressors engage circuits that also are 
engaged by satiety signals.  Restraint increases PrRP gene expression (Mera et al., 2006) and 
also activates cFos in NA neurons, including PrRP neurons (Dayas et al., 2001b; Dayas et al., 
2001a; Maruyama et al., 2001; Banihashemi et al., 2011), apparently via descending projections 
from the PVN (Dayas and Day, 2001; Dayas et al., 2004).  Recent findings in our laboratory 
indicate that restraint also activates GLP-1 neurons in rats (Maniscalco et al., 2012).  The ability 
of restraint to inhibit food intake is closely linked to its ability to inhibit vagally-mediated gastric 
emptying (Seto et al., 2008; Suzuki and Hibi, 2010).  However, it currently is unknown whether 
the ability of restraint or any other cognitive stressor to decrease gastric emptying and food 
intake depends on central PrRP or GLP-1 receptor signaling. 
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B.5 CONCLUSION 
Stress affects both food intake and energy balance, and food intake can itself be stressful 
(Woods, 1991).  For the purpose of this review, we set out to gather and interpret experimental 
evidence that satiety signals and stress engage a common set of neurons that contribute to the 
inhibition of food intake. Hindbrain PrRP and GLP-1 neurons satisfy many of the criteria that 
one might consider important for such a common set of neurons.  Both neuronal populations are 
recruited to express cFos in animals exposed to satiety signals and many hypophagic stressors, 
and PrRP and GLP-1 signaling pathways impact body energy balance by reducing food intake 
and activating the HPA axis.  Based on our review of the available literature, we propose that 
hindbrain PrRP and GLP-1 neurons represent important points of central integration in the 
control of energy intake and metabolism during feeding and in response to other acute 
homeostatic challenges.  We do not argue that PrRP and GLP-1 neurons are the only important 
players in these coordinated processes.  Instead, we present this evidence to establish a working 
hypothesis about the unique role played by these cNST neurons within the anatomically broad 
and complex neural systems that regulate energy homeostasis on a day-to-day basis.  
Experimental predictions arising from this hypothesis will be challenged by ongoing and future 
work in our laboratory. 
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